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Abstract 
 
he extracellular matrix of bone has been described as a composite material made  
constituted by collagen type I fibrils mineralized with nanocrystals of hydroxyapatite. 
Approximately 70% of bone by weight is composed of calcium salts, with hydroxyapatite 
Ca10(PO4)6(OH)2 as the primary mineral constituent. Bone formation occurs in two phases: 
matrix synthesis followed by extracellular mineralization. An impaired balance of bone 
resorption and formation by osteoclasts and osteoblasts, respectively, induces osteoporosis. 
Other bone defects can be caused by tumor removal, fractures (especially in the hip, wrist, knee 
and spine) or congenital defects. A more complex substrate is represented by osteochondral 
tissue, where defects penetrate the subchondral bone.  
To mimic natural structure, we propose different approaches to repair bone and osteochondral 
defects and to promote a potential bone healing filler. 
In general, injectable materials (cements/natural polymer) hold great promise in tissue 
engineering applications due to the ability of these systems to conform to complex bone shapes, 
contours, and defects with less invasive surgery. The target is the osteogenic differentiation 
induced by bioactive component  (natural polymers and/or modified hydroxyapatite) of the 
injectable systems. In this work, we proposed the following bone filler materials: 
1. Strontium-substituted hydroxyapatite cement (to contrast bone resorpsion). 
2. Bioactive hydroxyapatite - graphene oxide (to support high viability and osteogenic 
differentiation of  hMSC cells).    
3. Modified-cellulose hydrogels crosslinked by citric acid (to increase hydrophilicity and 
roughness surface in order to stimulate osteogenic differentiation of hMSC). 
 
Osteocondral region has two distinct tissues (bone and cartilage) with different properties: to 
mimic its structure, we realized two different gelatin  scaffolds biomineralized by HA. The use of 
a 3D scaffold depends on the necessity to provide a shape control, while the biological signals 
are induced by HA presence, realized by bulk sol-gel transition, and surface biomimetic 
treatment, as reported in the two type of scaffolds realized: 
1. Gelatin scaffold crosslinked by EDC solution, and biomineralized by modified Kokubo 
treatment (to increase  osteogenic proliferation and differentiation); 
T 
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2. Gelatin/hydroxyapatite scaffold realized by in situ sol-gel synthesis and crosslinked by 
EDC solution (where the biological signals occur into the scaffold as a gradient and 
crystalline degree is modulated by gelatin/hydroxyapatite ratio). 
 
The results are confirming the feasibility of the proposed systems a potential substitutes/scaffolds 
for both bone an osteochondral tissue regeneration. 
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INTRODUCTION  
 
Cartilage and bone injuries occur due to several reasons including degenerative, surgical, and 
traumatic processes, which significantly compromise quality of life and for this reason, they have 
long presented a challenge to physicians. Currently, millions of patients are suffering from bone 
and cartilage defects. One approach is the regenerative medicine, a thriving new area of 
multidisciplinary research that has the potential to revolutionize the treatment of disease and 
damaged tissue. The ability to develop materials that can interface with tissues structurally, 
mechanically and biofunctionally is important to the success of regenerative strategies [1]. Bone 
and cartilage are highly organized tissues that assemble from the nano- to macro-scales to 
produce complex structural networks (Figure 1). Cartilage is an avascular tissue with a disperse 
cell population, and has a limited capacity for self-renewal [2]. Even small chondral defects may 
necessitate surgical intervention and would benefit from the development of new materials that 
fill the damaged area and integrate with the surrounding tissue, preventing further degeneration 
and consequent osteoarthritis. By contrast, bone is a highly vascular tissue, and remodels rapidly 
to heal traumatic fractures [3]. There is, however, a driving need to develop scaffolds or 
injectable systems that guide bone regeneration across defects that are too large to heal naturally. 
For both cartilage and bone tissues, it is advantageous to find two different strategies that direct 
tissue regeneration: 
 versatile, implantable, biocompatible scaffold; 
 non invasive injectable systems, as a bone filler. 
 
Successful design of scaffold and injectable materials requires an intimate understanding of 
molecular interactions that occur within tissues, between cells and the extracellular matrix 
(ECM). Both must provide space and a supportive environment for development, while avoiding 
hostile immune response, and degrade slowly to allow for tissue in-growth. In this project, we 
explore recent approaches that combine varying degrees of synthetic, natural and biomimetic 
materials and different fabrication techniques to construct highly tailored environments for bone 
and osteochondral regeneration.  
The molecular interplay within tissues leans heavily towards weak interactions — hydrogen 
bonding, electrostatics, and the effects of solvation forces, such as hydrophobicity. These lower 
energy molecular couplings are responsive and adaptive, enabling rapid assembly and 
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disassembly, protein conformation changes and structural remodelling. The self-assembly of 
collagen, a major ECM protein found in bone and cartilage, is strongly dependent on 
hydrophobic interactions within the physiological environment, and takes place over multiple 
steps from the expression of pro-collagen proteins to their assembly into triple-helical fibres [4]. 
Weak forces complement the dynamic nature of tissue, for example, the shock absorbing nature 
of cartilage is provided in part by the movement of water from a network of hydrophilic 
proteoglycan molecular chains. Likewise, bone is strengthened by the nucleation of 
hydroxyapatite into the nanodimensional gaps between collagen molecules. Secondary to 
assembly, stronger covalent bonding, termed covalent capture [5], also occurs throughout tissues, 
to reinforce structures. For example, the enzymatic crosslinking of lysine leads to the 
stabilization of proteins, such as collagen and elastin. In addition to a structural role, the ECM 
that surrounds bone and cartilage presents cells with instructive cues needed to maintain cell 
phenotype and behaviour [6]. 
Many strategies for guiding tissue regeneration involve the incorporation of varying degrees of 
biological context into implantable scaffolds  to create biomimetic environments. 
One way to mimic this context is to create scaffolds from natural biopolymers such as fibrin, 
collagen and hyaluronic acid, which incorporate many of the cues needed by cells. However, 
non-autologous materials carry the risk of disease transmission and immunological rejection, and 
are associated with challenges pertaining to material quality, harvesting, and processing. In light 
of this, many researchers are investigating the development of biofunctional synthetic polymers 
as alternative scaffold materials. 
Biomineralisation in bone is another form of natural self-assembly, where the nucleation and 
alignment of hydroxyapatite crystals onto bundles of collagen fibres results in a composite 
material resistant to high compressive loads. Although the mechanisms of this protein-mediated 
mineralisation are not fully understood, it is known that acidic phosphoproteins play a significant 
role in the control over non-specific nucleation by sequestering calcium ions from the 
physiological environment [5,7]. 
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Fig. 1: complex structural networks [19]. 
 
 
Aim 
In the bone defects, there are often three-dimensional complex shapes. Presently, the strategies to 
address bone defects include the use of autogeneous grafts and flaps, allograft or xenograft bone, 
non-degradable bone cement, metals and ceramics. The use of autogenous bone grafts and bone 
flap is considered the standard in management of bony defects but has limited source of graft 
material, especially in children. The allograft and xenograft are good substitutes of autogenous 
bone graft, however, there are potentials of transferring pathogens and difficulties of shaping into 
the desired form. Most of synthetic implants are not biodegradable and may result in stress 
shielding in the surrounding bone or fatigue failure of the implant. Therefore, the search for 
improved materials and surgical strategies for repairing skeletal defects continues [8-11]. 
The approaches of tissue engineering have the potential to evolve the present clinical strategies. 
They attempt to create tissue replacements by providing a scaffold with the proper size and 
predetermined shape for tissue development and permitting cells from the surrounding tissue to 
migrate into the matrixes [10,12,13].  
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In 1893, Barth [11,14] first introduced the concept of “scaffolding” as a porous matrix or an 
implant in which cells can infiltrate and regenerate the local tissue. In the last two decades, this 
concept has been extended to indicate natural and synthetic substrates that can temporarily 
support cells and direct their fate towards cell-material interactions and the release of biological 
factors [11,14]. 
The scaffolds are often three-dimensional porous polymeric matrices, which provides a space 
with the proper size and shape for tissue regeneration [4,12]. The surface of the polymers 
(natural or synthetic) would also ideally promote cell attachment, as many cells are anchorage 
dependent for survival. More concerns in truly clinical need, are to engineer structural tissues 
with supporting vascular network. Under these circumstances, the reconstructions with tissue 
engineering techniques require different strategies that establish an extensive, patent vascular 
network within the engineered bone [9,13]. 
The evolution consists on the development of novel scaffold materials, compatible with the cell 
guidance concept and resulting from contemporary advances in the fields of materials science 
and molecular biology [15]. 
The aim is to realize a scaffold with these properties and an increased biological and biochemical 
signals. However these porous structures have been produced in several ways, both by using 
conventional fabrication methods and more advanced methods.  
In the other hand, it is possible to consider an injectable gel like support to cells growth and drug 
delivery base. 
A gel is defined as a three-dimensional network swollen by a solvent. Usually, the solvent is the 
major component of the gel system. Gels can be classified into two categories based on the way 
the network is connected: chemical gels formed by covalent bonds and physical gels formed by 
secondary forces [16]. Some of physical gels are heat reversible and these are called 
thermoreversible gels [17]. 
The mechanisms that may be involved in the in situ gel formation are the following: gelation in 
response to temperature or pH change, ionic cross-linking, solvent exchange or crystallization, 
and simply thickening upon removal of the injection shear [18]. 
 
Anyway collagen and hydroxyapatite, are the two major components of bone tissue and they 
have been used as the bone substitute materials in orthopedic, oral-maxillo-facial and plastic 
surgery. The collagen fibers can serve as the scaffold for cell growth and tissue repair, and the 
hydroxyapatite (HA) is biocompatible and osteoconductive for bone regeneration [3,9,13].  
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While  most of the collagen matrices are prepared in a slab form, spherical gel beads of collagen 
and hydroxyapatite are more versatile in biomedical applications [10]. 
 
The aim of this work, is realized two different systems for the bone and osteochondral defect 
respectively. 
To obtain the optimization of this result, we study different systems: 
 
1. Injectable modified gel for bone defect: 
a) Injectable modified-hydroxyapatite: Sr substituted nano-hydroxyapatite (Sr-HA) 
was synthesized to simulate bone crystal with Sr incorporation. Based on pilot studies, 
Sr-HA  with different Sr concentrations were synthesized. The purpose of this study was 
to examine the effects of Sr incorporation on chemical composition, crystal size, 
crystallinity and lattice structure, growth of biocompatibility and cell adhesion and 
proliferation, of Sr-HA nanocrystallite. 
 
b) Bioactive hydroxyapatite - Graphene oxide hybrid injectable material: HA-GO 
hybrid  material was prepared by sol-gel technology using different GO concentration. 
Throw  physico-chemical, morphological and biological analysis, was evaluated the 
hybridization of HA nanoparticles in GO sheet and the cell proliferation. 
 
c) Modified Cellulose-based hydrogels: natural polymer was crosslinked with a  
innovative  treatment by citric acid. The study evaluated the possibility to increase the 
hydrophilicity and roughness surface of modified-cellulose hydrogels. Injectable 
modified-cellulose gels have  potentially a good effect on the cell attachment, cell 
proliferation and osteoblastic differentiation. 
 
2. Porous scaffold for osteocondral defect: 
a) Three-dimensional (3D) porous gelatin scaffolds fabricated by  freeze-
drying followed by biomimetic method in order to obtain a superficial mineralization. 
This work shows the hydroxyapatite coating and the effect of crosslinking time on the 
scaffold.  
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b) Gelatin/hydroxyapatite 3D multicomponent systems were prepared by sol-gel and 
freeze-drying  technologies. The aim is obtain an HA gradient in a scaffold structure how 
the osteogenic differentiation growth with the gradient meanwhile the chondrocyte ones 
decrease. Physico-Chemical-characterization (FTIR-XRD) and morphological analysis 
(SEM) were performed to evaluate the composition, the chemical interaction among the 
phases and the presence of hydroxyapatite gradient. 
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CHAPTER 1  
SYSTEMS FOR BONE AND OSTEOCHONDRAL DEFECTS 
 
onnective tissue is one of the four traditionally classified types of biological tissue. There are 
many different kinds of connective tissue. In general, they serve functions of structure and 
support, often connecting two other types of tissue to each other and usually derives from the 
mesoderm, the middle of three layers in an animal embryo. The characteristics of connective tissue 
are largely derived from the extracellular matrix, non-living material that surrounds and supports 
the living cells. The older classification of connective tissue had two subtypes: proper, which 
covered fibrous tissue; and specialized, which included bone, blood, cartilage, adipose (fat) tissue, 
and reticular tissue. A wider classification can be made considering the proper connective tissue, 
such as bone and cartilage to support function, and blood as a fluid connective tissue. 
 
Fig. 1: Connective tissue. Classification. 
 
 
As reported, our target is realized a biointeractive systems able to regenerate a complex 
environment. In this chapter, we propose an overview on bone and cartilage tissues, in order to 
correlate the natural structures with synthetic systems proposed. 
 
C 
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1.1 Bone  
Bones are the main constituent of the skeleton and differs from the soft tissue (i.e. cartilage, 
ligaments and tendons) in rigidity and hardness. Bones are important to the body both 
biomechanically and metabolically. The skeletal tissue performs three main functions for the life of 
any vertebrate; support, protection and homeostasis of calcium. In fact the rigidity and hardness of 
bone enable the skeleton to maintain the shape of the body and support it, to transmit muscular 
forces from one part of the body to another during movement, to protect the soft tissues of the 
cranial, thoracic and pelvic cavities, to supply the framework for the bone marrow. The mineral 
content of bone serves as a reservoir for ions, particularly calcium, and also contributes to the 
regulation of extracellular fluid composition, mainly ionized calcium ion concentration. 
 
 
Fig. 2: Anterior view of a human adult male skeleton. 
 
 
1.1.1 Bone composition 
Bone matrix is composed of approximately 28% by weight of organic matter, from 60% of 
inorganic substance and the remaining 12% of water (38.4% in volume organic matter, 37.7% 
mineral and 23.9% water) [1]. The mineral is largely impure hydroxyapatite, Ca10(PO4)6(OH)2, 
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containing carbonate, citrate, fluoride and strontium. The organic matrix consists of 90% collagen 
and about 10% noncollagenous proteins. From a mechanical point of view, the bone matrix is 
comparable to a composite material: the organic matrix is responsible to give toughness to the bone, 
while the inorganic matrix has the function to stiffen and strengthen the bone [2]. 
 
 
1.1.2 Cortical and Trabecular bone 
Bones are composed in general of two basic structures, i.e. cortical and trabecular, or cancellous, 
bone (figure 3) [2]. Cortical bone is solid compact bone, containing microscopic channels. 
Approximately 80% of the skeletal mass in the adult skeleton is cortical bone. However, due to the 
different structures, Ftrabecular bone fill the bigger volume. Cortical bone forms the outer wall of 
all bones, being largely responsible for the supportive and protective function of the skeleton. The 
remaining 20% of the bone mass is cancellous bone, a lattice of plates and rods having typical mean 
thicknesses ranging from 50 μm to 300 μm known as trabecula, found in the inner parts of the 
skeleton.  
 
 
Fig. 3: Photograph of a section of a tibia showing trabecular (cancellous) and cortical (compact) bone. 
 
 Cortical Bone 
Adult cortical bone is composed of 3- to 7-μm-thick unit layers (called lamellae) which contain 
collagen fibres that run parallel to each other [2]. In histological preparations, under polarized light, 
the lamellae appear as alternating light and dark levels, which is the result of differing orientations 
of collagen fibers within adjacent lamellae (figure 4). The main structural unit of cortical bone is 
given by the osteon or Haversian system (figures 4,5 ). A typical osteon is a cylinder about 200 μm 
in diameter, consisting of a central canal (Haversian canal) surrounded by about 20-30 concentric 
lamellae. The external surface of every bone is surrounded by several layers of lamellae, called 
circumferential lamellae.  
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Fig. 4: (A) Histological cross-section of cortical bone, showing osteon with its Haversian canals, lacunae and 
capillar canaliculi. (B) Same cross-section in polarized light, which shows the osteons composed of 
numerous concentric lamellae 
 
Within the Haversian canals run blood and lymphatics vessels, and nerves. The outer border of each 
osteon is surrounded by a cement line, which is a 1- to 2-μm-thick layer of mineralized matrix, 
deficient in collagen fibers. Throughout the bone, small cavities (lacunae) containing entrapped 
bone cells (osteocytes) are found.  
 
 
Fig. 5: Representation of a long bone with a detailed schematic representation of cortical bone and 
periosteum. 
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 Trabecular Bone 
The trabecular bone has not Havers systems, but consists of an array of interconnected beams 
(trabecule), of a thickness less than 0.2 mm and variable in shape (figure 6). Each trabecula is 
constituted by a packages of parallel lamellae. Usually a package of lamellae is up to 1 mm long 
and 50-60 microns in section. According to the site of analysis is possible to find trabecular bone 
with different characteristics, within different anatomical sites. This leads to great differences in 
bone density. Moreover the orientation of the trabecular structure is tightly bonded to the 
anatomical site and its mechanical role. In fact the correlation between the trabecular orientation 
and the load direction was already showed in literature [3,4]; trabecular structure result to be mainly 
oriented along the primary load direction. However load direction depends by the motion, therefore 
trabecular structure can became very complex. In order to classify structure that can be very 
different, and to obtain some quantitative information, some models were developed [5]. 
 
 
Fig. 6: (A) vertical section of trabecular bone from lumbar vertebra. (B) single trabecula leaving from the 
endosteal wall. 
 
The trabecular bone is compliant and less strong than cortical bone, generally because of its 
discontinuous structure. Consequently it gives a smaller contribute to the rigidity of the bone. 
Moreover can show greater variability in mechanical behaviour than cortical bone, due to its greater 
structural irregularity. However we must not underestimate his role: 
• It stiffens the structure connecting the outer shell of cortical bone; 
• It supports the layer of the cortex and distributes the loads in the case of lateral impacts; 
• It supports the articular cartilage and act as shock-absorber during loads; 
• It transfers and distributes the load to the surrounding cortical bone; 
• It protects the cave bones from phenomena of instability (buckling). 
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1.1.3 Bone development and turnover 
In normal conditions, bone is characterized by a balanced coexistence of resorptive and appositional 
processes. The main characters of these processes are the bone cells. Even if they represent a not 
influential part of the whole skeletal weight they are responsible for all the processes of bone 
resoption, formation, modeling and remodeling. It is still not clear what really drive them 
behaviour, however the scientific community agrees to the hypothesis that the development of a 
particular structure, during remodelling process, can be a reaction to mechanical loads.  
 
 
1.1.4 Bone cells 
The major cellular elements of bone can be grouped in [2,6]: 
• osteoblasts 
• bone-lining cells 
• osteocytes 
• osteoclasts 
  
 Osteoblasts 
Osteoblasts are bone-forming cells that synthesize and secrete unmineralized bone matrix (the 
osteoid). They seem to participate in the calcification and resorption of bone and to regulate the flux 
of calcium and phosphate in and out of bone. Osteoblasts  (figure 7) occur as a layer of contiguous 
cells which in their active state are cuboidal (15 to 30 μm thick). Bone formation occurs in two 
stages: matrix formation followed by mineralization, denoted by deposition of crystals of 
hydroxyapatite. 
Their life cycle can be summarized as follows [2,6,7]: the birth from a progenitor cell; the 
differentiation from stem cells to osteoblasts and participation in elaborating matrix and calcifying 
units; either returning to the pre-osteoblast pool, transform into bone-lining cell and burial as 
osteocytes, or death. 
The development of osteoblasts and osteoclasts are inseparably linked on a molecular basis. Both 
are derived from precursor cells originating in bone marrow  with osteoblasts from multipotent 
mesenchymal stem cells, while osteoclasts from hemaiopoietic cells of the monocyte/macrophage 
lineage), and osteoblast differerentiation is a prerequisite for osteoclast development [2]. 
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Fig. 7: Histological picture of osteoblasts. 
 
 Bone-lining cells  
Bone-lining cells are believed to be derived from osteoblasts that have become inactive, or 
osteoblast precursors that have ceased activity or differentiated and flattened out on bone surfaces. 
Bone-lining cells occupy the majority of the adult bone surface. They serve as an ion barrier 
separating fluids percolating through the osteocyte and lacunar canalicular system from the 
interstitial fluids. Bone lining cells are also involved in osteoclastic bone resorption, by digesting 
the surface osteoid and subsequently allow the osteoclast access to mineralized tissue. Furthermore, 
it has been postulated that the 3D-networks of bone-lining cells and osteocytes are able to sense the 
shape of the bone, together with its reaction to stress and strain, and to transmit these sensations as 
signals to the bone surface for new bone formation/resorption. 
 
 Osteocytes 
During bone formation, some osteoblasts are left behind in the newly formed osteoid as osteocytes 
when the bone formation moves on. The osteoblasts embedded in lacunae differentiate into 
osteocytes. In mature bone osteocytes are the most abundant cell type. They are found to be about 
ten times more than osteoblasts in normal human bone. Mature osteocytes posses a cell body that 
has the shape of an ellipsoid, with the longest axis (25 μm) parallel to the surrounding bone lamella. 
The osteocytes are thought to be the cells best placed to sense the magnitude and distribution of 
strains. They are thought both to respond to changes in mechanical strain and to respond to fluid 
flow to transduce information to surface cells, via the canalicular processes and the communicating 
gap junctions. Osteocytes play a key role in homeostatic, morphogenetic and restructuring process 
of bone mass that constitute the regulation of mineral and architecture [2]. 
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 Osteoclasts 
Osteoclasts are bone-resorbing cells, which contain one to more than 50 nuclei and range in 
diameter from 20 to over 100 μm. Their role is to resorb bone, by solubilizing both the mineral and 
the organic component of the matrix. The signals for the selection of sites to be resorbed are 
unknown. Biphoshponates, calcitonin and estrogen are commonly used to inhibit resorption. These 
are believed to act by inhibiting the formation and activity of osteoclats and promoting osteoclasts 
apoptosis. 
 
Fig. 8: osteoclasts with more 50 nuclei. 
 
 
1.1.5 Bone resorption 
The actual mechanism for the activation of osteoclast bone resorption is still unclear. Osteoclasts 
begin to erode the bone while coming in contact with the surface of bone. During this activity 
osteoclasts form cavities (Howship’s lacunae) in cancellous bone, and cutting cones or resorption 
cavities in cortical bone. The resorption process occurs in two steps, which occur essentially 
simultaneosly: dissolution of mineral and enzymic digestion of organic macromolecules. 
 
 
Fig. 9: Image representative of bone resorption. 
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1.1.6 Bone formation  
Bone formation occurs in two phases: matrix synthesis followed by extracellular mineralization. 
The osteoblasts begin to deposit a layer of bone matrix, referred to as the osteoid seam. After about 
5 to 10 days, the osteoid seam reaches a level of approximately 70% of its mineralization. The 
complete mineralization takes about 3 to 6 months in both cortical and trabecular bone. Bone 
formation is a complex process regulated by hormones (e.g. Parathyroid hormones) and growth 
factors (e.g. Transforming Growth Factor). The building of bone as a functional organ is an 
important process, as bone constantly enlarges, renews and develops itself in time. In the same time 
it adapts itself to support protection, mechanical needs and numerous metabolic and hematopoietic 
activities [8-10]. In this thesis, the normal growing of long bones will be addressed only briefly. It 
is just mentioned that this growth follows a cartilaginous model, involving the growth through the 
epiphyseal plates, the metaphyseal spongiosa growth, and the circumferential growth of the bone 
shaft. Modeling and remodeling process, play an important role both for normal bone growth as 
also for the adaptation processes that occur in pathological modification of bone (e.g. osteoporosis). 
 
 
1.1.7 Modeling 
In general, growth and modelling are linked together [2]. Modeling allows the development of 
normal architecture during growth, controlling the shape, size, strength and anatomy of bones and 
joints. It increases the outside cortex and marrow cavity diameters, gives shape to the ends of long 
bones, drifts trabeculae and cortices, enlarges the cranial vault and changes the cranial curvature. 
During normal growth, periostal bone is added faster by formation drifts than endosteal bone is 
removed by resorption drifts. This process is regulated so that the cylindrical shaft markedly 
expands in diameter, whereas the thickness of the wall and the marrow cavity slowly increase. 
Modeling controls also the modulation of the bone architecture and mass when the mechanical 
condition changes [11]. For example, bone surfaces can be moved to respond to mechanical 
requirements. A coordinate action of bone resorption and formation of one side of the periosteal and 
endosteal surfaces can move the entire shaft to the right or left, allowing some bones to grow 
eccentrically [12]. 
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1.1.8 Remodeling 
Remodelling can be defined as a process that produces and maintains bone that is biomechanically 
and metabolically competent [2]. At infancy, the immature (woven) bone at the metaphysis is 
structurally inferior to mature bone. In adult bone, the quality (e.g. mechanical properties) of bone 
deteriorates with time. Thus, as many other tissues, bone must replace or renew itself. This 
replacement of immature and old bone occurs by a process called remodeling, which is a sequence 
of resorption followed by formation of new lamellar bone [11]. The remodeling characterizes the 
whole life of bones. For normal rates of periodic bone replacement (bone turnover), cancellous bone 
has a mean age of 1 to 4 years, while cortical bone about 20 years. The remodeling has both 
positive and negative effects on bone quality on the tissue level. It allows to remove microdamage, 
replace dead and hyper-mineralized bone, adapt the microarchitecture to local stresses. But 
remodeling may also perforate or remove trabeculae, increase cortical bone porosity, decrease 
cortical width and possibly reduce bone strength.  
 
 
Fig. 10: Four phases of bone remodelling process. 
 
The group of bone cells that carries out one quantum of bone turnover, osteoclast, osteoblast and 
their progenitors, is called a bone remodeling unit (BRU). The life cycle of a unit can be 
summarized in the following stages: resting, activation, resorption, reversal (coupling), formation, 
mineralization and back to resting. 
Resting: About 80% of the cancellous and cortical bone surfaces (periosteal and endosteal) and 
about 95% of the intracortical bone surfaces in large adult animals (including humans) are inactive 
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with respect to bone remodeling stage, at any given time. These inactive surfaces are covered by 
bone-lining cells and a thin endosteal membrane. 
Activation: As activation is defined the conversion of the quiescent bone surface to resorption 
activity. Which factor initiates this process is unknown. However, activation is believed to occur 
partly in response to local structural or biomechanical stimuli. The remodeling cycle necessitates 
the recruitment of osteoclasts and the mean for them to access the bone surface. 
Resorption: Osteoclasts begin to erode bone, forming cavities. 
Reversal:  The 1- to 2- week interval between completion of resorption and the beginning of bone 
formation is called reversal. 
Formation and mineralization: Bone formation occurs, through matrix synthesis followed by 
extracellular mineralization. Bone turnover depends both on the surface-restricted activation 
frequency and on the surface-to-volume ratio. The activation frequency is the inverse of the time 
interval between consecutive cycles of remodeling at the same site. The surface to- volume ratio of 
cancellous bone is about 5- to 10 times bigger than in cortical bone. There are studies showing that 
remodeling does differ in different parts of the skeleton and also in different parts of a given bone at 
any moment. Possible reasons are that where micro-damage occurs, BRU-based remodeling 
increases to try to repair it. Usually, such regions are highly loaded sites, like the epiphyseal 
spongiosa [2,13]. Another reason could be, that during growth parts of the skeleton accumulated 
more bone than actually needed for mechanical usage, which will increase remodeling-dependent 
bone loss [2,9]. In the adult bone the bone remodeling provides a mechanism for the skeleton to 
adapt to its mechanical environment, due to inactivity or to hypervigorous activity. These 
phenomena are grouped together as biomechanical-driven remodeling. Conversely, it is sustained 
that there exist genetically driven remodeling or stochastic remodeling that prevents fatigue 
damage. This hypothesis is highly disputed [2,13,14]. 
 
 
Fig. 11: In the picture are represented 1. Osteoclast. 2. Bone surface resorbed by osteolclast. 
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1.1.9 Mechanical properties of bone 
The intimate blend of hard inorganic and resilient organic components results in excellent 
mechanical properties. For example, compact bone specimens have been found to have tensile 
strength in the range of 700 to 1400 kg/cm
2
, and compressive strength in the range of                  
1400 to 2100 kg/cm
2
. These values are within the same magnitude as for aluminum or mild steel, 
but bone is much lighter. The great strength of bone exists principally along its axis and hence 
roughly parallel both to the collagen fiber axis and to the long axis of mineral crystals. Although 
apparently stiff, bones exhibit a considerable degree of elasticity, which is important in the 
skeleton’s ability to withstand impact. Estimates of modulus of elasticity of bone samples are of the 
order of 420 to 700 kg/cm
2
, values very much less than steel, for example, indicating much greater 
elasticity of bone [15]. 
 
 
1.2 Cartilage tissue  
Cartilage is a connective tissue with special support functions. The cartilage is a particular tissue of 
mesenchymal origin characterized by a cellular component surrounded by an extracellular matrix 
that gives texture to fabric.  
According to the composition and texture of the amorphous component and the fibers contained in 
it is possible to distinguish the cartilaginous tissue in three types:  
- Elastic cartilage  
- Fibrous cartilage  
- Hyaline cartilage  
 
The elastic cartilage has a structure similar to hyaline. The difference between the two is due to the 
fact that the elastic cartilage is characterized by a lower amount of intercellular substance and large 
amounts of elastic fibers associated with collagen II fibers, which give greater flexibility and 
elasticity. These fibers form a three-dimensional network and are thicker and abundant in the 
central portion than in the peripheric areas. 
Hyaline cartilage (from the greek hyalos, glass) is characterized by an amorphous component and a 
rich proteoglycans rich in fibrillar collagen II. Due to its intracellular component, the high presence 
of water, the surface smooth and the synovial fluid, the cartilage allows the joint to withstand 
pressure from various directions and to make joint movement without friction. 
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The three zones (Elastic cartilage - Fibrous cartilage - Hyaline cartilage) contain different collagen 
organization have different amounts of proteoglycans. Infact the superficial or tangential zone 
contains the highest collagen content, about 85% by dry weight. In addition, the collagen fibrils are 
oriented parallel to the joint surface, indicating that the purpose of this zone may be primarily to 
resist shear stresses. The amount of collagen decreases in each zone moving closer to the tidemark, 
dropping to 68% in the middle zone. Moreover collagen changes its configuration from a central 
area of a cartilage layer to a more peripheral area. The structure of the collagen network is thought 
to be related to the mechanical stability of the tissue [16]. 
 
 
           (A)        (B)                                 (C) 
       
               (D) 
 
Fig. 12: A) cartilage, P = perichondrium, FE = elastic fibers; B) Cross section of disk inervertebrale,          
AF = fibrous ring, NP = nucleus pulposus; C) hyaline cartilage, AI = inter-territorial areas,                         
AT = geographical areas, arrow = proteoglycan; D) articular cartilage, ST = tangential layer,                         
IS = intermediate, SR = radial artery. 
 
 
The surface layer of cartilage is like the wall of a pressure vessel that is designed to withstand the 
swelling pressure in the tissue; the collagen fibers are oriented to achieve an optimal tangential 
stiffness of the tissue. Chondrocytes have different shapes and different volumetric concentrations 
in the different layers of articular cartilage. A given chondrocyte shape produces different effects on 
the global material properties, depending on the structure of the collagen fiber network. The shape 
and volumetric concentration of chondrocytes in articular cartilage appear to be related to the 
mechanical stability of the matrix [16].  
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(A)                                                                                      (B) 
Fig. 13: (A) Cartilage types in the body. (B) Schematic representation of a normal collagen architecture from 
central area to peropheal area. Additional laminae are visible depending on the location in the joint. 
 
  
1.2.1 Chondrocytes  
Chondrocytes are quiescent cells derived from chondroblasts, was secreting. Is contained in lacunae 
of the extracellular matrix such capsules basophils. Their morphology and distribution is a function 
of the level of depth within the cartilage. In the intermediate zone appear rounded, enclosed in 
capsules and isolated, moving towards the perichondrium are increasingly flattened with major axis 
parallel to the surface and aggregated. These groupings are made for those groups isogenic cell 
mitosis and are characterized by three to five cells per capsule. Moreover, since the matrix is jerky, 
while separating the cells completely go away.  
 
 
1.2.2 Extracellular matrix  
The extracellular matrix consists of an amorphous component or ground substance, a fibrillar 
component (fibrous proteins) and high amount of interstitial fluid (mainly water) that makes the 
matrix well hydrated. It consists of several channels that allow diffusion of nutrients, oxygen and 
metabolic products. Can be divided into three main areas:  
- Territorial, around the capsule basophil, characterized by an abundance of proteoglycans;  
- Inter-territorial, characterized by a smaller number of rich proteoglycans and collagen;  
- Pericellulare capsule, surrounds and protects the chondrocyte lacunae of mechanical stress.  
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1.2.3 Collagen components configuration 
Collagen is the most abundant protein in the human organism. It is primarily responsible for the 
tensile behaviour of soft connective tissues, and in particular, tendons and ligaments. Collagen is 
characterised by a strongly hierarchical organization: small tropocollagen molecules link together to 
form fibrils, which in turn give rise to fibres and fibre bundles. The primary structure of the 
tropocollagen molecule consists of an uninterrupted sequence of about 300 Glycine-X-Y triplets, 
where X and Y are frequently represented by proline. During post-translational modification, 
hydroxylation, oxidation and glycosylation processes of amino acid residues usually occur [17]. The 
triplets organize themselves into a right-handed α-helix secondary structure and the conformational 
arrangement is defined by a left-handed helix tertiary structure. The quaternary super-structure of 
the tropocollagen molecule is obtained by linking three helixes by hydrogen bonds (figure 14). The 
molecule is approximately 300 nm in length and 1.5 nm in diameter [17]. Tropocollagen molecules 
are highly reactive and undergo spontaneous fibrillogenesis. For collagen types I, II, III, V and XI, 
tropocollagen molecules link together by inter-molecular covalent bonds to form fibrils (Figure 
2.30), that are characterised by diameter and length ranging between 20 to over 280 nm [18] and 5 
μm to over 1 mm respectively [19]. Possible sites of cleavage by chemomechanical caries removal 
reagents by degradation of glycine or hydroxyproline are indicated by red arrows. b, triple helix. 
Sites of cleavage by degradation of intra-molecular cross links are shown by red arrows. c, 
tropocollagen molecules link together to form fibrils and inter-molecular cross links are shown by 
arrows in the following figure. 
 
Fig. 14: Schematic representation of polypeptide chain. 
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1.2.4 Elastic components 
Elastic fibers are a fibrous proteins found in large amounts in tissues and constist of two 
components: an amorphous central region containing elastin suttounded by a sheath of 14nm 
tubular microfibrils. The amino acid composition of elastin resembles that of collagen in that elstin 
is rich in glycine (Gly) and proline (Pro). Differences include greater quantities of valine (Val) and 
alanine (Ala) along with small amounts of hydroxyproline and no hidroxylysine. 
 
 
Fig. 15: (A) SEM image of elastic fibers with diameters in the range of 3 to 5 μm. (B) Fluorescence 
microscope image of immunostained fibrillin-microfibrils in elastic fibers. 
 
Elastin contains two unsual amino acid, desmosine and isodemsmosine, formed by covalent 
reactions among 4 lysine (Lys) residues. These are organized in two repetitive sequences: Val-Pro-
Gly-Val-Gly and Gly-Val-Gly-Val-Gly. Desmosine and isodesmosine need to be synthesized by a 
particular enzyme, lysyl oxidase, that contains copper. Elastin molecules are joined together by 
covalent bonds to generate an extensive cross-linked network. Because each elastin molecule in the 
network can expand and contracts as a random coil, the entire network can stretch and recoil lije a 
rubber. The effectively cross-links elastin and is thought to account for the rubberlike qualities of 
this protein. Through this structure and its numerous links, elastic fibers are capable of stretching to 
one and one-half times their length, yield easily to very small traction forces but return to their 
original shape when these forces are relaxed.  
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Fig. 16: Schematic explanation of stretching and relaxation of elastin molecules. 
 
 
1.2.5 Ground substance 
The amorphous intercellular ground substance is colorness, transparent and homogeneous. It fills 
the space between cells and fibers of the connective tissue. The ground substance is a viscous gel 
mainly composed of an electrolytic water solution and highly negatively charged proteoglycans 
(PGs). The water solution behaves as a pore fluid within the solid skeleton of the extracellular 
matrix and dissolved ionic species are mainly sodium Na
+
 cations and chloride Cl
-
 anions. 
Proteoglycans are long molecular structures, developing along an axis made of hyaluronic acid 
(figure 17). On that axis are laterally attached other proteins (aggregans) structured around their 
own axis. Along this axis are attached in turn threads of amino-acids, called glycosaminoglycans 
(GAGs). The basic structure of GAGs is made by disaccharide units containing a uronic acid and an 
amino-glycan. The uronic acid displays a negatively charged carboxyl COO
-
 and the amino-glycan 
displays at least one sulphate SO3
-
. The two main GAGs that compose proteoglycans are 
chondroitin-sulphate with valence -2 and keratin-sulphate with valence -1. Because of the high 
water content of ground substance, proteoglycans are hydrated and electroneutrality is ensured by 
sodium cations [20].  
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Fig. 17: SEM micrograph and schematic representation of proteoglycans structure. 
 
The compressive properties of cartilage are partly provided by the proteoglycans that resist 
compression because GAGs repulse each other due to their negative charges (figure 18A). The 
presence of cations Na
+
 shields the negative charges of the PG, and the mutual repulsive forces 
decrease with increasing sodium concentration [20]. Shielding results in decreasing macroscopic 
compressive moduli when the salt content increases (figure 18B) [21].  
 
 
Fig. 18: Compressive mechanical behaviour of glycosamminoglycans in NaCl solutions.                             
(A) Schematic representation of the experimental setup and (B) experimental results for different 
concentrations  of NaCl [21]. 
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1.3 Materials and methods 
 1.3.1 Technology 
Tissue engineering strategies rely on the use of cells, bioactive factors, and scaffolds or 
combinations thereof. The scaffold serves the purpose of a delivery vehicle, a space-filling and 
structurally supportive agent, and can be designed to be biointeractive, i.e. to guide tissue 
regeneration. The coordinated regeneration of multiple tissues in the complex osteocondral and 
bone environment requires a deep understanding of their physiology and remodeling characteristics. 
Complex tissues must be engineered with the structural and functional characteristics of native 
tissue in a process that is not only biocompatible but also interactive and integrative with 
neighboring tissues simultaneously. Another challenge lies in that one type of tissue can be found in 
various structures that serve different functions and have therefore different properties. In our case, 
for example, the structures found in the bone and/or osteocondral region have very distinct 
characteristics. A specifically tailored approach may be required to regenerate a weight-bearing, 
dense, and bilaminar cartilage, and a quite different approach required to create a compact and 
mineralized bone. The extracellular matrix of bone has been described as a composite material 
composed of collagen type I fibrils mineralized with nanocrystals of hydroxyapatite [22]. 
Approximately 70% of bone by weight is composed of calcium salts, with hydroxyapatite 
(Ca10(PO4)6(OH)2 as the primary mineral constituent [23]. Moreover, the inorganic mineral 
component provides the mechanical strength of the matrix [24]. Desirable bone tissue engineering 
constructs are osteoconductive and osteoinductive. Review articles on bone tissue engineering 
considerations have been extensively published [25-30]. Our group have been proposing: a) natural 
biomaterials in conjunction with growth factors and/or cellular delivery to regenerate bone and 
cartilage; b) injectable systems modified to improve the matrix properties.  
In general materials of natural, synthetic, semi-synthetic and hybrid origins have been proposed and 
tested as supports for tissue regeneration [31,32]. Synthetic and natural inorganic ceramic materials, 
such as hydroxyapatite and tricalcium phosphate, have been considered as candidates for injectable 
materials and biological active signals on scaffold surface or composition, for bone tissue 
engineering. These ceramics resemble the natural inorganic component of bone and possess 
osteoconductive properties [33]. 
Combining the literature whit our target, in the case (a) we propose a strategy employs the use of a 
scaffolds (natural polymer such as gelatin) and bioactive factors ( hydroxyapatite crystalline); in the 
other case (b) the use of injectable biomaterial (hydroxyapatite or cellulose) bone filler. 
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To realize these systems, we propose two consolidate technologies: sol-gel technique for the 
hydroxyapatite formation, and liophylization due to obtain a gelatin or gelatin hybrid system porous 
scaffold. 
 
 SOL-GEL technique 
The sol–gel process is a wet chemical method that needs an high pH value and not too high 
sintering temperature. This method offers a molecular mixing of the calcium and phosphorus which 
is capable of improving the chemical homogeneity. Moreover, the high reactivity of the sol–gel 
powders allows a reduction of the processing temperature and of any degradation phenomena 
during sintering. Many reported sol–gel processes require a strict pH control, vigorous agitation and 
a long time for hydrolysis. Here we will report a simple sol–gel method that does require 
controlling pH values, slowly stirring and short time for hydrolysis of phosphates [34]. 
 
 Freeze-drying 
Porous scaffolds have been manufactured using a freeze-drying, or lyophilization, technique 
[35,36]. Using this technique, a gelatin solution is solidified (frozen) to promote growing ice 
crystals, forming a continuous, interpenetrating network of ice. Sublimation of the ice crystals leads 
to formation of a highly porous sponge. The final pore structure depends on the underlying freezing 
processes during fabrication. The rapid, uncontrolled quench freezing process typically used in 
fabricating porous scaffolds via freeze-drying results in space- and time variable heat transfer 
through the suspension, leading to non-uniform nucleation and growth of ice crystals and, 
ultimately, scaffold heterogeneity. In localized regions of poor contact between the pan in which the 
suspension is frozen and the freeze-dryer shelf, there is a lower rate of ice-crystal nucleation than in 
neighboring regions, giving increased variation in pore size; due to poor heat conduction and the 
increased temperature of the suspension at these points, these areas have been termed ‘hot spots’. 
So, concentration of the polymer solution and freezing conditions used determine the pore size and 
orientation of formed matrices, as the porous structure depends on the crystallization of water into 
ice in the homogeneous polymer solution. After frozen, the samples were lyophilized for a several 
hours: the water sublimation create the porous structure.     
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1.3.2    Materials 
 Natural polymers  
 Gelatin 
Collagens are the major structural proteins of most connective tissues as skin, bone and tendons, 
where they provide structural integrity to the tissues. The peculiarity of the amino acid sequence 
accounts for the characteristic coiled coil structure of the collagen molecule, where three distinct 
polypeptide chains, each of which is coiled into a left-handed helix, are thrown into a right-handed 
superhelix stabilized through interchain hydrogen bonds and covalent crosslinks. Thermal 
denaturation or physical and chemical degradation of collagen involves the breaking of the 
triplehelix structure into random coils to give gelatin. The present wide interest in gelatin is mainly 
due to its biodegradability [37]. 
Gelatin is a naturally occurring biopolymer derived from collagen, which is the major structural 
protein in the connective tissue of animal bone and skin [38]. 
As a protein-based biomaterial, gelatin is biodegradable and has no antigenicity under physiological 
conditions. Thus, it is an indispensable ingredient in modern pharmaceuticals. Tabata et al. [39] 
have explored gelatin hydrogels as a delivery system to achieve the controlled release of 
biologically active growth factors. When electrostatically complexed with a positively or negatively 
charged gelatin, an oppositely charged protein can be modified to increase its stability, targeting, 
and sustained release, leading to enhanced therapeutic efficacy. Gelatin exhibits very high bio-
absorptivity when placed in vivo. In general, biocompatibility is governed mainly by the interface 
between foreign materials and host living cells/tissues. The intrinsic nature of the material including 
chemical composition, molecular weight, charge, and hydrophilicity may have an impact on the 
biocompatibility.  
 
Gelatin is obtained by thermal, physical or chemical degradation of collagen which involves the 
breaking of the triple-helix structure. The result is a biodegradable, biocompatible and 
nonimmunogenic product, suitable for medical applications [40,42]. 
 
The collagen molecule consists of three polypeptide chains, alpha chains, that spontaneously coil 
together, zipper fashion, to form a right-handed helix [43,44]. The strands are held together 
primarily by hydrogen bonds between adjacent –COO and –NH groups, but also by covalent bonds 
[45]. The conversion of collagen to gelatin occurs through one of two processes: an acid process 
(gelatin type A) or an alkaline process (gelatin type B). The collagen to gelatin transformation 
 32 
 
generally produces a mixture of single alpha (MW = 80,000 to 125,000), double alpha (also known 
as beta, MW = 160,000 to 250, 000), and triple alpha (also known as gamma, MW = 240,000 to 
375,000) stranded gelatin [46]. All the molecular species resulting from the processing of collagen 
to gelatin are considered to be gelatin provided that the molecular weight exceeds an arbitrary 
minimum of approximately 30,000 [47]. 
It is important to know by which of these two processes the gelatin was made, since the two types 
differ in properties: different viscosity, gel strength (Bloom index) and different isotonic point. 
Infact, the network structure and the physical properties of the gelatin gels are mainly conditioned 
by the source and the conditions of extraction of the gelatin.  
The processing of collagen can produce two types of gelatin with different isoelectric points (pI). 
The alkaline process, through hydrolysis of the asparagine to aspartic acid and glutamine to 
glutamic acid, yields a gelatin (Type B) with a high density of carboxyl groups, which makes the 
gelatin negatively charged with an isoelectric point of 4.5-5.2 [38,46]. The acid process, which is 
less invasive, produces little change in the isoelectric nature of collagen. As a result, the isoelectric 
point of the gelatin (Type A) that is obtained will remain similar to that of collagen, between 7-9. 
Gelatin swells least at its isoelectric point and it swells more in solutions of pH above and below its 
pI [48]. In general, gelatin extracted at lower temperature is stiffer, and exhibit greater value of the 
Bloom index, which is a measure of the stiffness of the hydrogel [38]. 
It has been reported that the increase in Bloom index of the gelatin leads to a remarkable 
improvement in the mechanical properties and a significant reduction in water-absorbing capacity 
of the membranes [38]. In addition, the Bloom strength strongly affects the atomistic structure of 
gelatin and therefore its biomedical applications including tissue engineering and drug delivery. 
Furthermore, the mechanical properties of drawn gelatin films have been related to the denaturation 
level of the protein, that is the triple-helix content, evaluated through differential scanning 
calorimetry [37]. 
  
Fig. 19: Gelatin structural unit. 
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Table1: amminoacids (g) for 100g of gelatin. 
 
Chemical structure. Regarding the chemical structure of gelatin, being it a protein, it contains 18 
different amino acids (AA) linked together in sequence to form polypeptide chains of about 1000 
AA for chain, known as primary structure (Table 1). The most frequent amino acid sequences are: - 
(Gly-X-Pro) n-and - (Gly-X-Hypro) n  [37]. The most frequent amino acid sequences are: - (Gly-X-
Pro n- and -(Gly-X-Hypro)n. As reported in the table 1 glycine, proline and lysine are present in the 
extremely high concentration. In general, regardless of the type of extraction, gelatin obtained is a 
heterogeneous mixture of single or multi-stranded polypeptides, each with extended left-handed 
proline helix conformations and containing between 50 – 1000 amino acids.  
Serine, theronine, aspartic acid, and glutamic acid are predominate at the N-terminal in alkali 
processed gelatin and alanine in the acid processed gelatin [49]. At the C-terminal, glycine, 
glutamic acid, and aspartic acid are the predominate amino acids [49]. Amino Acids are linked 
together by peptide bonds, covalent bonds between the carbon atom of an AA carboxyl group 
(COOH) and the nitrogen atom of another AA amino group (NH2). Amino acids are characterised 
by the presence in their structure of simultaneously basic (NH2) and acid (COOH) groups, bound to 
an α carbon atom in an hydrocarbon chain. 
A key feature of collagen is its "isoelectric point", or pI, that is represented by the medium’s pH 
value at which the protein’s positive and negative charges balance each other; in other words, the 
protein is in a state of great reactive inertia.  
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At pI value, collagen presents a great chemical and physical inertia, characterized by: 
• Low tendency to react;  
• Low viscosity;  
• Minimal swelling. 
Thanks to the large number of functional side groups it contains, gelatin readily undergoes chemical 
cross-linking, which is very important for its possible use as a biomaterial. In fact, as collagen based 
biomaterials are rapidly degraded in vivo, their structure must be reinforced so that they will not 
significantly alter in the body for the required period. Since gelatin is soluble in aqueous solution, 
gelatin materials for long-term biomedical applications must be submitted to crosslinking, which 
improves both the thermal and the mechanical stability of the biopolymer [38]. 
 
Crosslinking. Depending on what degradable properties are desired, different cross-linking 
treatments, including chemical and physical methods, can be used to prolong the absorption of the 
gelatin. Physical cross-linking methods include drying, heating or exposure to gamma or ultraviolet 
radiation. The primary advantage of physical methods is that they do not cause potential harm. 
However, the limitation of such methods is that obtaining the desired amount of cross-linking is 
difficult . In chemical cross-linking methods, cross-linkers are used to bond functional groups of 
amino acids [50-53]. Because gelatin itself is nontoxic, it is important that the crosslinking agents 
also are nontoxic to the cells that will attach to the scaffold. However, many chemical cross-linking 
agents are cytotoxic as a result of the residual unreacted cross-linking agent or the degradation 
products that result from hydrolytic or enzymatic degradation [51,52,54]. 
According to the cytotoxic study, Sisson and colleagues compared the most commonly agent for 
crosslinking gelatin: glyceraldehydes, glutaraldehyde and genipin. Glutaraldehyde is the most 
commonly used agent for crosslinking collagen and gelatin. It is inexpensive, soluble in aqueous 
solution and has a rapid reaction rate due to the many available amine groups in proteins [55]. 
Glutaraldehyde reacts to form crosslinks in two different ways. First, the aldehyde group can react 
with the amine group of lysine, hydroxlysine, or arginine in the collagen polypeptide and form a 
Schiff base [55]. Second, two adjacent aldehydes can undergo aldol condensation [55]. 
Glutaraldehyde has, however, been shown to be cytotoxic at high concentrations. The residual 
unreacted glutaraldehyde, cross-linked collagen and gelatin, and the products from the hydrolytic 
degradation of the cross-linked collagen are cytotoxic [56]. Cytotoxicity can be reduced by using 
low concentrations of glutaraldehyde for crosslinking and thoroughly washing the scaffolds before 
use in tissue engineering applications. D,L-Glyceraldehyde has been used to cross-link gelatin and 
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is nontoxic. Furthermore, glyceraldehyde is a natural product of a metabolic process. Studies 
suggest that gelatin crosslinked with glyceraldehyde is well tolerated in vivo. However, the 
mechanism of the cross-linking reaction between glyceraldehydes and amine groups remains widely 
debated and the subject of continued discussion [56]. 
 
In the present study we propose the gelatin scaffold realized by freezing-dried, cross-linked with 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) was proposed.  
 
EDC reaction. The mechanism of crosslinking with carbodiimide involves the formation of an O-
acylisourea derivative between carbodiimide and the carboxylic acid groups of glutamic and 
aspartic acid residues in gelatin molecules, followed by a nucleophilic substitution with an amino 
group, most often -NH2 of a lysine residue [57]. No spacer is introduced for this amide-bond-type 
crosslinking [58]. 
 
 
Fig. 20: 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) structure. 
  
However, Nakajima and Ikada [59] reported that amide formation from carboxyl and amino groups 
in aqueous media in the presence of carbodiimide required the formation of carboxylic anhydride as 
an intermediate. Hence, carbodiimide may couple carboxylic acid and amino groups that are located 
within 1.0 nm of one another [60]. Therefore, carbodiimide may form intramolecular crosslinks 
within a gelatin molecule or short-range intermolecular crosslinks between two adjacent gelatin 
molecules as long as the crosslinked carboxylic acid and amino groups are less than 1.0 nm apart. 
The free-amino-group contents of the EDC-crosslinked gelatin hydrogels declined significantly 
within 30 min of crosslinking and stayed at their minimal values subsequently [61]. This indicated 
that the crosslinking of a gelatin hydrogel with carbodiimide was essentially completed within 30 
min after the initiation of crosslinking. It has been reported that carbodiimide crosslinking is a rapid 
reaction [58,62]. 
As Hsing-Wen Sung et al. [61] have reported, the reduction in the free-amino-group content for the 
carbodiimide-crosslinked gelatin was approximately 33%. This was because carbodiimide could 
basically form intramolecular and short-range intermolecular crosslinks within collagen based 
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materials, and each crosslinking produced with carbodiimide simply consumed one free amino 
group [61]. 
 
Gelation. Gelatin has the ability to immobilize liquid and undergo gelation. Gelation is a disorder 
to order transition usually induced by cooling and is always reversible. Gelation begins with 
conformational changes which result in partial unfolding of gelatin within the solution, exposing the 
interior reactive region of the gelatin. As the gelatin is cooled, the unfolded proteins create a 
network throughout the system through intermolecular contacts or covalent bonds. The network is 
then stabilized by secondary forces rather than by covalent bonds and the intermolecular attractions 
are negligible [63]. As the molecular network develops, additional gelatin molecules become 
attracted through electrostatic interactions. This ultimately leads to a more rigid structure and 
thickening of the gel. The maturation process involves two processes: an increasing order and 
stiffening of the network and general thickening of the whole network. As the gel continues to cool, 
additional parts of the gelatin chain become more ordered and stable due to the growth of existing 
links and formation of new links (both physical and chemical bonds) [63]. The decrease in 
temperature causes the water molecules to be less mobile, the hydrogen bonds remain intact, 
ultimately rendering the chains immobile. The ability of the chains to continue to re-organize is lost. 
A slow cooling rate produces a strong, stable network. 
 
Fig. 21: Fishnet structure of gelatin with strong points separated by flexible strands. 
 
Russo [64] morphologically classified gelatin as a fishnet gel (figure 21) in which cross-links, 
whether reversible or covalent, provide ‘strong points’ of the structure (formation of crystallites) 
and are separated by flexible strands which provide elasticity. The strong points within the gelatin 
strands are due to intermolecular cross-linking (interstrand) that can occur between arginine-lysine 
or arginine-arginine within the same strand. Amino acid residues from two neighboring strands may 
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also interact and form intramolecular (intrastrand) cross-linked strands that provide strength to the 
gelatin. 
 
Swelling phenomena. Two physical processes occur when a gelatin matrix is exposed to water. 
The first phase is the transition to a rubbery state as water penetrates the gelatin matrix and 
mobilizes the entangled strands [65]. The second phase is the continual swelling of the rubbery 
network as more water is absorbed. The rate of water absorption will be governed by pH of the 
environment, gelatin isoelectric point (pI), moisture content, particle size, presence of dissolved 
salts, and the extent of cross-linking. The pH and the isoelectric point are important because when 
the pH of the environment and the isoelectric point are equal there is a net neutral charge on the 
gelatin. At this point, there is minimal absorption and swelling. Extensive swelling is seen when the 
pH deviates from the pI range. The extent of cross-linking is an essential characteristic of the 
delivery system due to its ability to reduce polymer chain mobility, increase glass transition 
temperature and decrease molecular diffusivity. 
 
Factors that influence the swelling: 
a) Effect of Bloom strength  
The gel strength is one of important criteria which determine the quality of gelatin as required by 
manufacturers and users. It indicates the hardness, stiffness, firmness and compressibility of the gel 
at a particular temperature and concentration. It is associated with the contents of proline and 
hydroxyproline in gelatin and molecular weight [66]. In general, a high molecular weight gelatin 
gives a high Bloom value [67].  
Haixia Ren et al. [68], supposed that it is difficult to develop a firm network formation for low 
molecular weight protein chain, so as to hydrogel cannot be formed. The Bloom strength has a 
significant influence on the swelling behavior of hydrogel: in fact lower swelling ratio was observed 
at higher Bloom strength. This is most likely due to a higher molecular weight gelatin chain, which 
are able to interact with one another and are prone to form a more compact network, and hence a 
lower water holding capacity. 
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Fig. 22: The swelling ratio Q (a) and t/Qt (b) of gelatin-based hydrogels obtained with different 
Bloom strength gelatins versus the swelling time [68]. 
 
b) Effect of temperature  
The equilibrium swelling and swelling ratio is significantly different over the temperature range of 
[25 – 50]°C. It is known that the ratio increases with increasing the temperature. Moreover, the 
swelling rate is not significantly affected when the temperature exceeds 30°C. On the other hand, 
the swelling at lower temperature (25°C to 30°C) shows a much lower swelling rate. The observed 
results can be explained by the fact that when the temperature increases from lower to 30°C, the 
water sorption capacity increases significantly due to an increased segmental mobility of hydrogel 
chains. Several studies [69,70] have investigated that gelatin gel involves formation of triple helical 
sequences connected in an essentially random fashion by peptide sequences in disordered 
conformation. The gelatin chains in hydrogel revert partially to the tropocollagenic triple helix, 
from disordered to rather ordered status, depending on temperature, concentration and rate of 
cooling. This phenomenon occurs usually at around 28°C, where the coil to helix transition is 
observed. And when a crosslinker was introduced the resulting gelatin hydrogel is composed of 
both chemical and physical cross-links. The result is that parts of either three chains or two chains 
in a physical ‘‘hair-pin’’ bond type [71] are stabilized mainly through hydrogen bonds, forming 
thus a basic physical network coupled to the covalent one (figure 23, left). As temperature increased 
to 30°C, the hydrogen bonds within tropocollagenic triple helix break (figure 23, right), and a 
majority of triple helix disappear. Therefore, the hydrogel chains become more mobile and the 
swelling of hydrogel is increased. However, on increasing the temperature from 30°C to 50°C, the 
hydrogel chains must have acquired complete relaxation, so that with a further increase in 
temperature, they do not loosen and, as a consequence, no appreciable change in swelling behavior 
could be observed at a higher temperature. 
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Fig. 23: Scheme illustrating a gelatin hydrogel network [68]. 
 
 
 
Fig. 24: The effect of temperature on the weight equilibrium swelling ratio in distilled water. (A): Swelling 
behavior of hydrogels at different temperature. (B): Viability of swelling ratio immerging in distilled water 
for 24h at different temperature [68]. 
 
c) Effect of pH   
Ionic hydrogels exhibit swelling changes at a wide range of pH values. Since the swelling capacity 
of all “ionic” hydrogels is appreciably decreased by addition of counter ions to the swelling medium 
[72] , without any buffer solutions.  
Haixia Ren et al. [68], have used a series solutions with acidic and basic pH values, prepared by 
dilution of NaOH (pH 12.0) and HCl (pH 1.0) solutions to achieve pH>6.0 and pH < 6.0, 
respectively.  
 40 
 
Figure 25 (A) shows the effect of pH on the swelling ratio of hydrogel. The results clearly indicate 
that the hydrogel exhibits extensive swelling in the swelling medium of pH<2 and pH>8, whereas 
the hydrogel demonstrates low degree of swelling in the medium between pH 3 to pH 7.  
In general, a polyampholytic gelatin hydrogel crosslinked presents a network that contains positive 
and negative ionizing groups. In acidic medium, gelatin acts as base and takes up H
+
 ions from the 
medium forming -NH3
+
 and -COOH and proteins become positively charged. In alkaline medium, 
protein acts as an acid gives H
+
, forming -COO
-
 and – NH2 groups and proteins become negatively 
charged. In an acidic environment, the swelling is controlled mainly by the -NH3
+
, in basic medium 
by COO
-
, and between pH 3.0 and 7.0 by -NH3
+
 and COO
-
. In figure 25 (A), we can observe that in 
basic medium the swelling is higher; this behavior is due to the presence of the hydrophilic 
functional groups (mainly COO
-
) in the gelatin structure. Moreover, the gelatin hydrogels begin 
hydrolyze in a pH close to 11.0, giving up carboxy groups, which also result in increasing of 
swelling ratio. The swelling datum of pH 12 was not present in figure 25 (A) because the hydrolysis 
degree of hydrogel sample was too severe to measure the swelling ratio accurately. 
 
d) Effect of salts  
The swelling ratio is mainly related to the characteristics of the external solution, such as charge 
number, ionic strength and polymer nature, i.e. network elasticity, presence of hydrophilic 
functional groups, and extent of crosslinking density [73].  
Same study have demonstrated that the electrolyte effect has been observed by adding univalents 
salts to the external solution in the concentration range 0.05M to 0.5 M and the results are depicted 
in figure 25 (B). It could be noted that the swelling ratio of the hydrogel increased in the 
concentration range investigated. This situation between the swollen hydrogel and the surrounding 
aqueous phase is usually described as a Donnan equilibrium where the biopolymer network acts as 
its own membrane [74,75] thus preventing the diffusion of the attached ionizing groups toward 
aqueous phase. Therefore, the osmotic pressure resulting from the mobile ion concentration 
difference between the gel and aqueous phase increased in a certain range of NaCl concentration, 
and consequently, the swelling ratio increased. A similar type of increase has also been reported by 
Baker [76] and Bajpai [77] in ampholytic and non-ionic acrylamide based hydrogels. The effect of 
cation type (cations with different radius and charge) on swelling behavior is shown in figure 25. 
From these data, a distinct effect on swelling ratio could be found for trivalent cations (FeCl3, 
CrCl3) comparing to monovalent (NaCl) and divalent (CaCl2). Electrostatic screening effect and 
ionic crosslinking are the main explanations for the intense loss of swelling [73]. The electrostatic 
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screening effect of salt can weaken the electrostatic interaction and de-swell hydrogel through 
causing a non-perfect anion-anion electrostatic repulsion. As for ionic crosslinking, it is well known 
that gelatin hydrogels consisting of carboxylic groups can chelate with multivalent cations, such as 
Cr
3+
, and Fe
3+
 ions, which leads to network contraction and decreases porosity of the gel network, 
therefore, results in the deswelling of hydrogels. It could be noted from figure 26 that CaCl2 affect 
the swelling behavior of hydrogel non significantly, and the swelling ratio was slightly higher than 
that in distilled water. Moreover, the swelling ratio increases when NaCl concentration range is 
from 0.05M to 0.5 M. Therefore, the effect of the ionic crosslinking acts as more effective factor 
against swelling rather than the electrostatic screening effect of the cation [68]. 
 
 
(A)                                                     (B) 
Fig. 25: (A) Effect of pH of solutions on swelling capacity of the hydrogel at 25°C for 12h [68]; (B) The 
swelling ratio of the hydrogel in NaCl solution with the concentration range 0.05M  to 0.5M 25°C for 12h. 
 
 
Fig. 26: Swelling capacity of hydrogel in different chloride salt solutions at 25°C for 12h [68]. 
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Dissolution. The dissolution of a polymer into water involves two transport processes, solvent 
diffusion and chain disentanglement [78]. The dissolution of an uncross-linked, amorphous, glassy 
polymer occurs when a solvent diffuses into the polymer forming a gel-like layer. This layer is 
formed due to the increased mobility of the polymer strands and is contiguous to the solvent-
polymer front. After an induction time (dissolution is not immediate upon polymer exposure to 
water), the polymer dissolves [78].  
Semicrystalline polymers, such as cross-linked gelatin, undergo a slightly different dissolution 
process. Semicrystalline polymers contain both amorphous and crystalline sections spread 
throughout the polymer. An additional step, unfolding of the crystalline regions, must take place in 
order for the polymer to dissolve when exposed to a solvent. The penetration of solvent into the 
amorphous sections is fast and extensive because of their lower density, producing high initial 
swelling rates and leading to high equilibrium uptakes [79]. Crystalline regions are more tightly 
ordered with a higher density resulting in a limited and slower penetration of the solvent. The 
equilibrium swelling of the crystalline sections is considerably less extensive than that of the 
amorphous regions because the regular arrangement of the polymer chains in the crystallites results 
in greater lateral interchain attraction and greater elastic forces resisting expansion and swelling 
[79]. The final step in the dissolution process is chain disentanglement in which the polymer 
structure falls apart and dissolves. 
The dissolution of polymer and non-polymer materials differs in two ways. Polymers require an 
induction time before starting to dissolve, while non-polymeric materials can dissolve 
instantaneously [78]. The external mass transfer resistance through a liquid layer adjacent to the 
solid-liquid interface (diffusion layer and its thickness) generally controls non-polymeric material 
dissolution. Polymer dissolution can be controlled either by the disentanglement of the polymer 
chains or by diffusion of the chains through a boundary layer adjacent to the solvent-polymer 
interface [78]. These processes contribute to the induction time prior to the polymer dissolution. 
 
Type of chemical bond  importance for polymer degradation. It is mainly the type of bond 
within the polymer backbone that determines the rate of hydrolysis [80]. Several classifications for 
ranking the reactivity exist which are either based on hydrolysis kinetics data for polymers [81,82] 
or are extrapolated from low-molecular weight compounds containing the same functional group 
[83]. Reactivities can change tremendously upon catalysis [84,85] or by altering the chemical 
neighborhood of the functional group [86] through steric and electronic effects in is demonstrated 
that steric effects decrees the degradation, because the voluminous group hinders the attack of 
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water. Polymer erosion is far more complex than degradation, because it depends on many other 
processes, such as degradation, swelling, the dissolution and diffusion of oligomers and monomers, 
and morphological changes. Although degradation is the most important process of erosion, 
depending on the type of polymer, other parameters may also become critical in controlling erosion 
behavior. The knowledge of the erosion mechanism is, therefore, most important for the successful 
application of a degradable polymer. In tissue engineering, surface properties or porosity determine 
the performance of implantable scaffolds [87]. For example, in drug delivery, swelling and porosity 
are critical to the release behaviour of drugs”. As with degradation, many different indicators of 
erosion have been proposed, such as molecular weight loss, sample weight loss and changing 
geometry. 
 
Degradation and erosion phenomena. All degradable polymers share the property of eroding 
upon degradation. Degradation and erosion are the decisive performance parameters of a device 
made of such materials. To classify degradable polymers a distinction is made between surface [or 
heterogeneous) and bulk (or homogeneous) eroding materials [88], which is illustrated in figure 27. 
During an application, surface eroding polymers lose material from the surface only. They get 
smaller but keep their original geometric shape. For bulk eroding polymers, degradation and erosion 
are not confined to the surface of the device. Therefore, the size of a device will remain constant for 
a considerable portion of time during its application [89]. 
 
 
Fig. 27: Schematic illustration of surface erosion and bulk erosion [90]. 
 
The first morphological changes during erosion are confined to the polymer surface. With 
proceeding erosion, polymers change to more porous structures [90]. 
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As already mentioned, the degradation rate depends strongly on pH. Through the chain scission, 
polymers are transformed into oligomers and monomers, which have different functional groups 
than the polymer [90]. 
 
 
 Cellulose 
Cellulose is the world’s most abundant natural, renewable and biodegradable polymer. It is 
produced by various species in nature, both plants and other organisms. It has versatile properties 
such as hydrophilicity, chirality, biodegradability, biocompatibility etc. Similarly to other 
polysaccharides, cellulose has a long background in medical applications, essentially due to its lack 
of toxicity (monomer residues are part of metabolites found in the human body), water solubility or 
high swelling ability, and stability to temperature and pH variations. The biocompatibility of 
unmodified and derivative cellulose is well documented.  
 
Chemical properties. The structure of cellulose can be described as a carbohydrate polymer with 
repeating D-glucose units which are covalently linked through β(1→4)-glycosidic bonds. The most 
stable conformation about the β(1→4) linkage involves alternating 180° flips of every second 
glucose unit, so that the repeating unit of cellulose is rather a cellobiose molecule than a glucose 
unit.  
 
Fig. 28: The cell wall hierarchy, from a single cellulose polymer to the cellulose fibre composite. 
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Thus, cellulose is a polymer with multiple hydroxyl groups which form hydrogen bonds with 
oxygen atoms on the same or an adjacent chain, holding the chains firmly alongside each other. In 
other words, the cellulose molecules form long, straight chains which are strengthened by 
intramolecular hydrogen bonds and van der Waals interaction, which pack together to form 
crystalline structures. Cousins and Brown Jr. [91] also showed that the hydrophobic groups 
contributed to the crystal stability by calculating the inter- and intramolecular energy for cellulose 
forms. 
Due to its supra-molecular structure, the solid state of cellulose reveals as both crystalline (high 
order) and amorphous (low order). The crystalline structure of native cellulose appears as cellulose 
I, presenting in two polymorphs: triclinic (Iα) and monoclinic (Iβ) which appear alongside each 
other. Iα and Iβ are two crystalline allomorphs phases of native cellulose (cellulose I) [92]. The 
main difference between the two crystalline phases is the relative position of the chains to each 
other. This difference brings a staggered conformation to the cellulose chains in the Iβ phase, 
stabilising the structure like bricks in a wall. Allomorph Iα can irreversibly be transformed into Iβ 
by annealing (slightly heating), thus Iβ is the most stable phase. 
Corresponding to the inter- and intra- molecular hydrogen bonds, cellulose may occur in other 
crystal structures, e.g. cellulose II, III and IV. By treatment with aqueous sodium hydroxide 
(mercerization) or by dissolution of the cellulose followed by precipitation, cellulose II which has 
an antiparallel orientation, in contrast to native cellulose parallel chains (figure 29) can be formed. 
The conversion cannot be reversed, indicating that cellulose II is more stable. Cellulose III and IV 
can be produced by treatment with various chemicals and in combination of heating and pressure 
[93- 94]. 
 
Fig. 29: Projection of a two-chain model of cellulose I and II. (a) cellulose I: parallel orientation;                
(b) cellulose II: anti-parallel orientation [93]. 
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The properties and numerous applications of cellulose depends highly on its chain length and its 
fiber morphology. The chain length, i.e the number of glucose units, varies with the origins and the 
chemical treatment of the raw materials. The chain length for a cellulose from wood pulp is 
between 300 and 1700 units; cotton and other plant fibers have the values ranging from 800 to 
10,000 units; bacterial cellulose are observed to have similar range as cotton and other plant fibers. 
The number of the repeating units of the regenerated cellulose varies depending on the 
dissolution/regeneration process, Klemm et al.[94] reviewed that it is about 250-500. Powdery 
cellulose can be produced from partial chain degradation, yielding chain length of 150-300 units, 
e.g microcrystalline cellulose. 
Cellulose is insoluble in water and in most conventional organic solvents. Most of the literatures 
agree on that the insolubility of cellulose is due to the hydrogen bonding between cellulose and the 
solvent. However, Lindman et al. [95] has another explanation on that, which is that the 
amphiphilic property of the cellulose draws strong attention to the hydrophobic interactions which 
may result in low aqueous solubility. Yamane et al. [96] also reported the hydrophobic nature of 
cellulose from a structural point of view. 
 
Cellulose derivatives. This work is focused on the preparation of new environmentally friendly 
hydrogels derived from cellulose and hence originating from renewable resources and characterized 
by biodegradable properties. Two cellulose derivatives, sodium carboxymethylcellulose (CMCNa) 
and hydroxyethylcellulose (HEC), were used for superabsorbent hydrogel preparation. CMCNa and 
HEC are crosslinked hydrophilic polymers insoluble in water, but capable to absorb large amounts 
of water through a swelling process. Swollen hydrogels swell to a volume much larger than their 
original size with a weight 10–1000 times higher than their initial one. The swelling capacity of 
hydrogels has been studied by different authors, as already reported for gelatin. It is well known that 
the presence of fixed charges, typical of polyelectrolyte gels, determines a significant swelling of 
the polymer in water. This behavior is due to a Donnan equilibrium established between gel and the 
external solution, whose ionic strength strongly affects the swelling degree [97]. In the previous 
works, [98,99] cellulose-based superabsorbent hydrogels, with sorption properties similar to those 
displayed by traditional acrylate-based products were synthesized and characterized by reacting in 
water mixtures of CMCNa and HEC crosslinked with divinylsulphone (DVS) or with a 
carbodiimide crosslinking agent. In this study citric acid (CA), a new crosslinking agent able to 
overcome toxicity and costs compared with the former reagents was selected. 
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Cellulose crosslinking reaction. CA, widely used in food and drug industry, is an excellent 
crosslinking agent. CA, extensively widespread in nature (lemon juice contains  5% of CA), is 
prepared commercially by fungal fermentation of glucose. CA and its salts, with a good affinity for 
metal ions, are used in a wide variety of applications: in soft drinks and effervescent salts, as an 
antioxidant in food, as a sequestering agent for metal ions, as a cleaning, and polishing agent for 
metals, as a mordant in dyeing. Moreover, CA and its salts have fundamental biological functions. 
For example, CA is involved as intermediate in the ‘‘Krebs cycle’’ in all living cells, also known as 
‘‘citric acid cycle’’ for the production of usable energy [100]. Recently, CA was used as 
crosslinking agent in various cellulose derivative systems [100-102] and different mechanisms have 
been proposed in the literature to explain the crosslinking reaction of cellulose polymers with CA. 
Xie et al. [102] for example, studied the optimum conditions for corn starch and CA reaction to 
produce resistant starch and studied the thermal stability of citrate starch products. The authors 
reported that when CA is heated, it will dehydrate to yield the cyclic anhydride that reacts with 
starch; successively anther cyclic anhydride function can be achieved into CA structure through the 
other two non-reacted carboxylic groups allowing the attachment of another hydroxyl starch group 
(Fig. 30). Coma et al. [101] carried out the crosslinking of hydroxypropyl- methyl cellulose with 
CA simply heating the reagents and determining the rate of crosslinking. According to Zhou et al. 
[103] the two main stages of the reaction of polyfunctional carboxylic acids with cellulose are due 
to the attachment of the polyfunctional carboxylic acids via esterification with a cellulosic hydroxyl 
group and its further reaction- via esterification- with another cellulosic hydroxyl group producing a 
crosslink between cellulose chains. This mechanism is based on an anhydride intermediate 
formation. Attachment of the carboxylic acid moiety to celluloses hydroxyl group via esterification 
reaction of the first cyclic anhydride would expose a new carboxylic acid unit in CA, which has the 
proper chemical connectivity to form a new intra molecular anhydride moiety with the adjacent 
carboxylic acid unit. Further reaction with a cellulose hydroxyl of another chain can then lead to 
crosslinking [104]. 
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Fig. 30: Possible crosslinking reaction mechanism of citric acid with cellulose. 
  
 Inorganic phase: Hydroxyapatite 
In the last 30 years, the synthesized calcium phosphate compounds have generated a great deal of 
interest because of the wide variety of their medical applications, especially in orthopedics and 
plastic and dental surgery. These bioceramics are biocompatible and bioactive because they display 
links with bone. Among these compounds hydroxiapatite, HA [Ca10(PO4)6(OH)2] has the chemical 
structure of the mineral component of bones. Infact, its synthetic formulation resembles with the 
crystalline bioapatite mineral which constitutes 45% by volume, 65% by weight of the mineral 
fraction of human bone [105]. Moreover, also the extracellular matrix of bone has been described as 
a composite material composed of collagen type I fibrils mineralized with nanocrystals of 
hydroxyapatite. Approximately 70% of bone by weight is composed of calcium salts, with 
hydroxyapatite (Ca10(PO4)6(OH)2 as the primary mineral constituent. Strictly speaking, bone 
mineral is not purely hydroxyapatite, and the presence of ion impurities has actually led to the 
consensus that a more accurate term for the inorganic component is carbonatehydroxyapatite with 
the formula (Ca,Mg,Na)10(PO4HPO4CO3)6(OH)2 [23]. Devoid of an organic component, calcium 
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salts such as hydroxyapatite are biocompatible, nonimmunogenic components of bone and are 
considered to be osteoconductive. Consequently, there has been much interest in designing 
synthetic osteoconductive grafting materials based on these naturally occurring calcium salts. HA is 
widely used to repair, fill, extend and reconstruct damaged bone tissue. It can also be used in soft 
tissue. Since 1920 its powder has been used with the aim of promoting bone consolidation [106]. 
This crystalline molecule was firstly used as a coating for metallic implants in order to improve the 
osteoconductive and osteointegrative properties of the prostheses [107]. This material can be 
obtained from mammal bones or coral. In the lab, it can be synthesized by reactions in solid state, 
co-precipitation, hydrothermal methods, or sol-gel process, among others. Precipitation in aqueous 
solutions is the  experimental procedure most employed because HA is insoluble in water. The 
molar ratio of calcium to phosphorus Ca/P varies from 1.2 to almost 2 in HA. The stoichiometric 
molar ratio of HA is 1.67; however, this is not the value observed in the organism because small 
amounts of other materials such as carbon, nitrogen, iron and another elements are incorporated. 
Thus, the general chemical formula is Ca10x(HPO4)x(PO4)6x(OH)2x where Young and Posner [108] 
determined the crystal structure of HA.  
Numerous synthetic CaP biomaterials are commercially available [23] as hydroxyapatite, unsintered 
calcium deficient apatite, beta-tricalcium phosphate, or biphasic calcium phosphate. Hydroxyapatite 
can be produced with either a dense or macroporous morphology, and is typically sintered at 
temperatures above 1000 °C in granular or block forms. The high heat of sintering produces a 
material that cannot be reshaped to fit into a bone defect (i.e. if in block form) and is non-
resorbable. Beta-tricalcium phosphate (β-TCP) has the formula Ca3(PO4)2 and like hydroxyapatite 
is a brittle material with low fracture resistance. Both hydroxyapatite and β-TCP are biocompatible, 
osteoconductive, and bioactive (i.e. they develop a direct, adherent bond with bone) [23]. 
Under physiological conditions, hydroxyapatite is essentially a non-resorbable material, while on 
the other hand β-TCP has been shown to degrade within 6 weeks after implantation [109]. The 
dissolution of CaP biomaterials is dependent on composition (hydroxyapatite vs. β-TCP ratio), 
surface area of the implant (particulate vs. block form), porosity, and crystallinity (sintering creates 
larger, slower dissolving crystals) [23]. 
Biphasic CaP products which contain hydroxyapatite and β-TCP in various ratios (the higher the β-
TCP content, the greater the resorbability [110] are aimed at the provision of a bone grafting 
material which is able to degrade within a physiologically optimized time frame, while providing 
some measure of mechanical stability until sufficient bone in-growth has occurred [109]. CaP 
cements are also available, and these combine a dry powder (CaP) and a liquid component (i.e. an 
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inorganic or organic acid, or sodium phosphate solutions) in a setting reaction that occurs under 
physiologic pH and temperatures [23]. A variety of CaP compounds have been used for the solid 
phase such as dicalcium phosphate, dicalcium phosphate dihydrate, calcium-deficient 
hydroxyapatite, and amorphous calcium phosphate. These cements are injectable and able to be 
molded for variable periods before hardening. They are also described as resorbable, though clinical 
experience has demonstrated retention of the material over extended periods. While CaP cements 
have been successfully used for clinical applications such as vertebroplasty [111] and bone defect 
repair, they are brittle and contraindicated for use in areas of mobility, active infection, or in 
situations where they directly contact the sinuses or dura. 
At the beginning of the 70’s, it was shown that HA displayed two crystalline systems, hexagonal 
and monoclinic. HA contained in teeth and bones and mineral HA present a hexagonal structure; 
instead of dental enamel HA has a monoclinical structure. HA obtained in the lab presents a 
structure which depends on the of method synthesis [112,113] 
 
 
 Graphene oxide 
Graphene, a free-standing 2D crystal with one-atom thickness, has become one of the hottest topics 
in the fields of materials science, physics, chemistry, and nanotechnology [114]. This allotrope of 
carbon comprises layers of six-atom rings in a honeycombed network and can be conceptually 
viewed as a true planar aromatic macromolecule [115]. As a basic building block of other carbon 
allotropes, graphene can be wrapped to generate 1D fullerenes, rolled up to form 2D carbon 
nanotubes, and stacked to produce 3D graphite [116]. Although graphene is the fundamental basis 
of different carbon forms, it was first prepared unambiguously in 2004, 440 years after the 
invention of graphite, by peeling a single layer of graphene using sticky tape and a pencil [117]. 
During the past several years, various methods for producing graphene have been developed, such 
as micromechanical exfoliation, chemical vapour deposition, epitaxial growth, and chemically 
synthesis. Although it is considered as the basic block of carbon allotropes, graphene exhibits 
distinctly different properties, such as its unusual structural characteristics and electronic flexibility 
[118-120]. Other extraordinary properties include high planar surface (calculated value, 2630m
2
/g) 
[121], superlative mechanical strength (Young’s modulus,1100 GPa) [122], unparalleled thermal 
conductivity (5000 W/m/K) [123], and remarkable electronic properties. 
As a result of the unique chemical and physical properties mentioned above, graphene and 
graphene-based nanomaterials have attracted strong interest in biological studies [124-127]. Various 
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graphene-based nanomaterials [128-133] have been used to fabricate functionalized biosystems 
integrated with nucleic acids (NAs), peptides, proteins and even cells. Moreover, the discovery of 
the adsorption of single-stranded DNA (ssDNA) onto graphene sheets, the ability of graphene to 
quench electron donors, the ability of graphene to protect biomolecules from enzymatic cleavage, as 
well as transportation capability in living cells and in vivo systems, have revealed the potential for 
graphene application in biological studies and biotechnology [134]. 
 
Synthesis of GO. Despite the relative novelty of graphene as a material of broad interest and 
potential [119,135]. GO has a history that extends back many decades to some of the earliest studies 
involving the chemistry of graphite. The first, well-known example came in 1859 when British 
chemist Brodie was exploring the structure of graphite by investigating the reactivity of flake 
graphite. One of the reactions he performed involved adding ‘‘potash of chlorate’’ (potassium 
chlorate; KClO3) to a slurry of graphite in fuming nitric acid (HNO3) [136]. Brodie et al.  
determined that the resulting material was composed of carbon, hydrogen, and oxygen, resulting in 
an increase in the overall mass of the flake graphite. He isolated crystals of the material, but the 
interfacial angles of the crystal lattice were unable to be measured via reflective goniometry. 
Successive oxidative treatments resulted in a further increase in the oxygen content, reaching a limit 
after four reactions. Nearly 40 years after Brodie’s seminal discovery of the ability to oxidize 
graphite, Staudenmaier improved Brodie’s KClO3-fuming HNO3 preparation by adding the chlorate 
in multiple aliquots over the course of the reaction (also, with the addition of concentrated sulfuric 
acid, to increase the acidity of the mixture), rather than in a single addition as Brodie had done. This 
slight change in the procedure resulted in an overall extent of oxidation similar to Brodie’s multiple 
oxidation approach, but performed more practically in a single reaction vessel [137]. Nearly 60 
years after Staudenmaier, Hummers and Offeman developed an alternate oxidation method by 
reacting graphite with a mixture of potassium permanganate (KMnO4) and concentrated sulfuric 
acid (H2SO4), again, achieving similar levels of oxidation [138]. Though others have developed 
slightly modified versions, these three methods comprise the primary routes for forming GO, and 
little about them has changed. Importantly, it has since been demonstrated that the products of these 
reactions show strong variance, depending not only on the particular oxidants used, but also on the 
graphite source and reaction conditions.  
 
Structural features. Aside from the operative oxidative mechanisms, the precise chemical 
structure of GO has been the subject of considerable debate over the years, and even to this day no 
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unambiguous model exists. There are many reasons for this, but the primary contributors are the 
complexity of the material (including sample-to-sample variability) due to its amorphous, 
berthollide character (i.e. non-stoichiometric atomic composition) and the lack of precise analytical 
techniques for characterizing such materials (or mixtures of materials). Despite these obstacles, 
considerable effort has been directed toward understanding the structure of GO, much of it with 
great success. 
Many of the earliest structural models of GO proposed regular lattices composed of discrete repeat 
units. Hofmann and Holst’s stucture (figure 30) consisted of epoxy groups spread across the basal 
planes of graphite, with a net molecular formula of C2O [139].  Another remarkable model by 
Nakajima and Matsuo relied on the assumption of a lattice framework akin to poly(dicarbon 
monofluoride), (C2F)n, which forms a stage 2 graphite intercalation compound (GIC) [140]. These 
individuals also made a valuable contribution to understanding the chemical nature of GO by 
proposing a stepwise mechanism for its formation via 3 of the more common oxidation protocols 
[141]. The most recent models of GO have rejected the lattice based model and have focused on a 
nonstoichiometric, amorphous alternative. Certainly the most well-known model is the one by Lerf 
and Klinowski (figure 30). Lerf and Klinowski have published several papers on the structure and 
hydration behavior of GO, and these are the most widely cited in the contemporary literature. The 
initial studies done by Lerf and coworkers used solid state nuclear magnetic resonance (NMR) 
spectroscopy to characterize the material [142]. This was a first for the field as earlier models relied 
primarily on elemental composition, reactivity and X-ray diffraction studies. By preparing a series 
of GO derivatives, Lerf was also able to isolate structural features based on the material’s reactivity 
[143].  
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Fig. 31: Summary of several older structural models of GO 
 
 
 
Fig. 32: Variations of the Lerf-Klinowski model indicating ambiguity regarding the presence (top [143]), or 
absence  (bottom, [142])  of carboxylic acids on the periphery of the basal plane of the graphitic platelets of 
GO. 
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After several analyses about fundamental structural features of GO, it is clear the necessity of more 
complex picture to define the material. Lerf and coworkers determined that the double bonds were 
likely either aromatic or conjugated, the logic being that isolated double bonds would be unlikely to 
persist in the strong oxidizing conditions used (a modified Hummers method). 
This revised Lerf–Klinowski model earlier indicates that carboxylic acid groups were present in 
very low quantities at the periphery of the graphitic platelets, in addition to other keto groups. As 
Brodie observed in 1859, along with many others since, Lerf and coworkers noted the thermal 
instability of GO. The decomposition process is known to involve the evolution of CO and CO2, 
rather than O2, due to the high surface reactivity of GO itself. Though the Lerf–Klinowski model 
remains largely unchanged since its initial report over 10 years ago, others have made slight 
modifications to the proposed structure including the presence of 5- and 6-membered lactols on the 
periphery of the graphitic platelets as well as the presence of esters of the tertiary alcohols on the 
surface, though all accounts maintain the dominance of epoxides and alcohols on the basal 
plane[146,145]. Cai et al. have also recently demonstrated the ability to isotopically label GO, 
greatly expanding the scope of potential spectroscopic techniques [148]. One notable exception to 
this adherence to the Lerf– Klinowski model has been proposed by Dekany and coworkers (figure 
33)[146] The Dekany model work revived and updated the Ruess and Scholz–Boehm models, 
which suggested a regular, corrugated quinoidal structure interrupted by trans-linked cyclohexyl 
regions, functionalized by tertiary alcohols and 1,3-ethers. 
 
 
Fig. 33: Structure of GO proposed by Dekany and coworkers [148]. 
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Dekany model is composed of two distinct domains: trans-linked cyclo-hexyl species interspersed 
with tertiary alcohols and and 1,3-ethers, and a corrugated network of keto/quinoidal species. No 
carboxylic acids are believed to be present in this description of GO.  
As a final note, variations in the degree of oxidation caused by differences in starting materials 
(principally the graphite source) or oxidation protocol can cause substantial variation in the 
structure and properties of the material, rendering the term ‘‘graphite oxide’’ somewhat fluid, and 
subject to misinterpretation. This experimental observation has been compared with density 
functional calculations, which predict that partial oxidation is thermodynamically favored over 
complete oxidation [147]. However, the exact identity and distribution of oxide functional groups 
depends strongly on the extent of coverage. This is illustrated in the theoretical prediction that the 
ratio of epoxides to alcohols increases with increasing oxidation [147].  
 
Chemical functionalization. An important GO aspect is the possibility to add other groups on 
graphene oxide platelets using various chemical reactions that provide for either covalent or non-
covalent attachment to the resulting chemically modified graphenes (CMGs). Such approaches, 
which add functionality to groups already present on the graphene oxide, render graphene/graphite 
oxide a more versatile precursor for a wide range of applications. Graphene oxide platelets have 
chemically reactive oxygen functionality, such as carboxylic acid, groups at their edges (according 
to the widely accepted Lerf–Klinowski model), and epoxy and hydroxyl groups on the basal planes. 
An ideal approach to the chemical modification of graphene oxide would utilize orthogonal 
reactions of these groups to selectively functionalize one site over another. Demonstration of the 
selectivity of these chemical transformations remains challenging, however. In some instances, 
reaction with multiple functionalities is possible, and the wide range of chemical compositions 
present in the reactant known as ‘‘graphene oxide’’ makes isolation and rigorous characterization of 
the products practically impossible. 
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CHAPTER 2    
INJECTABLE MODIFIED HYDROXYAPATITE GEL FOR BONE 
DEFECT 
 
n the past decade osteoporosis has been widely recognized as a major health issue by medical 
profession. Public awareness has increased the demands on healthcare agencies. Many 
definitions of osteoporosis have been offered to describe variously the outcome events (fragility 
fractures), the process giving rise to porous bones, or the resultant diminution of bone mass. In 
particular, osteoporosis is a disease where bone resorption occurs faster than new bone 
production, causing the trabeculae to become thinner, which leads to a reduction in total bone 
density and strength. The disease eventually leads to bone fracture, especially in the hip, wrist, knee 
and spine. So, we propose an injectable systems (strontium-substituted hydroxyapatite cement) in 
order to stimulate osteoblast differentiation and inhibit osteoclast differentiation. 
In general injectable materials (cements/natural polymer) hold great promise in tissue engineering 
applications due to the ability of these systems to conform to complex bone shapes, contours, and 
defects without invasive operations, thus reducing the negative aesthetic effects associated with 
these repeated procedures. In this chapter we describe different approaches to repair bone defects 
and to promote a potential osteoporosis-decrease-filler. The target is the osteogenic differentiation 
induced by polymeric (cellulose) or inorganic (hydroxyapatite) matrix of injectable systems, 
proposed as a filler materials. To increase matrix properties, we suggest different treatments or 
chemical modifications: 
4. Strontium-substituted hydroxyapatite cement (to contrast osteoporosis effects). 
5. Bioactive hydroxyapatite - graphene oxide (to support high viability and osteogenic 
differentiation of  hMSC cells).    
6. Modified-cellulose hydrogels crosslinked by citric acid (to increase hydrophilicity and 
roughness surface in order to stimulate osteogenic differentiation of hMSC). 
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2.1 STRONTIUM-SUBSTITUTED HYDROXYAPATITE CEMENT 
 
Introduction 
Osteoporosis is a systemic disease ‘‘characterized by low bone mass and microarchitectural 
deterioration of  bone tissue, leading to enhanced bone fragility and a consequent increase in 
fracture risk’’ [1], which results from an impaired balance of bone resorption and formation by 
osteoclasts and osteoblasts, respectively. For the year 2000, the number of primary osteoporosis-
related fractures was estimated to be 9 million worldwide, with 61% of fractures occurring in 
women [2]. Considering the worldwide demographic development, the burden of osteoporosis will 
further increase in the near future. Various therapies have been developed for the clinical treatment 
of osteoporosis based on either the inhibition of bone resorption (e.g. by bisphosphonates, strontium 
ranelate SrR, RANKL antibody denosumab) or the anabolic stimulation of bone formation (e.g. by 
parathyroid hormone peptides, SrR) [3,4]. The impact of strontium(II), acting both as an inhibitor of 
resorption as well as a stimulus of bone formation, has already been demonstrated in vitro and in 
vivo [4–6]. Strontium was shown to affect cellular processes via the membrane-bound calcium 
sensing receptor (CaSR), not only in osteoblasts but also in cells of the osteoclasts lineage, where 
CaSR interaction with strontium can inhibit pre-osteoclast maturation and induce apoptosis in 
mature osteoclasts [7,9,10]. Mesenchymal stem cell as well as pre-osteoblast proliferation and 
differentiation into bone-forming osteoblasts is enhanced by the presence of strontium as well as the 
rate of extracellular matrix formation and mineralization (new bone deposition) [4,5,7]. This effect 
is based on an influence of Sr
2+
 on the Wnt/b-catenin pathway resulting in enhanced extracellular 
matrix formation [4] and triggering of mitogenic signalling [8]. 
Furthermore, Bakker et al. recently found evidence that SrR affects the signalling between 
osteocytes and both osteoblasts and osteoclasts [11]. The mechanism is thought to lie in Sr
2+
 having 
the ability not only to increase osteoblast-related gene expression and the alkaline phosphatase 
(ALP) activity of mesenchymal stem cells (MSCs), but also to inhibit the differentiation of 
osteoclasts [12]. As a result, Sr
2+
 is thought to be effective in enhancing the bioactivity and 
biocompatibility of  biomaterials and, in particular, to have potential in the treatment of 
osteoporosis [13,14]. A poly(methyl methacrylate) bone cement containing Sr-containing calcium 
phosphate has been reported to have enhanced bioactivity and biocompatibility, said to be due to the 
release of Sr
2+
, which not only promoted osteoblast proliferation, but also facilitated precipitation of 
apatite, and thus increased the mechanical strength of the bone–implant interface [15,16]. An 
injectable, Sr-containing calcium phosphate bone cement (CPC) could meet the requirements of 
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vertebroplasty because its radio-opacity was three times that of cortical bone [17]. Recently, 
attention has been given to the modification of bioceramics with Sr, which has tended to enhance 
their biological performance, including 45S5 bioglass [18], hydroxyapatite (HA) [19] and α- and β-
tricalcium phosphate [20,21]. 
In vivo tests with strontium-substituted hydroxyapatite (Sr/Ca = 0.10) cement were performed using 
a rabbit hip replacement model and an apatite layer was found six months later between the cement 
and the cancellous bone [22]. As reported, strontium-containing hydroxyapatite (Sr-HA) appears to 
be an interesting bone substitute material. Because of the difference in the atomic radius between 
strontium and calcium, the crystal lattice becomes distorted and therefore the Sr-HA stability 
decreases, facilitating its replacement by new bone [23].  Moreover, the ability of strontium to 
stabilize the apatitic structure against degradation by bacterial acids may be useful in preventing 
dental caries, considering the significant differences in strontium content in human enamel for high 
and low caries populations (104.1 and 184.0 µgg
-1
, respectively) [24]. The inorganic phase 
constituting bone is a non-stoichiometric calcium-deficient apatite whose crystal structure is 
basically that of hydroxyapatite (HA); for this reason synthetic apatites are typically used as elective 
bone substitutes. Sr-substituted apatite powders have been prepared by ion exchange of Sr for Ca 
using a biomimetic approach  [25] as well as by chemical synthesis [26,27]. Here, we propose 
Strontium - modified CaP gels obtained at room temperature by using sol-gel method. In fact, sol-
gel synthesis approach appears to be among the most suitable route towards performing injectable 
calcium phosphate cements [28,29]. 
The sol-gel approach has recently attracted attention because of the well-known inherent advantages 
that include a homogeneous “molecular” mixing of the components, high purity of the final 
products, possibility to produce hybrid materials [30-32] and low temperature of synthesis allowing 
the incorporation of bioactive molecules.  
Furthermore, the method allows the synthesis of calcium phosphate gels at different pHs where the 
gel formation is achieved without the need of any refluxing steps required for the synthesis by wet-
chemical method [33]. In particular, calcium phosphate obtained by sol-gel synthesis combines 
hydroxyapatite (HA) with other calcium phosphate phases such as dicalcium phosphate (DCP), a 
precursor of natural HA in bone [34]. As sintered HA has a relatively slow rate of resorption in 
vivo, dicalcium phosphate (DCP) and dicalcium phosphate dehydrate (DCPD) have also been 
considered for their relatively more rapid resorption rate. The effect of these modified gel materials 
on the proliferation and differentiation of cell line osteoblast-like cells and stem cells have been 
studied in the light of the biomaterial compositional changes. 
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2.1.1 Materials and Methods 
 2.1.1.1 Synthesis of Sr modified Hydroxyapatite gels 
Sr-HA gels containing 5 - 10 - 15 and 20 mol % Ca
2+
 replaced by Sr
2+
 were synthesized  at room 
temperature by using calcium nitrate tetrahydrated Ca(NO3)2·4H2O (Sigma-Aldrich, Italy) and  di-
ammonium hydrogen phosphate (NH4)2HPO4  (Sigma-Aldrich, Italy) as precursors and using water 
as solvent. Strontium nitrate Sr(NO3)2 (Sigma-Aldrich, Italy) was dissolved in water and used to 
replace Ca
2+
 ions.   In particular, the procedure (figure 1A) consists of adding di-ammonium 
hydrogen phosphate (NH4)2HPO4 in water and, after 30min the medium alkalinity was adjusted by 
drop-wise addition of NH4OH up to pH 9 (P solution). Calcium nitrate tetrahydrated  was dissolved 
in water at room temperature (Ca solution); then Sr(NO3)2 was added forming Ca+Sr solution. After 
mixing for 20min, P solution was added drop wise to Ca+Sr solution in proper proportion in order 
to achieve a Ca+Sr/P ratio of about 1.67. CaP solutions were placed in a shaking incubator at 100 
rpm, 37°C until gelling occurred. After gelling the gels were dialysed in 0.01M phosphate buffered 
saline pH 7.4 until equilibrated to the buffer pH.  
 
 
 
Fig. 1: Flowchart of Sr-HA synthesis by sol-gel method. 
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2.1.2 Characterization  
 2.1.2.1 Infrared Spectroscopy FTIR analysis  
FTIR investigation was performed on non-modified hydroxyapatite and strontium-doped 
hydroxyapatite. In order to examine the chemical composition of Sr-HA, FTIR was performed to 
study the powder using a typical KBr pellet technique. The HA and Sr-HA powders were grounded 
with KBr in the proportion of 1/150 (by weight) and pressed into a 3mm pellet using a hand press. 
FTIR spectroscopy was performed on Nicolet Nexus spectrophotometer with KBr discs in the 500-
4000 cm
-1
 region (4 cm
-1
 resolution, average 64 scans). FTIR investigation was performed on dry 
materials. 
 
 
 2.1.2.2  Morphological Investigations 
The surfaces of gel materials were analysed by Scanning Electron Microscopy (SEM, JEOL 6310). 
For SEM analysis, the materials were mounted by a double adhesive tape to aluminum stubs. The 
stubs were sputter-coated with gold to a thickness of around 20nm. SEM analysis was performed at 
different magnification at 20 keV. The transmission electron microscopy (TEM) images were taken 
by a Hitachi H-9000NAR model instrument operated at an accelerating voltage of 100 kV. Samples 
for TEM imaging were prepared by placing a drop of the aged gel suspensions (the suspensions 
were diluted in deionized water and dispersed by ultrasonic waves before use) onto carbon coated 
copper grids, dried in air and loaded into the electron microscope chamber. 
 
 
 2.1.2.3  Biological studies 
 Cell proliferation 
Cell proliferation assays were performed on human mesenchymal stem cells (hMSC) obtained from 
LONZA (Milano, Italy). hMSC were cultured in 75 cm
2
 cell culture flask in Eagle’s alpha 
minimum essential medium (α-MEM) supplemented with 10% fetal bovine serum, antibiotic 
solution (streptomycin 100 µg/ml and penicillin 100U/ml, Sigma Chem. Co) and 2 mM L-
glutamine and hMSCs from passages 3 were used for all the experimental procedures and incubated 
at 37°C in a humidified atmosphere (5% CO2, 95% air). For cell proliferation, hMSC were plated at 
concentration of 1.6x10
4
 in triplicate onto gel materials with and without Sr sterilized by autoclave 
at 121°C for 30 min. The cell proliferation was checked by the Alamar Blue assay for 3, 7, 14, 21 
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and 28 days of culture, the fluorescence was measured at 540 and 600 nm. The culture medium 
during experimental time was changed every two days.  
 
 Cell morphology 
hMSC were seeded at 1x10
3
/sample onto coupons of gel materials (HA, Sr-HA 5, 10, 15 and 
20mol%) and then incubated with the tested gel materials for 24 h. At the end of the incubation 
time, the non-attached cells were removed by careful rinsing with PBS for three times and then 
incubated with cell tracker green CMFDA in phenol red-free medium at 37°C for 30 min. 
Subsequently cell culture was washed with PBS and incubated for 1 h in complete medium. The 
cell morphology and cell spreading pattern interaction of hMSC onto gel materials was evaluated by 
confocal laser scanning microscopy (LSM 510, CarlZeiss). 
  
 Colorimetric ALP activity assay  
hMSC differentiation was tested by measuring their alkaline phosphatase (ALP) activity upon 
culture onto gel materials after 7, 14 and 21 days (SensoLyte pNPP ALP assay kit, ANASPEC, 
Milano, Italy). Briefly, at the end of each time point, cultures were washed gently with PBS 
followed by washing twice with cold 1X assay buffer (BD Biosciences, Milano, Italy). For extract 
cell layers the cultures were lysing with 1X lysis buffer with 0.2% of Triton X-100. The ALP 
activity was analyzed onto the cell lysates (50μl). Sample absorbance was measured in a 96-well 
plate at 405 nm. To correct the ALP values for the number of cells present on each gel material 
double stranded DNA (dsDNA), as a marker for cell number, was measured using a 
PicoGreen_dsDNA quantification kit (Invitrogen). First, 100µl of  200µl diluted Picogreen_dsDNA 
quantification reagent was added to 100 μl of cell lysates in a flat-bottomed, 96-well plate. 
Following 10 min incubation, the fluorescence of Picogreen was determined at a wavelength of 520 
nm after excitation at 585 nm using a plate reader (multilabel counter 1420 Victor, Perkin-Elmer, 
Italy). dsDNA was quantified according to a calibration curve of l-dsDNA standard in 10 mM Tris, 
1 mM EDTA, pH 7.5, buffer. Each experiment was performed three times in triplicate. The results 
of ALP activity were reported as nanograms (ng) of ALP normalized to the micrograms (µg) of 
total DNA content. ALP experiments were repeated twice and three gel scaffolds were used in each 
experiment. 
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 Assay for gene expression 
hMSC cultures onto HA and Sr-HA gel materials grown in medium for 21 days were characterized 
by reverse transcription-polymerase chain reaction (RT-PCR) for gene expression of bone-related 
markers. At the end of the culture period, total RNA was extracted from hMSC cultured onto gel 
materials using the Trizol reagent, according to the manufacturer’s protocol (Invitrogen, Carlsbad, 
CA, USA). The RNA was precipitated with isopropyl alcohol and the final pellet resuspended in 
DEPC-water and DNAse I digested (Invitrogen Carlsbad, CA) to remove contaminating of genomic 
DNA. The absorbency at 260/280 nm was measured to determine the RNA concentration. One μg 
of total RNA was used to perform one-step RT-PCR reaction (Invitrogen Carlsbad, CA) according 
to the manufacturer’s protocol. Briefly, cDNA synthesis program was 1 cycle at 60°C for 30 min 
followed of denaturation cycle of 94°C for 2 min. cDNA was amplified at 94°C for 15 s, 55°C for 
30 s and 68°C for 1 min for 35 cycles in a thermal cycler (Applied, Biosystem). Primers used for 
amplification of bone-related molecules were upstream and downstream as follow for alkaline 
phosphatase (ALP): 5’-GGAGGGACCCTCGCCAGTGCT-3’, 5’-
AGAGGGCCACGAAGGGGAACT-3’, osteocalcin (OCN): 5’-
CAGCAGAGCGACACCCTAGACC-3’, 5’-CATGAGAGCCCCTCACACTCC-3’, osteopontin 
(OPN): 5’-TTCGGATGAGTCTGATGAGACC-3’, 5’-GGAAGAACAGAAGCAAAGTGC-3’. 
Glyceraldheyde-3-phosphate dehydrogenase (GAPDH): 5’-
CCACCCATGGCAAATTCCATGGCA-3’, 5’-TCTAGACTGGCAGGTCAGGTCCACC-3’ was 
utilized as housekeeping gene. Reaction products were separated using gel electrophoresis on 1.2% 
agarose gel stained with ethidium-bromide. Bands were visualized using ultraviolet illumination 
and captured with BioRad Imaging System (BIORAD). 
 
 
2.1.3. Results 
 2.1.3.1 Synthesis of Gels Materials 
A preliminary investigation showed a difference in the gelification time of the biomaterials 
prepared at different Sr concentration. In particular, gels prepared at 0, 10 and 15 mol% of Sr 
reached a final setting after 1hr of stirring at 40°C. The gels prepared at 5 and 20 mol% of Sr 
showed a slight delay, their gelation time was achieved after 2-3 hrs. However, all gels synthesised 
at room temperature could be successfully equilibrated at pH 7.4 without any significant dissolution 
thus ensuring their compatibility with biological systems.  
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 2.1.3.2 Infrared Spectroscopy FTIR analysis  
Figure 2 shows the FTIR spectrum of as-dried non-modified hydroxyapatite sample after 48 h aging 
time. The first indication of the formation of HA is in the form of broad FTIR band centered around 
1000–1100 cm−1 [35]. Furthermore, the peaks around 3600 cm−1 and 601 cm−1 are the characteristic 
peaks of stoichiometric HA [36].  
Fig.2: FTIR of non modified hydroxyapatite synthesized at room temperature. 
 
The peak at 951 cm
−1
 [37–40] corresponds to a non-degenerate symmetric stretching mode, ν1, of 
the P-O bond in phosphate group. The weak peak at 499 cm
−1
 [41,42] is the doubly degenerate 
bending mode, ν2, of the phosphate group. As a major peak of phosphate group, triply degenerate 
asymmetric P-O stretching peak, ν3, which is the most intensified peak among the phosphate 
vibration modes, could be identified approximately around 1074 cm
−1
 [37–39,43]. The band 
between 564 cm
−1
 and 604 cm
−1
 [37,39] belongs to triply degenerate ν4, O-P-O bending mode in the 
phosphate group, which occupies two sites in the crystal lattice. Two distinguishable splitting of ν4 
vibrations indicate the low site symmetry of molecules, as two peaks confirm the presence of more 
than one distinct site for the phosphate group in hydroxyapatite lattice [44]. The peaks at 633 and 
3564 cm
−1
 [37–39] are assigned to the librational mode and intro molecular stretching vibration of 
the hydroxyl group in crystal structure of HA, respectively. The peak at 1644 cm
−1
 [45] is signature 
of the bending mode of hydroxyl group in the adsorbed water. The peak at 3664 cm
−1
 is assigned to 
free O-H stretching mode, which may be present on the surface of the crystallites. As the 
crystallization was carried out in alkaline range (pH=10.5), dissolving of atmospheric CO2 yielding 
CO3
2−
 based on the peaks at 1397 cm
−1
 [46]. The band at 875 cm
−1
 [44] indicates ν2 bending mode 
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of CO3
2−
 group and suggests a B type carbonate substitution. The ν3 stretching mode of CO3
2−
 
groups was also observed at 1397 cm
−1
 [47] in the FTIR spectra. Carbonate ions can substitute for 
either OH
−
 or PO4
3−
 ions in the apatite structure. Since carbonates are constituents of bone 
structures [48], the presence of CO3
2− 
may improve the bioactivity of HA rather than being a cause 
of concern. 
 
 
Fig. 3: FTIR of strontium-doped hydroxyapatite at 0 - 5 - 10 - 15 - 20mol%. 
 
Figure 3 shows the FTIR spectra of the powders at different Sr concentrations. A typical HA 
structure containing sharp PO4 bands at 1000 cm
-1
 – 950 cm-1 was observed. As the concentration of 
Sr increased, the OH bands at 550 cm
-1
 – 650 cm-1 disappeared gradually. This is because Sr has 
substituted OH and the reaction is represented by equation (1) below: 
       Ca5(PO4)3OH       Ca5-x Srx(PO4)3OH1-x(SrO)x     (1) 
At about 1500 cm
-1 – 1400 cm-1, the HPO4 band becomes more apparent while PO4 band at about 
1020 cm
-1 
shows reduction in its intensity as the concentration of Sr increases. The presence of 
HPO4
2-
 band at 875 cm
-1
 and P2O7
2-
 band at 712 cm
-1
, were detected in 5 - 10 and 15mol% Sr-doped 
HA; meanwhile, the two bands were reduced in 20 Sr-doped HA. 
 
 
 2.1.3.3 Morphological Investigations  
SEM imaging performed on strontium-doped hydroxyapatite gel (figure 4A) and non-modified 
hydroxyapatite (Fig.4B) showed a change in crystal morphology when a Sr at 15mol% was 
introduced in substitution of Ca
2+
 ions. In that case, an agglomerate structure (figure 4A) with 
grains smaller than 1µm on average was observed. Moreover, a presence of microporosity due to 
solvent evaporation and ammonium nitrate removal was also observed. Meanwhile a crystal plates 
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with a length about 70 nm were observed in non-modified hydroxyapatite. EDS (figure. 4C) 
analysis performed on gel material with 15%mol Sr demonstrated a presence of the typical ions of 
modified-hydroxyapatite with an atomic ratio Ca+Sr/P about 1.65. 
 
 
Fig. 4: SEM images of HA (A) and HA-15Sr (B). EDS analysis performed on Strontium-doped 
hydroxyapatite (C). 
 
From the TEM evaluation in figure 5, it is shown that the HA particles show a length about 70-
80nm and a diameter of 4-5nm. In 10 and 20mol% Sr-doped HA an agglomerate structure was 
observed; the particles were reduced in size, in fact a length of 40 nm and diameter of 10nm were 
observed. An increasing in the amount of Sr ions doped into HA made the agglomerated particles 
smaller. The substitution of large Sr
2+
 into small Ca
2+
 lead to denser atomic packing of the system 
causing retardation of crystals growth. When the crystal has less freedom to grow, the formation of 
TCP will be blocked and the particle size becomes smaller [49].  
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Fig. 5: TEM analysis on HA gel and strontium-doped hydroxyapatite  at  10 and 20 mol%. 
   
2.1.3.4  Biological studies 
Figures 6 and 7 show the effect of the materials on the adhesion and metabolic activity of  hMSC at 
different times. The cellular attachment is the first step in evaluating the biocompatibility of hMSC 
onto the HA material with and without Strontium. Figure 6 illustrates the hMSC cellular attachment 
onto each material after 1 day of cell culture. Moreover, in the presence of the doped HA with 
strontium cells attached to the surface and it can also observed that cells were beginning to flattened 
and elongated over the surface and this representative morphology is a positive sign that cells have 
a good biocompatibility and affinity for the HA scaffolds. Our results demonstrated that cell 
adhesion and spreading of cell were optimal in the cases where is present Sr and appeared not to be 
cytotoxic or show a negative response to cell adhesion when increased the strontium content (5, 10, 
15 and 20 Sr mol%). In fact, the cell attachment and spreading was consistently higher on HA-15Sr 
and HA-20Sr when comparing to non-doped HA.   
Cell proliferation is assessed by Alamar blue and as shown in figure 7 the cells on all scaffolds 
proliferate with time. hMSC cell proliferation on HA doped with different concentration of 
strontium induce similar levels of cell proliferation at all cell culture times. However HA-5Sr 
showed better cell proliferation as compared with control scaffold as HA and higher cell 
proliferation when compared with HA-10Sr, HA-15Sr and HA-20Sr.  Meanwhile, gel materials 
with more Strontium (HA-10Sr, HA-15Sr and HA-20Sr) show a lower cell proliferation in the 
beginning of cell proliferation times then showed an increased cell proliferation after longer 
incubation times (14 to 21 days). Moreover, cell proliferation on the HA-10Sr, HA-15Sr and HA-
20Sr showed similar cell metabolic respond and low cell proliferation is not originated by 
cytotoxicity of the material because Alamar blue showed metabolic activity in all incubation times; 
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so this behavior on the cell proliferation response might due to the differentiation tendency of 
hMSC on the scaffolds doped with more strontium.  
 
 
Fig. 6: Confocal images of hMSCs adhesion and cell material-interaction on HA-Sr (0 - 5-10-15-20mol%) 
base scaffolds after culturing for 24 h. 
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Fig. 7: Alamar blue of HA and HA-Sr (5-10-15-20 mol%) at 7, 14 and 21 days. 
 
The ALP activity was determined on cell cultures and as early as 7 days (figure 8); cells already 
produce the early marker of osteogenic differentiation. ALP activity showed that at 7 and 14 days 
has an increased in amount of enzymatic activity on all HA scaffolds (HA-10Sr, HA-15Sr and HA-
20Sr). However, at 21 days of culture there is a tendency to less activity on the ALP and could be 
part of the late phases of osteogenesis; although only the amount of ALP enzymatic activity 
continue on the HA-10Sr and HA-15Sr scaffolds.  
 
 
Fig. 8: ALP activity of HA and HA-Sr (5-10-15-20 mol%) at 7, 14 and 21 days in basal medium. 
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Gene expression analysis shows that HA doped with strontium significantly promote the expression 
of osteogenesis related genes including an early marker for osteogenic differentiation ALP; a non-
collagen protein OPN and a late marker for osteogenic differentiation OCN. Figure 9 shows  that 
HA-10Sr, HA-15Sr and HA-20Sr promote the expression of ALP; in contrast HA-10 and 20Sr 
promote the expression of OPN on lesser degree as compared with the expression of OPN promoted 
by HA-15Sr. Moreover, OCN expression was significantly enhanced  on HA-15 and 20Sr 
meanwhile faint signal was detected on HA-10Sr. 
 
 
 
Fig. 9: Gene Expression of HA-strontium gel materials after 21 days of culture in a basal medium. 
 
2.1.4 Discussions 
The interest in Sr in the context of biomedical materials can be attributed to its apparently unique 
property of promoting ‘‘uncoupled” bone remodelling, i.e. not only stimulating osteoblast 
differentiation, but also inhibiting osteoclast differentiation [50]. The expectation or assumption is, 
therefore, that the continuous release of Sr can serve as a ‘‘drug” to stimulate bone regeneration. 
In order to maintain the general physical, mechanical and chemical properties of the materials Sr is 
generally substituted for Mg or Ca, given their chemical similarity.  
Strontium(II) ions have been demonstrated to both increase the bone formation by osteoblasts as 
well as to decrease the osteoclast-mediated resorption of the bone matrix [51,52]. Therefore, 
strontium has gained considerable attention in osteoporosis therapy because of its anti-resorptive 
and osteo-anabolic potential, which led to its clinical application in the form of strontium ranelate 
some years ago. Besides its systemic administration, a local release of Sr
2+
 ions from bone cements 
used in the treatment of osteoporotic bone fractures and defects is considered a promising approach 
since it could help to avoid implications of high dose treatment and compensate for the relatively 
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low bioavailability of the drug. In addition, the agent then is concentrated at the location of bone 
healing and can directly interact with all cell types present  there.  
In this study, the influence of strontium(II) modification of a hydroxyapatite-forming bone cement 
on proliferation and osteogenic differentiation of hMSC was investigated. Strontium was introduced 
into a calcium phosphate gel as substitute of Ca
2+
 ions by using a sol-gel technology. Moreover, we 
have evaluated the effect of Strontium on physico-chemical and morphological properties of 
hydroxyapatite gel. We have observed that for Sr–HA, while the crystal structure remained apatitic, 
even up to full substitution, the crystallinity decreased slightly, possibly due to the structural strain 
caused by the larger Sr ion [53], i.e. the slight disorder introduced by random substitution. In 
addition, CO3
2-
 and HPO4  were both detected with increasing Sr content, possibly due to the larger 
structural strain caused by partial substitution of Sr for Ca, which would suggest that Sr–HA can 
more easily accommodate more carbonate, resulting in the formation of a non-stoichiometric 
material. Moreover, Capuccini et al. [54] showed that the presence of strontium significantly 
improved osteoblast adhesion in early culture phases. Moreover, cell adhesion increased with 
increasing strontium content (1, 5, and 10 Sr at.%). The cytotoxicity of Sr-HA containing 1, 5, 10, 
and 100 mol. (%) was also evaluated by Yuan-Fei et al. [55] via methyltetrazolium (MTT) assay 
and showed that all of the bioceramics studied had good biocompatibility. Furthermore, osteoblast-
like MG63 cells cultured on the Sr-HA nanocrystals containing 0, 1, 3, and 7 atom. (%) displayed 
good proliferation and increased values of the differentiation parameters [56]. Osteoprecursor cell 
behavior was examined through MTT reduction at 3, 7, and 14 days of incubation by culturing them 
onto 10 mol % Sr-HA surface. The authors concluded that Sr-HA induced better cell attachment 
and proliferation when compared to HA [57]. 
Here, we have demonstrated that strontium-doped hydroxyapatite gels up 20mol% show a good 
biocompatibility and are non toxic. Ours preliminary studies of the differentiation of hMSCs 
towards the osteoblastic-like phenotype was quantitatively determined by carrying out a destructive 
assay for ALP activity using the p-nitrophenyl phosphate method. ALP is an enzyme produced by 
differentiating osteoblasts and is present both on the extracellular membrane and in vesicles of the 
bone matrix, which is the initial site of the formation of calcium phosphate crystals. The enzymatic 
activity of ALP is crucial for the mineralization process; it acts on the organic phosphate to increase 
the local concentration of free phosphate and to induce the active transport of both phosphate and 
calcium across the cell membrane [58]. In our results a steady increase in ALP activity was 
observed, which may confirm the ability of the gel materials to support hMSC differentiation 
towards the osteoblast-like phenotype and future could  support the ECM mineralization. 
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Osteogenic differentiation seems to be stimulated by the general presence of strontium, which was 
shown by the enhanced levels of ALP enzyme activity on all Sr-modified cements. This is 
strengthened by the higher expression of the late marker of osteogenic differentiation, osteocalcin 
(OCN). Gene expression shows that HA-10Sr, HA-15Sr and HA-20Sr promote the expression of 
ALP; in contrast HA-10 and 20Sr promote the expression of OPN on lesser degree as compared 
with the expression of OPN promoted by HA-15Sr. Moreover, OCN expression was significantly 
enhanced  on HA-15 and 20Sr meanwhile faint signal was detected on HA-10Sr. 
The results demonstrated that hydroxyapatite gel containing from 0 to 20 mol. (%) of Sr was 
successfully produced at room temperature  and presented no cytotoxicity. The strontium 
incorporated in the HA crystal resulted in a solid gel  shows good osteogenic properties. Further 
studies are required to evaluate the potential benefits of Sr-HA as a bone substitute biomaterial and 
its effects in osteoporosis treatment.  
 
 
2.1.5 Conclusions 
In this study,  strontium-substituted hydroxyapatite with different Sr content (5%, 10%, 15% and 
20% Sr-HA in mole ratio) has been synthesized at room temperature by using a sol-gel approach.  
The strontium incorporated in the hydroxyapatite structure decrease slightly the size of HA 
nanoparticles as demonsrated by morphological analyses. Moreover, the results demonstrated that 
strontium-doped hydroxyapatite gels up 20mol% show good biocompatibility without significative 
cytotoxic effect. 
This work confirms the ability of the hydroxyapatite modified Sr materials to induce hMSC 
differentiation towards the osteoblast-like phenotype and future could  support the ECM 
mineralization. 
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2.2 BIOACTIVE HYDROXYAPATITE-GRAPHENE OXIDE INJECTABLE 
MATERIAL  
 
Introduction 
The synthesis of new biocompatible materials to be used in medicine has acquired a great deal of 
importance in material science [1]. Hydroxyapatite (Ca10(PO4)6(OH)2, HA) is the major component 
of natural bone tissues. It exhibits excellent biocompatibility and bioactivity with human tissues [2]; 
as a result, it is currently widely used in various forms and shapes in bone and tissue engineering. 
Nonetheless, the poor tensile strength and fracture toughness compared with natural bone limit its 
applications for replacing various parts of the bone systems.  
However, the inferior wear resistance and fracture toughness of pure HA cannot match the 
mechanical behavior of natural bone and would hinder its clinical application in major load-bearing 
devices as coating materials. To solve this problem, materials such as polyethylene [3], Al2O3 [4], 
TiO2 [5], zirconia (ZrO2) [6,7] and carbon nanotubes (CNT) [8] are used as reinforcements in HA to 
improve its mechanical properties. Although increased mechanical properties have been obtained, 
these reinforcements, e.g. CNT, due to the presence of metallic catalyst therein, could usually 
impair the biological property of HA or have adverse effects on adjacent tissues [9]. Some 
reinforcing material (e.g., ZrO2) could induce the decomposition of HA during the fabrication 
process, leading to a substantially reduction in the bioactivity of HA [10].  
However, an ideal reinforcement material should impart mechanical integrity to the composite 
without diminishing its bioactivity. Carbonaceous materials with high chemical inertness are widely 
recognized to exhibit good biocompatibility [11]. A recently discovered carbon-based two-
dimensional (2D) nanostructure, known as graphene, is particularly attractive.  
Graphene is a flat monolayer of carbon atoms tightly packed into a two-dimensional (2D) 
honeycomb lattice and is a basic building block for graphitic materials of all other dimensionalities 
with unique physical, chemical, and mechanical properties [12]. Graphene and graphene oxide 
(GO) layers have become a hotspot so far and have been actively investigated to build new 
composite materials [13].  
 It has been shown that graphene induces no obvious toxic effects in vivo [14]. It possess the large 
aspect ratio, high mechanical strength, and superior electrical conductivity [15,16], as a result, has 
the potential to strengthen and toughen HA without offsetting its bioactivity.  
 88 
 
The presence of abundant epoxide, hydroxyl and carboxylic groups on the GO basal plane could 
provide enormous reactive sites for chemical interactions. Furthermore, the good high mechanical 
properties, high hydrophilicity and good biocompatibility of GO sheets suggest that the GO could 
be ideal and promising nanoscale reinforcement fillers in biocomposites, enhance the interfacial 
bonding in the composites and increases its bioactivity. 
The reactive oxygenic groups, present on the edges (carbonyl and carboxyl groups) and planes 
(hydroxyl and  epoxide groups) of GO sheets, can stabilize the dispersion of GO in aqueous media, 
enhance the interfacial bonding within the components, and facilitate the stress transfer in the 
composites [17], which render GO as attractive and promising nanoscale reinforcement fillers in 
biocomposites (incorporated into either a polymer or an inorganic matrix) [18]. Improved 
mechanical properties have been observed in GO based chitosan [19], gelatin [20], starch [21], and 
poly(e-caprolactone) (PCL) [22] biopolymer composites. In addition, GO increased the bioactivity 
of gelatin [20] and PCL [22] during biomineralization, by promoting the nucleation of 
hydroxyapatite (HA) nanoparticles in simulated body fluid (SBF). 
Recently, more and more research works have been devoted to the fabrication of graphene or its 
derivatives reinforced HA biocomposites [23-26]. The incorporation of graphene or its derivatives 
in HA composites has been reported in several literatures using biomimetic mineralization process 
[26,27], spark plasma sintering (SPS) technique [28], radio-frequency chemical vapor deposition 
[29],  electrospinning method [30] and so on. The cytotoxicity of the graphene based fillers shown a 
dose-dependent [31]. And most of the resulting composites displayed a favorable biological 
performances toward the proliferation and growth of L929 fibroblast cells [32], MC3T3-E1        
pre-osteoblast cells [33,34] and MG63 human osteosarcoma cells [32]. GO can be produced simply 
in large scale with significantly low cost and little impurities (metals) as opposed to CNT, a 
significant advantages for synthesizing high-performance biocomposites. In addition, GO is an 
emerging material with good biocompatibility [35] as well as antibacterial activity [36], which 
provide promising opportunities to improve orthopedic implant application [37]. 
For these reasons, our research activity concerns the possibility to use a dual approach to prepare  
biomineralized hydroxyapatite nanocrystals/graphene for bone tissue regeneration. The first 
approach is represented by sol-gel technology [38] that is a facile, economical and effective process 
to prepare hybrid material based on nano-HA embedded in GO sheet. The second approach 
concerns the use of biomimetic method in order to obtain a coating of calcium phosphate on GO 
sheet. In both cases, we evaluate their effect on human Mesenchymal Stem Cells (hMSC) in terms 
of proliferation and early osteogenic differentiation [39], in order to develop a new class of      
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multi-functional hybrid material with excellent biological and conductive properties, and make 
them highly promising materials for biomedicine. 
 
 
2.2.1 Materials and methods 
 2.2.1.1  Synthesis of GO 
Graphene oxide was synthesized from Graphene Nanoplatelets using a modified and simplified 
Hummers’ method [40]. In particular this material was obtained by oxidation of 0,5g of GNP with 
25mL of H2SO4 (sulfuric acid 99,999%, Aldrich), 1g of KNO3 (potassium nitrate Aldrich) and 3g of 
KMnO4 (potassium permanganate Aldrich). Typically a mixture of GNP and KNO3 in H2SO4 was 
stirred for few min below 5°C in ice bath. After than KMnO4 was added slowly with stirring in 
small portions to prevent temperature rise in excess of 20 °C. Then, the temperature of the reaction 
mixture was raised to 35 °C and the mixture was stirred for 60 min. After completion of the 
reaction, 100 mL of deionized water was gradually added into the solution. The suspension was 
reacted further by adding a mixture of  H2O2 (7 mL, 30%) and water (55 mL). During oxidation, the 
color of the mixture changed from dark purplish-green to dark brown. To stop the oxidation 
process, H2O2 solution was added and the color of the mixture changed to bright yellow, indicating 
a high oxidation level of graphite. The GO was separated from the reaction mixture by filtration and 
successively was washed five times with deionized water until a pH of 4–5 was achieved. The 
washing process was carried out using a simple decantation of the supernatant with a centrifugation 
technique. During the washing process with deionized water, the graphite oxide underwent 
exfoliation, which resulted in thickening of the graphene oxide solution, forming graphene oxide 
gel which was used to obtain the graphene oxide solid. 
 
 
 2.2.1.2 In situ preparation of HA-GO 
HA [Ca10(PO4)6(OH)2] is synthesized by sol-gel process (figure 1). The molar ratio of calcium to 
phosphorus Ca/P varies from 1.2 to almost 2 in HA. The stoichiometric molar ratio of HA is 1.67; 
however, this is not the value observed in the organism because small amounts of other materials 
such as carbon, nitrogen, iron and another elements are incorporated. 
Ca(NO3)2x4H2O and (NH2)4H2PO4 were used as the Ca and P sources, respectively. HA-GO with 
different GO content (1%, 1.5%, 2%  w/w) were synthesized. Ca(NO3)2x4H2O and (NH2)4H2PO4  
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were dissolved in distilled water in appropriate ratio. Exfoliation of graphene was carried out in 
appropriated amount of water through sonication for several hours.  
When Ca(NO3)2x4H2O was completely dissolved in water, Ca
2+
 solution was added to GO sheet 
water solution to promote the interaction between ions Ca
2+
  and lateral and superficial groups of 
GO. A homogeneous system was obtained by ultrasonic dispersion for 30 min, after them a 
phosphorous solution was added drop wise and pH was adjusted at alkaline value (pH equal to 11) 
by NH4OH solution. Gelation take place  after 2hrs of magnetic stirring at room temperature. 
 
 
 2.2.1.3  Biomimetic approach to prepare biomineralized GO 
To produce biomineralized products GO sheets were submitted to a bio-inspired procedure, namely 
biomimetic treatment, inspired by the method described by Kokubo and co-workers [41,42].          
In particular, the treatment combines the preliminary use of a supersaturated SBF solution (5xSBF1) 
to stimulate the nuclei formation, while a fresh chemically-modified solution (5xSBF2) is further 
used, in order to promote the growing of apatite nuclei, once formed. Meanwhile, 5xSBF1 was 
prepared by sequentially dissolving CaCl2, MgCl2·6H2O, NaHCO3 and K2HPO4·3H2O in distilled 
water. Solution pH was lowered to 6 by adding hydrochloric acid HCl (1M) to increase the 
solubility. Na2SO4, KCl and NaCl were added until the previous solution become clear. The final 
pH was adjusted with 1M NaOH to reach a final pH equal to 6.5 (5xSBF1).  
Therefore, Mg
2+
 and HCO3
-
 free 5xSBF was prepared by adding CaCl2, K2HPO4·3H2O and NaCl 
subsequently to distilled water up to obtain a fresh solution (5xSBF2). In this case, the solution pH 
was lowered to 6.0 with hydrochloric acid to increase the solubility. Both solutions were buffered at 
pH 6.5 and 6 respectively, by using Trishydroxymethylaminomethane-chloric acid (Trizma-HCl). 
In table 1, the ionic concentration of blood plasma, SBF, 5xSBF1 and 5xSBF2 were reported. All 
solutions were prepared freshly before the use.  
The biomimetic treatment consists in two steps in pH-controlled environment: during the first step, 
samples with pre-ordered size were soaked into 5xSBF1 at pH=6.5 where the 5xSBF solution 
volumes have been calculated respect to the total scaffold material surface by using an exposed 
surface to SBF volume ratio equal to 10 mm
2
/ml, as reported in literature [43]. The solution 
temperature was fixed at 37°C during the treatment. After the sequential immersion in 5xSBF1 (3 
days) and in 5xSBF2 (4 days), all scaffolds were gently rinsed in distilled water to remove excess 
ions and, then, dried overnight under laminar hood.  
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Ion Concentration 
(mM) 
Na
+
 K
+
 Ca
2+
 Mg
2+
 HCO3
-
 Cl
-
 HPO4
-
 SO4
2-
 
Blood plasma 142 5 2.5 1.5 27 103 1 0.5 
SBF 142 5 2.5 1.5 4.2 148 1 0.5 
5xSBF1 710 25 12.5 7.5 21 740 5 2.5 
5xSBF2 710 10 12.5 - - 735 5 - 
 
Table 1: The ionic concentration of human blood plasma, SBF, 5xSBF1 and 5xSBF. 
 
 
2.2.2 Characterization 
 2.2.2.1 X-Ray diffraction and Infrared Spectroscopy FTIR analyses  
Phase analysis was conducted using X-ray diffraction (XRD) to detect phase composition and 
crystallinity of HA-GO materials. An X-ray diffractometer (XRD-PANalytical X’Pert Pro) was 
used; the specimens were scanned from 2 = 0° to 70° using CuK radiation. FTIR spectroscopy 
was performed on Nicolet Nexus spectrophotometer with KBr discs in the 500-4000 cm
-1
 region (4 
cm
-1
 resolution, average 64 scans).  
 
 
 2.2.2.2 Morphological characterization 
The morphology of the composite materials was characterized by using a Scanning Electron 
Microscope (SEM) and Transmission Electron Microscope (TEM). For SEM analysis, the materials 
were mounted by a double adhesive tape to aluminum stubs. The stubs were sputter-coated with 
gold to a thickness of around 20nm. SEM analysis was performed at different magnification at      
20 keV. X-ray energy dispersive spectroscopy (EDAX, Genesis 2000i) analysis was used for a 
qualitative estimation of the Ca/P ratio.  
The Transmission Electron Microscopy (TEM) images were taken by a Hitachi H-9000NAR model 
instrument operated at an accelerating voltage of 100 kV. Samples for TEM imaging were prepared 
by placing a drop of the aged HA-GO composite suspensions (the suspensions were diluted in 
deionized water and dispersed by ultrasonic waves before use) onto carbon coated copper grids, 
dried in air and loaded into the electron microscope chamber. 
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 2.2.2.3 Bioactivity test 
To evaluate the bioactivity properties of HA-GO hybrid material, only one formulation             
(HA-GO1,5wt%) was submitted to a bio-inspired procedure,  inspired by the method described by 
Kokubo and co-workers [41,42] as discussed previously. 
  
 
 2.2.2.4 Biological properties 
 In vitro cell culture 
Biological assays were performed using human mesenchymal stem cells line (hMSC) obtained from 
LONZA (Milano, Italy). hMSC were cultured in 75 cm
2
 cell culture flask in Eagle’s alpha 
Minimum Essential Medium (α-MEM) supplemented with 10% Fetal Bovine Serum (FBS), 
antibiotic solution (streptomycin 100 µg/ml and penicillin 100U/ml, Sigma Chem. Co) and 2 mM 
L-glutamine. hMSCs from passages 4 through 6 passage were used for all the experimental 
procedures and incubated at 37°C in a humidified atmosphere with 5% CO2 and 95% air. 
 
 Viability test 
To evaluate cell biocompatibility, hMSC were plated at concentration of 1.6x10
4
 in triplicate onto 
HA, GO, GO_SBF and HA-GO materials at different concentrations (1 - 1.5 - 2 wt%). The medium 
in cell-load gel materials culture plates were removed after cultured for 7, 14 and 21 and the in vitro 
cell viability was checked by the Alamar blue assay (AbD Serotec, Milano, Italy). This assay 
quantified the redox indicator which changed to a fluorescent product in response to the chemical 
reduction by mitochondrial enzymes such as flavin mononucleotide dehydrogenase, flavin adenine 
dinucleotide dehydrogenase, and nicotinamide adenine dinucleotide dehydrogenase. In addition, a 
redox phenomenon gave a quantitative indication of metabolic activity of live cells. An aliquot of 
1mL of Alamar Blue™ diluted 1:10 in phenol red-free medium was added to each well and 
incubated for a further 4 h at 37°C, 5% CO2. Later, 200µL of this solution was transferred into a 96 
well plate for colorimetric analysis. Wells without any cells were used to correct any background 
interference from the redox indicator. The optical density was immediately measured with a 
spectrophotometer (Sunrise, TECAN, Männedorf, Zurich, Switzerland) at wavelengths of 540 and 
600 nm. The cell viability percentage was evaluated in according to the manufacturer’s protocol. 
The culture medium during experimental time was changed every two days.  
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 Alkaline Phosphatase assay 
The alkaline phosphatase activity of the hMSC onto HA, GO, GO_SBF and HA-GO at different 
concentrations (1 - 1.5 - 2 wt%). was determined for 7, 14 and 21 days of culture by a 
spectrophotometric end-point assay that determined the conversion of colourless p-nitrophenyl 
phosphate as substrate to coloured p-nitrophenol following the manufacturer’s protocol (Sensolyte 
pNPP ALP assay Kit, AnaSpec). Briefly, at the end of each time point, cultures were washed gently 
with PBS followed by washing twice with cold 1X assay buffer. For extract cell layers the cultures 
were lysing with 1X lysis buffer with 0.2% of Triton X-100. The phosphatase activity was analyzed 
onto the cell lysates (50μl) by measuring the ALP activity when ALP enzyme catalyzes the 
cleavage of a phosphate group and release p-nitrophenol from p-nitrophenyl phosphate in alkaline 
buffer solution after 30 min at 37°C. Sample absorbance was measured in a 96-well plate at 405 
nm. To correct the ALP values for the number of cells present on each scaffold double stranded 
DNA (dsDNA), as a marker for cell number, was measured using a PicoGreen_dsDNA 
quantification kit (Invitrogen). First, 100µl of 200µl diluted Picogreen_dsDNA quantification 
reagent was added to 100 ml of cell lysates in a flat-bottomed, 96-well plate. Following 10 min 
incubation, the fluorescence of Picogreen was determined at a wavelength of 520 nm after 
excitation at 585 nm using a plate reader (multilabel counter 1420 Victor, Perkin-Elmer, Italy). 
dsDNA was quantified according to a calibration curve of l-dsDNA standard in 10 mM Tris, 1 mM 
EDTA, pH 7.5, buffer. Each experiment was performed three times in triplicate. The results of ALP 
activity were reported as nanograms of ALP normalized to the micrograms of total DNA content.  
 
 
2.2.3. Results and discussions 
 2.2.3.1 In situ preparation of HA-GO 
For HA-GO synthesis was supposed a simple mechanism (figure 1) where the oxygen-containing 
functional groups (such as hydroxyl and carboxyl identified by the FTIR analysis) present on the 
basal plane and edges of the GO sheets may play a pivotal part in anchoring calcium ions. When 
Ca(NO3)2x4H2O was added into the GO solution, the Ca
2+
 cations would be attracted and anchored 
on the oxygen atoms through electrostatic interactions [44] and functioned as the nuclei for the 
crystallization and growth of the HA particles. The Ca
2+
 could in situ react with the ambient drop 
wise phosphate ions via electrovalent bonds to form HA nanoparticles [45]. Furthermore the high 
pH values (pH > 10) and high reaction temperature could be beneficial for the in situ crystallization 
of HA on GO sheets with better crystallographic quality [46]. It is reported that high pH values 
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would promote the deprotonation of carboxyl groups (-COOH) on the GO sheets and make GO 
more charged and hydrophilic [47], which in turn might enhance the interaction between the GO 
substrates and HA nanoparticles. 
 
 
 2.2.3.2 Biomimetic approach to prepare biomineralized GO sheet 
Biomimetic mineralization was induced by incubating GO sheet in a supersaturated 5×SBF 
solution. The presence of  anionic functional groups in GO facilitates, in the first step of treatment 
(3days), the nucleation of biominerals by attracting more Ca
2+
 cations to deposit onto film surface 
and subsequently forming biominerals with PO4
3−
. The second step of treatment concerns the 
growth and crystallization of apatite in a Mg
2+
 and HCO3
-
 free 5xSBF  solution for 2 days (figure 
2). In our experiments a deposition of amorphous calcium phosphate (ACP) was observed. ACP is 
often encountered as a transient phase during the formation of calcium phosphates in aqueous 
systems. Usually, ACP is the first phase that is precipitated from a supersaturated solution prepared 
by rapid mixing of solutions containing of calcium cations and phosphate anions [48]. ACP is also 
treated as a precursor of biological apatite during bone formation. 
 
 
 
Fig. 1: Mechanism of in situ preparation of HA-GO hybrid materials by sol-gel method. 
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Fig. 2: Mechanism of biomimetic preparation of biomineralized GO. 
 
 
 2.2.3.3 X-Ray diffraction and Infrared Spectroscopy FTIR analyses  
Sol-gel technology allows to synthesize HA-GO hybrid materials at room temperature. When 
Ca(NO3)2 was added into the GO solution, the Ca
2+
 cations would be attracted and anchored on the 
oxygen atoms through electrostatic interactions
 
and functioned as the nuclei for the crystallization 
and growth of the HA nanoparticles as demonstrated by FTIR analysis.  
The FTIR spectra of the GO, HA, GO and HA-GO at different concentrations are shown in figure  
3A; meanwhile FTIR spectra of GO sheet before and after SBF treatment are shown in figure 3B. 
The transmittance bands at 3398 cm
-1
 were assigned to hydroxyl group (–OH) stretching, 1730 cm-1 
to the stretching vibration of carboxyl groups (–COOH) on the edges of the basal planes or 
conjugated carbonyl groups (–C=O), 1623 cm-1 to the stretching vibration of C=C, 1266 cm-1 to the 
stretching vibration of C–OH, 1054 cm-1 to the stretching vibration of C–O, and the 833 cm-1 to the 
characteristic adsorption peak of epoxy groups. The stretching band of phosphate at 1039 cm
-1
 in 
pure HA  shifted to 1037 cm
-1
 and 1033 cm
-1
 in HA-GO, respectively, indicating the formation of 
strong hydrogen bonding between the HA nanoparticles and the GO-based sheets.  
The phases of the GO, HA, GO_SBF and HA-GO  at different concentrations were investigated by 
XRD. The Bragg diffraction peaks of the two GO-based HA composites, shown in figure 4A, 
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agreed quite well with those of the pure synthesized HA (PDF# 09-0432) at 2θ values of 25.9°, 
31.8°, 39.8°, 46.7°, 49.5° and 53.2°, which were indexed to be (002),(211), (310), (222), (213) and 
(004) planes, respectively. Meanwhile, the broad diffraction peaks suggested that the prepared HA 
particles were nanocrystallites [49], which were proposed to have superior osteointegrative 
properties toward micro HA [50,51], and were much easier to be embedded or incorporated into the 
GO matrix [52]. The strong and sharp (002) peak of the GO sheets at 2θ = 11.1°, as shown in the 
inset of figure, shifted and become more sharp in the composites, indicating the successful 
exfoliation of the graphene oxide sheets (due to the loss of their crystallographic  order after being 
treated by ultrasonic dispersion) and the intercalation of the HA nanoparticles. Meanwhile an 
amorphous state appears in biomineralized composite obtained by biomimetic approach (figure 4B). 
This result could be obtained by a short treatment involving only 2 days of incubation (5xSBF2) for 
growth and crystallization. 
 
 
(A) 
 
(B) 
 
Fig. 3: FTIR analysis of GO, HA and HA-GO at different concentrations prepared by (A) sol-gel method and 
biomimetic approach (B). 
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  (A)                                                                 (B) 
 
Fig. 4: XRD analysis of GO, HA and HA-GO at different concentrations prepared by (A) sol-gel method and 
biomimetic approach (B). 
  
 2.2.3.4 Morphological characterization 
SEM and TEM analyses were performed on HA-GO hybrid materials obtained by in situ 
preparation and biomimetic approach. SEM images (figure 5) demonstrated that is not possible to 
evaluate a phase separation but there is a good intercalation of HA nanoparticles in GO sheet. 
Moreover for all materials with different amount of GO (1- 1.5 and 2wt%) is not observed the 
presence of any clusters (figures 5A-C). The Ca/P ratios of HA formed in graphene oxide 
determined by EDAX analysis (figre 5D) were about 1.65, slightly lower than the stoichiometric 
ratio of Ca/P in HA (1.67), but close to that of natural bone [53,54], which were thought to endow 
the biocomposites with higher bioactivity [55,56]. Meanwhile, different morphology was observed 
for composite material prepared by biomimetic approach. In fact, SEM/Energy Dispersive X-ray 
Spectroscopy (EDAX) image of GO sheet after treatment in supersaturated 5xSBF solutions is 
shown in figure 6. The image shows that after 3 days of soaking in 5xSBF1, followed by immersion 
for 4 days in 5xSBF, the GO sheet was covered by a calcium phosphate layer (figures 6A-B). The 
EDAX analysis shows that the layer is composed mainly of amorphous calcium phosphate, with a 
Ca/P molar ratio of 1.20 (figure 6C). More information are obtained by TEM analysis (figure 7). 
The TEM  images  of GO sheet (figure 7A) demonstrated a good exfoliation of material after 
ultrasonic treatment and by images is possible to evaluate that the presence of sheet modeling the 
distribution of ceramic nanoparticles. In fact, increasing GO amount a better dispersion id observed. 
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Fig. 5: SEM images of HA-GO 1 (A) - 1.5 (B) - 2 (C) wt%; EDS analysis performed on HA-GO 2wt% (D). 
 
This behavior could be explained because the sol-gel reaction allows a good interaction between  
the oxygenated regions in hydrophilic zones, such as carboxyl and hydroxyl of GO and hydrophilic 
HA nanoparticles. Moreover, the uniformly dispersion is explained by nanometric size of 
hydroxyapatite synthesized by sol-gel method as demonstrated by TEM analysis (figure 7). The HA 
particles were in a typical spindle-like shape with a diameter of about 5 nm and a length of around 
70 nm on the GO sheets.  
 
 
Fig. 6: SEM images at different magnifications and EDS analysis of GO sheet after 5 days SBF treatment. 
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In our study, the HA-GO samples were treated ultrasonically before TEM observation, it can be 
seen that almost no HA particles are scattered out of the matrix, indicating a strong interaction 
between the HA particles and the GO. The high specific surface area of GO is also beneficial for 
high loading levels of the HA particles and is helpful for forming an effective network inside the 
biocomposite. Different results were obtained by GO sheet after SBF treatment in both steps (figure 
8). In fact, TEM analysis clearly shows that the particles of amorphous calcium-phosphate were 
nanosphere-like and not nanocrystalline HA with acicular shape as appear for nanocomposite HA-
GO and in accordance with SEM results. 
 
 
 
Fig. 7: TEM analysis of GO, HA and HA-GO at different concentrations. 
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Fig. 8: TEM analysis of GO sheet after 5xSBF1 and 5xSBF2 treatments, respectively. 
 
  
2.2.3.5 Bioactivity test 
SEM observations performed on HA-GO1,5wt%, incubated for a shorter time (5days) in a 
supersatured 5xSBF solution further revealed that graphene–hydroxyapatite  hybrid material highly 
accelerated the formation of HAp crystals (figure 9) on the surface than to GO sheet.  
 
 
Fig. 9: SEM images of HA-GO1,5wt% in cross-section before (A) and after SBF treatment on surface at 
different magnification (B-D). 
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The images performed on the surface and in cross-section of  HA-GO, demonstrated a hybridization 
of HA nanoparticles in GO sheet and an increasing of bioactive properties of materials  after SBF 
treatment.  In fact, in the figure is possible to evaluate the presence of coating on surface and some 
depositions of calcium phosphate intercalated  among the GO sheet (Figures 9A-D).  
The analyses show that the rose petal-like apatite crystallites are composed mainly of 
hydroxyapatite, with a Ca/P molar ratio of 1.67. The EDAX spectra clearly shows Ca and P peaks 
which are typical of hydroxyapatite (figure 9E), and smaller peaks of sodium, chlorine and 
magnesium due to the presence of impurities such as sodium, chlorine and magnesium commonly 
present in biomimetic apatite.  
 
 
2.2.3.6 Biological results 
It is no doubt that the material used for bone tissue engineering should be non-toxic and have good 
cell biocompatibility, which is a central criterion to ultimately decide the feasibility of implantation 
in body [57]. The information of proliferation on the materials  provided by cell culture experiment 
in vitro is often used as an important initial evaluation of cell biocompatibility [58]. In this work 
human mesenchymal stem cells (hMSC), largely used to evaluate the regeneration of mineralized 
ECM in bone defects [59-62], were used as cell line model for in vitro testing of biocompatibility 
and osteogenic potential of the HA-GO materials. 
The cell proliferation on the different materials (HA, GO, HA-GO, GO_SBF) were assessed using 
Alamar Blue test.  Figure 10 shows the effect of the materials on the metabolic activity of hMSC 
after 7, 14 and 21 days of culture. According to the data, it can be found that MSCs dramatically 
increase with time during the in vitro culture period; suggesting that the materials are nontoxic, not 
affecting the cell proliferation and showed good biocompatibility. In particular, the results show 
that the cell proliferation is better for GO sheets than HA material, this is explained by the presence 
of active group and a charge surface. Moreover, GO_SBF materials after SBF treatment show a 
good proliferation in the time similar to GO sheet. This result could be explained by a large surface 
of GO in contact with cells and the presence of small clusters of amorphous calcium phosphate have 
a negligible effect on cell proliferation. Meanwhile, in the composite materials a slight decreasing 
of proliferation activity was observed even if it keep at higher value than the control.  
Besides the amount of the proliferated cells, the differentiations of the cell should be another 
important parameter to estimate the biological effect of calcium phosphate particles. ALP activity 
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assay (figure 11) was used to evaluate the differentiation of hMSCs on the different composite 
materials (HA, GO, HA-GO, GO_SBF).  
 
 
Fig. 10: Alamar blue of GO, HA, HA-GO (1 - 1,5 - 2wt%) and GO_SBF at 7, 14 and 21days. 
 
 
Fig. 11: ALP assay of GO, HA, HA-GO (1 - 1,5 - 2wt%) and GO_SBF at 7, 14 and 21days in basal medium. 
 
Ours preliminary studies of the differentiation of hMSCs towards the osteoblastic-like phenotype 
was quantitatively determined by carrying out a destructive assay for ALP activity using the p-
nitrophenyl phosphate method. ALP is an enzyme produced by differentiating osteoblasts and is 
present both on the extracellular membrane and in vesicles of the bone matrix, which is the initial 
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site of the formation of calcium phosphate crystals. The enzymatic activity of ALP is crucial for the 
mineralization process; it acts on the organic phosphate to increase the local concentration of free 
phosphate and to induce the active transport of both phosphate and calcium across the cell 
membrane [63]. ALP is an important feature of osteoblast cells expressed in their differentiation 
phase and a significant quantitative marker of osteogenesis.  
The in vitro ALP activity of hMSC cells cultivating with HA-GO hybrids was evaluated. As shown 
in Fig. 11, the combination of HA and GO allows to obtain the ALP expression already in the first 
days of  cell-materials interaction. The figure 11 shows that for GO and biocomposite obtained by 
sol-gel approach the ALP value are highest in the first 14 days; in particular it is possible to 
evaluate that ALP value increasing with the amount of GO in composite materials. Meanwhile the 
ALP values for GO sheet after SBF treatment are similar to control (CTR) and lowest than 
biocomposite materials. This result might be due to amorphous state of calcium phosphate clusters 
deposited on GO surface that delay the expression of ALP from hMSC in a basal medium without 
osteogenic factors like ascorbic acid, dexamethasone and β-glycerophosphate . 
 
 
2.2.4 Conclusions 
In this study, we have demonstrated a facile dual approach to prepare biomineralized 
hydroxyapatite nanocrystals/graphene oxide. In the first approach, we have demonstrated a facile 
solution-based in situ synthesis by sol-gel method of hydroxyapatite nanoparticles in graphene 
oxide sheets. The spindle-like HA nanoparticles with a diameter of about 5 nm and a length around  
70 nm, were intercalated uniformly and strongly with the GO sheets. The interaction between HA 
nanoparticles and GO improves the bioactivity of materials demonstrated by the formation of a 
hydroxyapatite layer on material surface after biomimetic treatment. Moreover, the thus-formed 
HA-GO hybrids supported high viability of hMSC cells and induce an osteogenic differentiation 
evaluated by using a media without osteogenic factors. The second approach is represented by using 
a simple biomimetic method based on supersaturated 5xSBF solution. A layer of amorphous 
calcium phosphate (ACP) appears on GO sheet after 5 days of incubation. The composite sustains 
the cell viability and proliferation, however it delays the expression of ALP, early marker of 
osteogenic differentiation, in a basal medium. In vitro bioactivity and biocompatibility of 
biomineralized graphene materials present the new prospect of utilizing graphene-based materials in 
clinical and biomedical applications. The combination of HA with GO leads to the further 
development of a broad new class of multi-functional biomaterials.  
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2.3 CELLULOSE-BASED HYDROGELS CROSSLINKED BY CITRIC 
ACID 
 
Introduction 
The classical tissue engineering paradigm relies on a scaffold that can be used as a space filling 
material for cell and therapeutic agent delivery. Injectable materials hold promise for tissue 
engineering applications as they offer some advantages over prefabricated scaffolds for certain 
indications. Injectable scaffolds eliminate the need for surgical interventions for delivery, and the 
minimally invasive procedure of injection reducing discomfort and complications for the patient 
[1]. Moreover, injectable scaffolds provide the ability to take the shape of the cavity in which 
they are placed and can thus fill irregular defects [2-4]. Aqueous polymer solutions that have the 
property to form a gel upon temperature change have been introduced for tissue engineering 
applications. These hydrogels do not require any additional chemical stimulus for their 
formation. Moreover, hydrogels due to their unique biocompatibility, flexible methods of 
synthesis, range of constituents, and desirable physical characteristics, have been the material of 
choice for many biomedical applications [5]. In particular, in the field of regenerative medicine 
they play a key role in supporting, promoting and stimulating the cell function, and for these 
reasons have been widely used [6-8]. Both natural-based and synthetic thermo-gelling polymer 
systems have been developed and tested in tissue engineering [9-11]. Among the natural 
polymer-based hydrogels that have been reported are cellulose derivatives, chitosan, and gelatin 
[12,13].  
Cellulose is the world’s most abundant natural, renewable and biodegradable polymer. Similarly 
to other polysaccharides, cellulose has a longstanding usage in medical applications due to its 
lack of toxicity (monomer residues are part of metabolites found in the human body), water 
solubility or high swelling ability, and stability to temperature and pH variations [14,15]. The 
biocompatibility of unmodified and derivative cellulose is well documented [16,17]. In this 
study, it was envisaged to take advantage of cellulose due to its good match with the mechanical 
properties of cortical bone and its hydroexpansivity, therefore allowing a satisfactory primary 
fixation to hard tissue [18]. Materials surface properties influence the composition of the 
adsorbed protein compounds, which in turn regulates how cells respond to the material [19-22]. 
Understanding the relationship between material surface properties, adsorbed molecules and 
cellular responses is essential to designing optimal material surfaces for implantation and tissue 
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engineering. In fact, it is recognized that the behaviour of the adhesion and proliferation of 
different cell lines on polymeric materials depend on the surface characteristic such as 
hydrophilicity/hydrophobicity, chemistry, charge, roughness etc. The presence of polar groups 
results in increased wettability of the material surface. It has been well-established that cells 
preferentially adhere to surfaces with moderate hydrophilicity [23,24]. For example, the highest 
cell adhesion of Chinese Hamster Ovary cells (CHO cells) was observed on surfaces with a 
water drop contact angles of about 50 degrees [23]. Good cell adhesion has been explained by 
the adsorption of protein molecules in an appropriate and flexible spatial conformation. This 
enables protein reorganization and accessibility of the specific ligands by cell adhesion receptors. 
On the other hand, on extremely hydrophilic surfaces, the cell adhesion-mediating proteins are 
bound too loosely, such that they do not ensure firm adhesion and spreading of cells on the 
material surface [25,26]. In contrast, hydrophobic surfaces are thought to cause strong adsorption 
and subsequent denaturation of proteins, which distorts the conformation of cell adhesion          
receptor-binding domains. In addition, a preferential and strong adsorption of albumin, which 
acts as non-adhesive for cells, has been reported on these surfaces [27]. 
Another important factor influencing the adhesion and subsequent behaviour of cells is the 
material surface roughness and topography [28]. Depending on the scale of irregularities of the 
material surface, we can distinguish macro-roughness (100 μm - millimetres), micro-roughness 
(100 nm - 100 μm), and nano-roughness (less than 100 nm), each with its specific influence. 
Macro-roughness seems to be favourable, because it enhances the anchorage of implant into the 
natural tissue and is not usually felt by the cells, e.g. it does not restrict their attachment and 
spreading [28]. The micro-scale roughness is more controversial, because the cells can be limited 
by the material surface topography in their adhesion area [29-31]. On the other hand, several 
authors have reported that osteoblasts, grown on micro-rough surfaces, were stimulated towards 
differentiation; as shown by their gene expression and higher level of mineralization in 
comparison with cells growing on smooth surfaces [32,33]. The nanoscale structure of the 
material surface have been found to have significant positive effects on osteoblast cell response, 
including initial cell adhesion and subsequent proliferation, and expression of differentiation 
markers. This finding is not so surprising when we keep in mind that the natural environment of 
cells, the extracellular matrix (ECM), is also organized into nano-dimensions. Interactions of 
cells and extracellular matrix (ECM) initiate signalling cascades involved in critical cell 
functions, such as regeneration [34-36]. An important goal of tissue engineering is to mimic 
critical aspects of the extracellular environment and to control cell function through cell–material 
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interactions [37]. The complexity of natural ECM and cell–matrix interactions makes design of 
materials for regenerative medicine applications challenging because a variety of factors will 
influence cell fate. The choice of the chemical environment used for a specific tissue engineering 
application is dependent on the desired outcome, and many studies have shown that chemical 
functionality and hydrophilicity have important roles in cell adhesion and function [38-40]. As a 
result, many of the newly-developed bio-inspired composite materials try to mimic this effect of 
ECM on cells by constructing nano-structured surfaces. The cells also require a certain level of 
substrate stiffness for their adhesion. During the process of adhesion and spreading, cells exert 
traction forces on the underlying substrate and they respond to comply. If the surface is too soft, 
as for example on polyacrylamide gels, it is not able to withstand these forces. The adhering cells 
are not able to spread: they are rounded, they show no assembly of cytoskeleton and focal 
adhesions, and consequently undergo apoptosis [41]. Moreover, a low, medium and high level of 
the substrate stiffness can direct the differentiation of mesenchymal stem cells towards neuronal, 
muscle or osteoblast phenotype, respectively [42]. 
In this work, cellulose-based hydrogels were prepared in order to evaluate the effect of material’s 
surface modifications on biological response of hMSC. In particular, samples before and after 
citric acid (CA) treatment were investigated to address improved performances such as 
hydrophilicity, roughness and rheological properties. The goal of study is to identify a novelty 
injectable materials to use in minimal non-invasive surgery.  
 
 
2.3.1 Material and Methods 
 2.3.1.1 Materials 
Carboxymethyl cellulose (CMCNa)  (MW 700 kDa, DS 0.9 viscosity 3400 cm/s), hydroxyl ethyl 
cellulose HEC (MW 250 kDa MS 2, viscosity 80–125 cm/s) and citric acid (CA) were purchased 
from Sigma-Aldrich (Milano, Italy) and used without any further purification. 
 
 
 2.3.1.2 Hydrogel Preparation 
Different hydrogels were prepared in order to evaluate their suitability in the interactions with 
the selected cell line. Two different cellulose derivatives were used in the preparation: a sodium 
salt of carboxymethyl cellulose (CMCNa) and hydroxyl ethyl cellulose (HEC) (figure 1A). The 
CMCNa is a cellulose derivative with carboxymethyl groups (-CH2-COOH) bound to some of 
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the hydroxyl groups of the glucopyranose monomers that make up the cellulose backbone. This 
functional group is responsible of the high sorption capacity due to the Donnan effect. HEC is a 
non-ionic polymer that is able to form stable networks with a lower sorption capacity. The 
samples were prepared via double esterification crosslinking using citric acid (CA) (figure 1B) as 
reported in a previous work [43].  
Briefly, hydrogel samples were obtained by reacting, in distilled water, CMCNa and HEC with 
CA (20% w/w on polymer weight) as a crosslinking agent, respectively. First, a total polymer 
concentration of 2% by weight of water were used for the two cellulose derivatives, by stirring 
gently at room temperature until a clear solution was obtained. This final solution was used to 
mould 10-mm thick samples. All samples were first pre-dried at 30°C for 24 h to remove 
absorbed water and then kept at 80°C for 12h for the crosslinking reaction (figure 1C). 
Crosslinked hydrogels, CMCNa-CA and HEC-CA, were compared with pure CMCNa and HEC 
as control. The samples were obtained by resuspending in PBS solution the samples after 
sterilization (autoclave, 121°C, for 20 min).   
 
    (A)       (B) 
 
 
(C) 
Fig. 1: Chemical Structure of cellulose derivatives CMCNa: R=H; CH2COO-Na
+ 
                                   
HEC: R=H; CH2CH2(OCH2CH2)mOH (A) , citric acid cross-linker (B) and final product (C). 
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2.3.2 Characterization 
 2.3.2.1 Infrared Spectroscopy FTIR analysis 
FTIR spectra were recorded on a Nexus FT-IR (Nicolet spectrometer) equipped with an 
attenuated total reflectance (ATR, Smart ARK, Nicolet) crystal sampler. Film samples were used 
directly on an ATR crystal sampler at a resolution of 4 cm
-1
, average 64 scans, at absorbance 
range from 4000 cm
-1
 to 650 cm
-1
. 
 
 
 2.3.2.2   Hydrophilicity 
To determine surface hydrophilicity, contact angle measurements were carried out on different 
cellulose gels (CMCNa-CA, CMCNa, HEC and HEC-CA) by the sessile drop method [44], at 
room temperature, using an optical bench-type contact angle goniometer (Dataphysics OCA). 
Samples were previously dried at 25°C and 50% relative humidity, until constant weight was 
achieved. Four replicas of each sample were used and at least two drops of approximately 10 μL 
of deionized water was deposited on each film, and the static contact angle was measured for 
each drop.  
 
 
 2.3.2.3   Rheological Analysis 
With the aim to prepare injectable hydrogels, the samples were milled using a Retsch rotor mill 
equipped with a screen with 1mm mesh. The resulting powder was sieved between 0.1 and 1 
mm, and used without any further modification. The viscoelastic properties of the wet samples 
(5% and 10% w/w in 0.9% NaCl solution) were investigated by means of a rotational rheomether 
(Ares, Rheometric Scientific) equipped with parallel plates having a diameter of 25 mm. The 
plate surfaces were properly modified through a fabric-based adhesive tape to prevent hydrogel 
slipping [13]. The viscosity tests were performed in a “steady state mode” at room temperature 
(25 °C), setting a shear rate ranging from 0.1 to 100 s
−1
 with step increasement of  0.02 s
−1
. The 
storage modulus (G’) and loss modulus (G”) were evaluated using the same experimental setup 
in a “frequency sweep mode” setting with a shear rate at 0.5 s−1. All experiments were carried out 
in triplicate, and the average values were reported. 
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 2.3.2.4   Atomic Force Microscopy 
The morphology of the film surface was also studied by Atomic Force Microscopy (AFM 
Perception, Assing, Italy). Small pieces of films were glued onto metal disks and attached to a 
magnetic sample holder located on the top of the scanner tube. Phase images were recorded 
under ambient air conditions. All of the images were recorded in contact mode in air using 
silicon cantilevers. A standard statistical software package (SPSS version 20.0, SPSS IBM, New 
York, NY) was used for data analysis. 
 
 
 2.3.2.5   Biological studies 
 In vitro cell culture 
Biological assays were performed using human mesenchymal stem cells line (hMSC) obtained 
from LONZA (Milano, Italy). hMSC were cultured in 75 cm
2
 cell culture flask in Eagle’s alpha 
Minimum Essential Medium (α-MEM) supplemented with 10% Fetal Bovine Serum (FBS), 
antibiotic solution (streptomycin 100 µg/ml and penicillin 100U/ml, Sigma Chem. Co) and 2 
mM L-glutamine. hMSCs from passages 4 through 6 passage were used for all the experimental 
procedures and incubated at 37°C in a humidified atmosphere with 5% CO2 and 95% air. 
 
 Cell morphology 
The cell morphology and cell spreading pattern interaction of hMSC onto cellulose gels 
(CMCNa, CMCNa-CA, HEC and HEC-CA) were evaluated by confocal laser scanning 
microscopy (LSM 510, CarlZeiss). Briefly, hMSC at 2x10
3
 were seeded onto gel materials and 
incubated for 24h.     At the end of the incubation time, the non-attached cells were removed by 
rinsing carefully three times with PBS and then incubated with CellTracker™ Green CMFDA in 
phenol red-free medium at 37°C for 30 min. Subsequently cell culture were washed with PBS 
and incubated for 1h in complete medium. After period of time the cells were visualized on 
LSM. 
 
 Viability test 
To evaluated cell biocompatibility, hMSC were plated at concentration of 1.6x10
4
 in triplicate 
onto different cellulose gels (CMCNa, CMCNa-CA, HEC and HEC-CA). The medium in cell-
load gel materials culture plates were removed after cultured for 7, 14 and 21 and the in vitro cell 
viability was checked by the Alamar blue assay (AbD Serotec, Milano, Italy). This assay 
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quantified the redox indicator which changed to a fluorescent product in response to the 
chemical reduction by mitochondrial enzymes such as flavin mononucleotide dehydrogenase, 
flavin adenine dinucleotide dehydrogenase, and nicotinamide adenine dinucleotide 
dehydrogenase. In addition, a redox phenomenon gave a quantitative indication of metabolic 
activity of live cells. An aliquot of 1mL of Alamar Blue™ diluted 1:10 in phenol red-free 
medium was added to each well and incubated for a further 4 h at 37°C, 5% CO2. Later, 200µL 
of this solution was transferred into a 96 well plate for colorimetric analysis. Wells without any 
cells were used to correct any background interference from the redox indicator. The optical 
density was immediately measured with a spectrophotometer (Sunrise, TECAN, Männedorf, 
Zurich, Switzerland) at wavelengths of 540 and 600 nm. The cell viability percentage was 
evaluated in according to the manufacturer’s protocol. The culture medium during experimental 
time was changed every two days.  
 
 Alkaline Phosphatase assay 
The alkaline phosphatase activity of the hMSC onto cellulose gel materials was determined for 7, 
14 and 21 days of culture by a spectrophotometric end-point assay that determined the 
conversion of colourless p-nitrophenyl phosphate as substrate to coloured p-nitrophenol 
following the manufacturer’s protocol (Sensolyte pNPP ALP assay Kit, AnaSpec). Briefly, at the 
end of each time point, cultures were washed gently with PBS followed by washing twice with 
cold 1X assay buffer. For extract cell layers the cultures were lysing with 1X lysis buffer with 
0.2% of Triton X-100.   The phosphatase activity was analyzed onto the cell lysates (50μl) by 
measuring the ALP activity when ALP enzyme catalyzes the cleavage of a phosphate group and 
release p-nitrophenol from pnitrophenyl phosphate in alkaline buffer solution after 30 min at 
37°C. Sample absorbance was measured in a 96-well plate at 405 nm. To correct the ALP values 
for the number of cells present on each scaffold double stranded DNA (dsDNA), as a marker for 
cell number, was measured using a PicoGreen_dsDNA quantification kit (Invitrogen). First, 
100µl of 200µl diluted Picogreen_dsDNA quantification reagent was added to 100 ml of cell 
lysates in a flat-bottomed, 96-well plate. Following 10 min incubation, the fluorescence of 
Picogreen was determined at a wavelength of   520 nm after excitation at 585 nm using a plate 
reader (multilabel counter 1420 Victor, Perkin-Elmer, Italy). dsDNA was quantified according to 
a calibration curve of l-dsDNA standard in        10 mM Tris, 1 mM EDTA, pH 7.5, buffer. Each 
experiment was performed three times in triplicate. The results of ALP activity were reported as 
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nanograms of ALP normalized to the micrograms of total DNA content. ALP experiments were 
repeated twice and three hydrogel scaffolds were used in each experiment. 
 
 RT-PCR assay 
hMSC cultures onto carboxymethyl cellulose gel composite materials grown in medium  for          
21 days were characterized by reverse transcription-polymerase chain reaction (RT-PCR) for 
gene expression of bone-related markers. Total RNA was isolated from cell materials using TRI-
reagent (SIGMA). The RNA was precipitated with isopropyl alcohol and the final pellet 
resuspended in DEPC-water and DNAse I digested (Life Technologies, Italy) to remove 
contaminating of genomic DNA. The absorbency at 260/280 nm was measured to determine the 
RNA concentration. One micrograms of total RNA was used to perform one-step RT-PCR 
reaction (Life Technologies, Italy) according to the manufacturer’s protocol. Briefly, cDNA 
synthesis program was 1 cycle at 60°C for 30 min followed of denaturation cycle of 94°C for 2 
min. cDNA was amplified at 94°C for 15 s, 58°C for 30 s and 68°C for 1 min for 40 cycles in a 
thermal cycler (Applied Biosystem). Primers used for amplification of bone-related molecules 
were upstream and downstream as follow: osteopontin: 5’-TTCGGATGAGTCTGATGAGACC-
3’,5’-GGAAGAACAGAAGCAAAGTGC-3’; osteocalcin: 5’-
CAGCAGAGCGACACCCTAGACC-3’,5’-CATGAGAGCCCCTCACACTCC-3 and 
Glyceraldheyde-3-phosphate dehydrogenase (GAPDH): 5´-
CCACCCATGGCAAATTCCATGGCA-3’, 5’-TCTAGACTGGCAGGTCAGGTCCACC-3’ 
was utilized as housekeeping gene. Reaction products were separated using gel electrophoresis 
on 1.2% agarose gel stained with ethidium-bromide. Bands were visualized using ultraviolet 
illumination and captured with BioRad Imaging System (BIORAD).  
 
 
 2.3.2.6   Statistical Analysis 
One-way analyses of variance (ANOVA) were performed to detect significant effects among 
treatment with post Bonferroni t-test. Results were considered to be significant at p < 0.05. 
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2.3.2 Results  
 2.3.2.1 Infrared Spectroscopy FTIR analysis  
The structure of the salt form of CMC and HEC is presented in Figure 1, showing a 
carboxymethyl-substituted unit in the C(6) position and two unsubstituted cellulose units. In 
general, cellulose is made up of glucose rings connected by -C-O-C ether bonds known as β-1,4 
glycosidic linkages with extensive intramolecular hydrogen bonding [45,46]. The cellulose 
monomer has a balance of hydrophilic (-OH, C-O-C) and hydrophobic (-CH, -CH2-) sections. 
The substitution of carboxymethyl groups on the oxygen in the C(6) position imparts a pH-
dependent anionic character to the molecule. Absorption band at 3318cm
-1
 is due to the 
stretching frequency of the –OH group as well as intramolecular and intermolecular hydrogen 
bonds in a cellulose. 
 
 
 
Fig. 2: FTIR analysis of CMCNa before (blue line) and after (red line) crosslinking reaction  by citric 
acid. 
 
Peaks at wavenumber of 1084.70 cm
-1
 is due to >CH2-O-CH2. Spectrum shows (figure 2) C-H 
stretching vibration at peak with wavenumber of 2925.20 cm
-1
. The peaks at 1450 and 1330 cm
-1
 
were attributed to CH2 and CH absorptions, respectively. The broad bands from 1200 to 1000 
cm
-1
 were due to sugar ring absorption. The HEC spectrum (figure 3) shows the band at 1590cm
-
1
 whereas the absorbance of the carbonyl group at 1723 cm
-1
 appears only after chemical 
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treatment with citric acid. Crosslinked cellulose hydrogels showed a decreasing of OH intensity 
peak, probably due to the chemical interaction with citric acid. 
 
 
Fig. 3: FTIR analysis of HEC before (green line) and after (red line) crosslinking reaction by citric acid. 
 
 
 2.3.2.2   Hydrophilicity 
The hydrophilicity of materials was determined by contact angle analysis. The figures show that 
the crosslinking by citric acid increases the hydrophilicity of materials by adding some -COOH 
groups on material surface.  
 
OH 
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(A) 
      
                       (B) 
Fig. 4: Contact angle images of  water drop at contact with  hydrogel films at t=0 and after few seconds 
t=15sec. Contact angle values of  different hydrogels (CMCNa, CMCNa-CA, HEC and HEC-CA)  at t=0 
and t=15" of contact with water drop. 
 
In fact, in the images (figure 4A) it is possible to evaluate the different shape of water drop at 
contact with the hydrogel materials before (CMCNa, HEC) and after (CMCNa-CA, HEC-CA) 
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chemical reaction. Moreover , it possible to observe a straight geometry of drop after few 
seconds (15seconds) of contact with hydrogel surfaces. This behavior is typical of hydrophilic 
materials and it is confirmed by a decreasing contact angle values (figure 4B) after 15 seconds 
[44]. Furthermore, the results show that there is a decreasing contact angle values of  about 50% 
and 67% after the crosslinking reaction between hydrogels HEC/HEC-CA and 
CMCNa/CMCNa-CA respectively.  
 
 
 2.3.2.3 Rheological Analyses  
In this study, the shear rate-dependent viscosity of hydrated cellulose samples in a powder form 
as a function of  concentration was evaluated. Figure 5A  shows the viscosity values (recorded at 
a shear rate of 10 s
-1
) for different samples and two different concentrations (5% and 10% w/w in 
0.9% NaCl solution). The samples without CA (both for HEC and CMCNa) after hydration 
resulted in a viscous solution, while the corresponding ones with CA will led to hydrated rigid 
particles due to the effect of crosslink. For this reason, it is evident that the samples without CA 
tested at the higher concentration (10%) show an increased viscosity values if compared with 
those prepared at 5% w/w concentration. The effect of molecular weight of the starting material 
is evident with the superior viscosity of the CMCNa sample when compared to the HEC. In the 
case of the samples with CA, this is an effect due to the number of hydrated particles per unit 
volume and can be explained with a different surface to volume ratio. The sample with a 
concentration of 10% presents a number of hydrated particles per unit volume that is double that 
the sample with 5%, resulting with an increased surface to volume ratio. This led to an increased 
contact area between particles with a higher viscosity. In addition, the samples made entirely 
with CMCNa (with the presence of CA) presented a reduced viscosity values due to a coupled 
effect of the molecular weight and the polyelectrolyte nature of the polymer backbone. These 
factors play an important role in the crosslinking rate of the polymer and sorption capability 
respectively. In particular, the Donnan effect, typical of polyelectrolyte systems, dramatically 
reduces the absorption capacity in presence of a solution with NaCl, leading to a less viscous 
system due to a reduced volume of the hydrated material [47]. 
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(A) 
 
(B) 
Fig. 5: (A) Viscosity of  cellulose hydrogels CMCNa-CA, CMC, HEC and HEC-CA. (B)  Rheological 
properties of  cellulose hydrogels CMCNa-CA, CMC, HEC and HEC-CA. 
 
 
The viscoelastic results performed on the same samples are shown in figure 5B. These results 
confirm the greater elastic response of the CMCNa based samples. These differences are 
addressed to the molecular weight of the starting cellulose and the effect of the crosslinker. The 
effect of concentration and the crosslinker is more evident for the G’ values than the G”. This 
confirmed the crosslinked hydrogel structure for the sample obtained in presence of CA. 
 
 
 
5% 10% 
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2.3.2.4  Atomic Force Microscopy   
An important factor influencing the adhesion and subsequent behaviour of cells is the material 
surface roughness. AFM images were taken to investigate surface morphology of hydrogels and 
determine the effect of crosslinker concentration on hydrogel surface roughness. 
AFM images of hydrogels before and after citric acid crosslinking have been shown in figure 6.  
 
 
Fig. 6:  AFM images of  cellulose hydrogels CMCNa-CA, CMC, HEC and HEC-CA. 
 
The change of morphology was evaluated for two types of hydrogel materials and a surface with 
the highest roughness was reported for HEC-CA hydrogel. However a citric acid treatment 
induces an increasing of roughness in terms of Ra and RMS as reported in Table 1. The Ra value 
is the most commonly used roughness parameter in both dentistry and engineering. Nevertheless, 
the Ra value is limited by the two-dimensional aspect, providing only information on the average 
roughness height, and also giving no information at all on the surface profile. Meanwhile, RMS 
(root mean square) is more sensitive to the occurrence of occasional high and low points. On 
average, the RMS values of CMCNa, CMCNa-CA, HEC and HEC-CA are 31.82, 39.72, 9.98, 
and 16.56 nm, respectively. AFM measurements show that RMS (nm) is related with citric acid 
concentration used for the crosslinking reaction. The nanoscale structure of the material surface 
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has been found to have significant positive effects on osteoblast cell response, including initial 
cell and expression of differentiation markers.  
 
 Ra[nm]  RMS[nm] 
CMC_Na 21.78±3.14  31.82±3.83 
CMC_CA 30.10±1.08  39.72±0.91 
HEC  6.46±2.45  9.98±3.63 
HEC_CA 16.68±2.07  16.56±2.60 
   
Table 1: Roughness in terms of Ra and RMS.  
 
 
 2.3.2.5 Biological studies 
To determine whether the different cellulose gels materials (CMCNa, CMCNa-CA, HEC and   
HEC-CA) are suitable as cell scaffolds, we evaluated the morphology of adhering cells. After 
one day in culture, we found that cells were viable and showed good attachment and spreading 
on the different scaffold materials (figure 7).  
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Fig. 7: Morphology of hMSCs adhesion and cell material-interaction on (A) CMCNa-CA; (B) HEC-CA; 
(C) CMC and (D) HEC hydrogel base scaffolds after culturing for 24 h. 
 
The representative morphology of adhering cells on cellulose gels showed an elongated 
morphology or tends to adopt a polygonal morphology typical of fibroblast-like cells. On all 
cellulose hydrogels materials, the cell adhesion and spreading showing the cells firmly anchored 
and elongated to the gel surface scaffolds. 
The cell proliferation on the different cellulose hydrogel materials (CMCNa, CMCNa-CA, HEC 
and HEC-CA) were assessed using Alamar Blue test. Figure 8 shows the effect of the hydrogel 
on the metabolic activity of hMSC after 7, 14 and 21 days of culture.  
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Fig.8: Alamar Blue assay of proliferation of hMSC material-interaction after 7, 14 and 21 days of cell 
culture. 
 
According to the data, it can be found that MSCs dramatically increase with time during the in 
vitro culture period; suggesting that the cellulose gels are nontoxic, not affecting the cell 
proliferation and showed good biocompatibility. Meanwhile, a reduced proliferation was 
observed  for hydrogels CMCNa-CA and HEC-CA; this behaviour could be explained by the 
promoting of differentiation of hMSC cells by the characteristic hydrogel surfaces properties 
(Figure 9). 
To assess the development of the osteoblastic-like phenotype of MSCs grown on the different 
cellulose gels materials (CMCNa, CMCNa-CA, HEC and HEC-CA), ALP activity was 
performed after 7, 14 and 21 days of culture. As shown in figure 9, the ALP activity closely 
reflected the cell morphological features as they showed that the cells adhering on treated 
hydrogel had the highest differentiation level, where the ALP enzyme activity was significantly 
high, reaching its peak after 14 days of culture. In particular, CMC and HEC hydrogels after 
crosslinking by citric acid show a better differentiation with significantly increased ALP activity 
at different time when compared with non-modified hydrogels (p < 0.005). This behaviour can 
be explained by the nano-roughness induced by crosslinking surface that improves the 
expression of differentiation markers. 
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Fig. 9: ALP activity per µg DNA (DNA picogreen) of hMSCs cultured on gel materials at 7, 14 and 21 
days. 
 
The effects of the different cellulose gels materials on osteoblastic differentiation in MSCs were 
determined by gene expression analysis of bone-related markers as osteopontin (OPN) and 
osteocalcin (OCN) by RT-PCR. Figure 10 showed the up-regulation of these genes of MSCs 
culture on gels materials, suggesting the differentiation  to osteoblastic-like phenotype 
throughout the assay period. This behaviour could be explained by the nano-roughness induced 
by crosslinking surface that could promote and improve the expression of differentiation 
markers. Based on the above results, the different cellulose hydrogel materials (CMCNa, 
CMCNa-CA, HEC and HEC-CA) had good cell biocompatibility in vitro and crosslinked 
hydrogels perform as a better support to induce an osteogenic differentiation through the 
expression of specific markers. 
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Fig. 10: RT-PCR analysis for the transcription of the bone-related markers as osteopontin (OPN) and 
osteocalcin (OCN) by hMSC cultured onto different cellulose gels materials CMCNa-CA, CMC, HEC 
and HEC-CA after 21 days of cell culture. 
 
 
2.3.4 Discussion 
Cellulose is a promising scaffold material for bone tissue engineering applications [48,49]
 
due to 
its bone compatible mechanical properties [50,51] in combination with its good machinability. 
Nevertheless, the clinical use of cellulose as bone replacement material is limited due to its 
insufficient osteointegration [52].  
Numerous efforts made to stimulate the bioactivity of cellulose. The substitution of functional 
groups (e.g., –COOH, –NH2) was found to improve the bone-bonding ability of the cellulose 
derivates at the implant/tissue interface [53,54]. The good hMSC attachment and proliferation 
found can be attributed to the peculiar properties of modified cellulose hydrogels for biomedical 
applications, namely their high purity and high water uptake or swelling, causing less physical 
damage to cells [55], associated with their moderate hydrophilicity. In the literature, the role of 
hydrophilicity in cell adhesion has been widely discussed and, despite the difficulty in isolating 
this property from the other influencing ones, the general conclusion seems to be that moderate 
hydrophilicity favours cell adhesion, and extreme values inhibit this phenomenon [56,57].  
Surfaces with –COOH also have shown an increase in cell growth. A more recent study showed 
that this phenomenon is dependent upon the concentration of –COOH on the surface, as an 
increase in functional group density results in a higher negative charge on the surface, which was 
shown to inhibit cell growth [58]. Surface wettability of artificial materials is one of the most 
important factors determining cell adhesion behaviours. Tamada et al. Claimed [59] that a 
surface with a water contact angle of 70 gave the most suitable surface for cell adhesion; 
OPN 
OCN 
GAPDH 
 
CCMCNa_CA   CMCNa_CA  HEC    HEC_CA CMCNa 
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however, the surfaces used in these studies were prepared using commercially available 
polymers and were not well controlled for factors of roughness, ionic charges, surface rigidity, 
etc. It is no doubt that the scaffold used for bone tissue engineering should be non-toxic and have 
good cell biocompatibility, which is a central criterion to ultimately decide the feasibility of 
implantation in body [60]. The information of the cell attachment and proliferation on the 
scaffold provided by cell culture experiment in vitro is often use as an important initial 
evaluation of cell biocompatibility. In this work human mesenchymal stem cells (hMSC), largely 
used to evaluate the regeneration of mineralized ECM in bone defects [61], were used as cell line 
model for in vitro testing of cell–material interaction, biocompatibility and osteogenic potential 
of the cellulose hydrogel materials. The paper reported the possibility to introduce new 
hydrophilic components such as  -COOH groups by a simple crosslinking of cellulose hydrogels 
using citric acid. The citric acid is a natural cross-linker component of lemon juice that allows a 
crosslinking of CMC and HEC at high temperature with an anhydride intermediate. The results 
show that the crosslinking reaction gives the final products (CMCNa-CA and HEC-CA) with 
lower contact angle and higher roughness. Furthermore, our results of the hMSC cells-material 
interaction by confocal microscopy observation and proliferation test by Alamar Blue assay 
showed that CMCNa, CMCNa-CA, HEC and HEC-CA gels scaffolds had no negative effects on 
biological respond of hMSC, are nontoxic and  are cell biocompatible. Ours preliminary studies 
of the differentiation of hMSCs towards the osteoblastic-like phenotype was quantitatively 
determined by carrying out a destructive assay for ALP activity using the p-nitrophenyl 
phosphate method. ALP is an enzyme produced by differentiating osteoblasts and is present both 
on the extracellular membrane and in vesicles of the bone matrix, which is the initial site of the 
formation of calcium phosphate crystals. The enzymatic activity of ALP is crucial for the 
mineralization process; it acts on the organic phosphate to increase the local concentration of 
free phosphate and to induce the active transport of both phosphate and calcium across the cell 
membrane [62]. In our results a steady increase in ALP activity was observed, which may 
confirm the ability of the gel materials to support hMSC differentiation towards the osteoblast-
like phenotype and future could  support the ECM mineralization. Previous in vitro works clearly 
demonstrate that osteogenic cells from hMSC remain vital and differentiate in the presence of 
CMCNa [63]. We performed the evaluation of expression of bone-related proteins involved in 
the mineralization process as osteopontin and osteocalcin onto CMCNa, CMCNa-CA, HEC and 
HEC-CA gels scaffolds. In our hands, the potential of differentiation of hMSC was not affected 
by the gels scaffolds and the finding of gene expression do not rule out the possibility that the 
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chemical modification of CMCNa, CMCNa-CA, HEC and HEC-CA gels scaffolds change the 
response of hMSC required for reproducing the bone ECM. 
Based on numerous previous studies and techniques, it is known that ALP expression rise as 
extracellular mineralization marker for osteoblasts phenotype and then declines as osteoid 
becomes heavily mineralized, while OCN expression is acquired latest and essentially is 
diagnostic of post-proliferative osteoblasts [64]. Some research groups [65] reported that the 
carboxylic acid group-grafted surfaces, even though they were negatively charged, show better 
cell attachment and proliferation than untreated hydrophobic surfaces. The results suggest that 
hydrophilic groups and their charge character as well as wettability play important roles for cell 
adhesion, spreading, and growth, even though cell-surface interaction is a very complicated 
phenomenon and thus it is still not clear which property could be really dominant for cell 
adhesion and growth on surfaces. 
 
 
2.3.5 Conclusions 
Citric acid could be successfully used as functionalizing agent for CMCNa and HEC hydrogel 
materials. Moreover, crosslinking by citric acid increases the hydrophilicity and roughness 
surface of modified-cellulose hydrogels. Injectable cellulose hydrogels have good effect on the 
cell attachment, cell proliferation and osteoblastic differentiation. Furthermore, the use of citric 
acid as crosslinker allows the attainment of a good hydrogel substrate that can stimulate 
osteogenic differentiation of hMSC by  the expression of bone markers. For these reasons, 
cellulose hydrogels  could have a great potential application as filler in bone repair and 
regeneration.  
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Conclusions of chapter 2 
In this chapter were proposed three  injectable systems as a bone-filler: 
1. Strontium-substituted hydroxyapatite cement (to contrast osteoporosis effects); 
2. Bioactive hydroxyapatite - graphene oxide (to support high viability of hMSC cells);    
3. Modified-cellulose hydrogels crosslinked by citric acid (to increase hydrophilicity and 
roughness surface in order to stimulate osteogenic differentiation of hMSC). 
 
All these gel materials could have a different medical application, such as osteoporosis therapy, 
filler for different (in terms of dimension and shape) bone cavity caused by tumor removal, 
fractures or congenital defects, carrier to growth factors or pharmacy, detection systems, antitumor 
therapy, or as a multifunction systems.  
 
Our researches have demonstrated that the injectable HA-modified systems (1 and 2) preserve the 
typical gel structure of traditional hydroxyapatite, in a macroscale. However in a nanoscale is 
possible to observe the real differences of the two systems: (1) HA structure results modified due to 
substitution of Ca with Sr atoms, during sol-gel synthesis. In particular, the nHA crystals have a 
different shape and crystalline decrease; (2) nHA, with a  typical spindle-like shape and a typical 
dimensions of about (5x70 nm), is uniformly distributed on GO sheets. In this case,  there is no one 
modification of traditional bond or atomic disposition during synthesis, that could be modified the 
nHA growth, but there is an electrostatic attraction between carboxyl group presents on GO sheets 
surface and Ca
2+
 ions.  
Indeed, in the two different cellulose systems (CMCNa and HEC) (3) we have demonstrated that 
crosslinking treatment by citric acid (CA) increases the hydrophilicity, by adding some -COOH 
groups on material surface, and the roughness of materials. 
The specific nanoscale structures of the materials surface have a significant positive effects on 
osteoblast cell response, including initial cell and expression of differentiation markers. 
Infact,  gel systems (1, 2 and 3) supported high viability of hMSC cells and have a good effect on 
cell attachment, proliferation and osteoblastic differentiation. In particular gene expression analysis 
shows that HA doped with strontium (1) and CMCNa-CA, HEC-CA hydrogels (3) significantly 
promote the expression of osteogenesis related genes including an early marker for osteogenic 
differentiation ALP; a non-collagen protein OPN and a late marker for osteogenic differentiation 
OCN. 
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Moreover, HA-GO hybrid system (2) induces an osteogenic differentiation evaluated by using a 
media without osteogenic factors.  
The proposed materials for osseous defects associated with orthopaedic reconstructive surgery may 
be good candidates as delivery vehicles for cells or drugs such as antibiotics, since they would 
conform to the defect. Moreover, one of the major properties is that they could be used in minimally 
invasive procedures. 
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CHAPTER 3  
POROUS SCAFFOLD FOR OSTEOCHONDRAL DEFECT 
 
 
rticular cartilage has limited reparative abilities. Purely chondral defects do not heal, and 
usually progress towards degeneration of the surrounding cartilage. Osteochondral defect - 
that is defect that penetrate the subchondral bone - can undergo spontaneous repair. Through an 
appropriate system it is possible to observe proliferation and differentiation of human mesenchymal 
stem cells (hMSCs), which invade the defect from the underlying bone marrow. The goal is hMSCs 
differentiation into fibroblasts, chondrocytes and osteoblasts, in order to synthesize new bone tissue 
in the base of the defect by both endochondral and direct intramembranous ossification, and 
synthesize cartilage tissue in the chondral region of the defect, with a layer of fibrous tissue forming 
at the articular surface. 
Experimental studies have shown that several physical factors such as size and location of the 
defect, or load acting, can influence the quality, type and durability of the repair tissue.  
Here, a new strategy of composite manufacturing has been proposed by two different techniques: 
bulk sol–gel transition and surface biomimetic treatment. Proposed approaches enable to efficiently 
exploit the peculiar features of composite material bulk, in the first case, and surfaces by 
modulating the spatial distribution of bioactive signals, in the second, moving toward a more 
efficient replacement of bone tissue. 
Moreover bone/cartilage defect fillers promote a dual effect: 1) natural polymer matrix’s effect; 2) 
presence of bioactive signals on the surface, inside the scaffold’s structure or in a specific region of 
the same. The use of a 3D scaffold depends on the necessity to have a shape control, while the 
biological signals are induced by HA presence on the surface, as a coating, or within the structure 
as a gradient. As hydrogel, the structure can adapt perfectly to the shape defect. 
In this chapter we propose two systems based on gelatin/hydroxyapatite, potentially able to support 
the osteochondral defect reparation. 
 
 
 
 
 
A 
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3.1 BIOMINERALIZED GELATIN SCAFFOLD 
 
Introduction 
The development of materials by mimicking the structure and composition of human tissues, 
namely the biomimetic approach, has long been a major goal in the field of biomaterials and tissue 
engineering. In bone-tissue regeneration, gaining an insight into the hierarchical structure of the 
bone matrix, i.e., the nanocomposite consisting of mineralized hydroxyapatite (HA) nanocrystals 
and collageneous fibres, has caused a considerable amount of research to be direct toward the 
synthesis of bio-inspired and biomimetic systems [1-4]. 
Several synthetic scaffolds, such as biodegradable polymers and bioactive ceramics, which have 
been developed to sustain the wound site and subsequently replace and regenerate new tissues, have 
proven to be applicable clinically. Human hard tissues, such as bones and teeth, consist of cells and 
surrounding extra cellular matrix (ECM). The ECM composition of hard tissues is mainly organic 
collagen type I ﬁbrils embedded with nanosized hydroxyapatite (HA) crystals. The ECM plays an 
important role in cell function and further tissue regeneration by providing speciﬁc signals to cells 
[5]. 
Signiﬁcant effort has been exerted to develop artiﬁcial ECM to promote cell function and 
differentiation as a temporary scaffold. One approach used in the design of materials has focused on 
the degradation and ultimate replacement of the material with new tissue. Whether or not a material 
is biodegradable, its surface properties will influence the initial cellular events at the cell-material 
interface. Among the biomaterials proposed, the composites of HA and natural polymers, such as 
collagen and gelatin, have great deal of attention in a sense that the composite system can provide 
the compositional beneﬁts and preserve the structural and biological functions of the damaged hard 
tissues in a more efﬁcient and similar way to the natural system [6-8]. One of the major 
disadvantages of gelatin as a biomaterial is their high degree of biodegradation due to enzymatic 
digestion. An inadequate mechanical stability of protein-derived scaffolds will lead to a mismatch 
between the new bone formation and the scaffold degradation rates. An appropriate ratio between 
bone formation and scaffold degradation is essential to provide a suitable environment for bone 
growth in defective areas. To overcome this problem, gelatin was crosslinked by a chemical agents 
such as various aldehydes (e.g. glutaraldehyde, formaldehyde), acyl acid, carbodiimides, 
hexamethylene-diisocyanate. Amoung all, carbodiimide is a condensation agent used between 
carboxylic acid and amino groups to form amide-type bonds [9]. Crosslinking a gelatin hydrogel 
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with carbodiimide involves the activation of its carboxylic acid groups of glutamic or aspartic acid 
residues to give O-acylisourea groups, which form crosslinks after a reaction with its free amino 
groups of lysine or hydroxyline residues [9,10]. The cross-linked structure results in a lower 
degradation rate, increasing the longevity of materials in the living environment. Porous gelatin 
scaffold can be fabricated by using the freeze-drying method [11].  
To engineer functional tissues and organs successfully, the scaffolds have to be designed to 
facilitate cell distribution and guide tissue regeneration in three dimensions. On the other hand, 
natural bone ECM is a composite mainly composed of nanoﬁbrous type I collagen and partially 
carbonated hydroxyapatite (HA). HA is orderly deposited within nanoﬁbrous collagen matrix. 
Hence synthetic HA has been developed in a variety of forms and is known to directly bond to 
bones and teeth in vivo   [12]. Its excellent bioactivity and osteoconductivity led to potential use in 
hard-tissue substitutes and regeneratives [13-15]. 
However, it is highly brittle and stiff; therefore its shape and size availability is limited, and it is 
difﬁcult to handle in clinical situations. In this manner, the composite design of gelatin and HA is 
expected to offer improved biocompatibility from biological and mechanical viewpoints. The 
gelatin-HA composite also is expected to be a good alternative for hard tissue regenerative, in view 
of combining the bioactivity and osteoconductivity of HA with the ﬂexibility and hydrogel 
characteristics of gelatin.  
A composite approach of the two components, gelatin and HA, has the potential to be an engineered 
biomaterial. Same authors suggest to disperse  HA powders directly  in the polymer solution. 
However, the HA powders in this case were not dispersed well or were easily agglomerated, and 
even settled, which made it difﬁcult to form a controlled structure [16-18]. For this reason, we 
propose a biomimetic approach, that consist in the precipitation of nanoapatite crystals on the  
polymer surface [6-8,19], due to modified material surface properties and influence the composition 
of the adsorbed protein compounds, which in turn regulates how cells respond to the material 
[20,21]. 
The crosslinked gelatin-HA composites were fabricated as a porous scaffold, through a combination 
of two process as freeze-drying and biomimetic method, to offer a porous system with a high 
speciﬁc surface area for vascularization and cell ingrowth, and appropriate biological repeals, such 
as hydroxyapatite [22]. 
We hypothesized that such gelatin/nanoapatite composite scaffold would provide not only excellent 
biocompatibility but also advantageous scaffolding properties, such as enhanced cell adhesion, 
proliferation, and osteoblastic differentiation. 
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In the context of a program aimed at investigating the biological behavior of biomineralized gelatin, 
the in vitro biocompatibility was evaluated with cultured MG-63, in terms of cell adhesion, 
proliferation and differentiation. It was demonstrated that these materials are cytocompatible, non-
cytotoxicity and support osteogenic differentiation. 
 
 
3.1.1 Materials and methods 
 3.1.1.1 Materials  
Gelatin type B (bovine skin, 225 Bloom), and type A (porcine skin, 90-110 Bloom ), 1-ethyl-(3-3-
dimethylaminopropyl carbodiimide hydrochloride) (EDC) and all reagents used to prepare SBF 
solution were purchased from Sigma-Aldrich (Milano, Italy). 
 
 
 3.1.1.2  Preparation of crosslinked Gelatin scaffolds 
Gelatin (A and B) was dissolved in deionised water (5-10 w/w%,) at 40°C, rpm 100. After 30 min 
of stirring the solution was sonicated to remove air bubbles. The solution was poured into a 
multiwall plate and processed throw freeze-drying process for 48 h, due to obtain a cylindrical 
gelatin samples non crosslinked. 
The main limitation of gelatin for the preparation of tissue substitutes is its rapid dissolution in 
aqueous environments, leading to fast degradation of grafts at body temperature. To overcame this 
gelatin drawback, it was proposed a crosslinking treatment. 
The crosslinking reaction was obtained soaking porous lyophilized scaffold in a solution of 
acetone–water-based solvent (4:1 in volume) containing a water-soluble 1-ethyl-(3-3-
dimethylaminopropyl carbodiimide hydrochloride) (EDC), firstly at room temperature for different 
times (1h, 3h and 6h) and then  at 4°C for 24 h. The ratio of scaffold to solvent was fixed at 1% 
(w/v) from preliminary tests to maintain pore structures. The amount of crosslinking agent was 
0.7% (w/v) respect to volume solution of  acetone-water [23]. 
The crosslinked gelatin scaffolds were washed in bi-distilled water for several time to remove non-
crosslinked components, EDC residual and eventual sub-products; then there were deswelling by 
dehydrated in ethanol.  
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 3.1.1.3  Preparation of biomineralized scaffolds: Biomimetic surface treatment 
To produce the apatite coating, scaffold substrates were submitted to a bio-inspired procedure, 
namely biomimetic treatment, inspired by the method described by Kokubo and co-workers [24] 
[25]. 
In particular, we used an accelerate treatment that combines the preliminary use of a supersaturated 
SBF solution (5xSBF1) to stimulate the nuclei formation, while a fresh chemically-modified 
solution (5xSBF2) is further used, in order to promote the growing of apatite nuclei, once formed. 
Meanwhile, 5xSBF1 was prepared by sequentially dissolving CaCl2, MgCl2·6H2O, NaHCO3 and 
K2HPO4·3H2O in distilled water. Solution pH was lowered to 6 by adding hydrochloric acid HCl 
(1M) to increase the solubility. Na2SO4, KCl were added until the previous solution become clear. 
The final pH was adjusted with 1M NaOH to reach a final pH equal to 6.5 (5xSBF1).  
Therefore, Mg
2+
 and HCO3
-
 free 5xSBF was prepared by adding CaCl2, K2HPO4·3H2O 
subsequently to distilled water up to obtain a fresh solution (5xSBF2). In this case, the solution pH 
was lowered to 6.0 with hydrochloric acid to increase the solubility. Both solutions were buffered at 
pH 6.5 and 6 respectively, by using Trishydroxymethylaminomethane-chloric acid (Trizma-HCl). 
In Table 1, the ionic concentration of blood plasma, SBF, 5xSBF1 and 5xSBF2 were reported. All 
solutions were prepared freshly before the use.  
The biomimetic treatment consists in two steps in pH-controlled environment: during the first step, 
samples with pre-ordered size were soaked into 5xSBF1 at pH=6.5 where the 5xSBF solution 
volumes have been calculated respect to the total scaffold material surface by using an exposed 
surface to SBF volume ratio equal to 10 mm
2
/ml, as reported in literature [26].  
The solution temperature was fixed at 37°C during the treatment. After the sequential immersion in 
5xSBF1 (4 days) and in 5xSBF2 (3 days), all scaffolds were gently rinsed in distilled water to 
remove excess ions and, then, dried overnight under laminar hood.  
 
 
Table1: The ionic concentration of human blood plasma, SBF, 5xSBF1 and 5xSBF. 
 
Ion Concentration 
(mM) 
Na
+
 K
+
 Ca
2+
 Mg
2+
 HCO3
-
 Cl
-
 HPO4
-
 SO4
2-
 
Blood plasma 142 5 2.5 1.5 27 103 1 0.5 
SBF 142 5 2.5 1.5 4.2 148 1 0.5 
5xSBF1 710 25 12.5 7.5 21 740 5 2.5 
5xSBF2 710 10 12.5 - - 735 5 - 
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To increase the nucleation phase, the scaffold materials were tested by using two different pre-
treatment: 
 Preliminary treatment in CaCl2 solution (0.1M) at 37°C for 2 days and then by accelerated 
biomimetic treatment; 
 Preliminary treatment in Ca(OH)2 solution (0.01 M) a 37°C for 30 min and then by a 
standard biomimetic ones: 1.5xSBF1 (4 days) and in SBF (3 days). 
 
 
3.1.2 Characterization 
 3.1.2.1 Morphological analysis  
The morphological analysis was performed on different scaffolds by using a Quanta FEG200 (FEI, 
the Netherland) Scanning electron microscope. The materials for SEM analysis were prepared by 
deposition of composite scaffold on one side of a double adhesive tape, and then stuck to an 
aluminium stub. The stub was then gold coated in an automatic sputter coater (EMSCOPE SC500, 
20KV) to a thickness of around 30 nm. X-ray energy dispersive spectroscopy (EDAX, Genesis 
2000i) was used for a qualitative estimation of elements in the material.  
All the samples were, firstly dehydrated using a freeze-dryer, and then broken in section by using a 
liquid nitrogen in order to investigate the cross-section surface. 
 
 
 3.1.2.2  Swelling test  
The swelling measurements of crosslinked gelatin scaffolds were carried out by using pieces of 
lyophilized samples (9x6 mm) immersed into 4 ml distilled water at 37°C for different times. The 
samples of swollen hydrogel were weighed after removal of surface water using filter paper at 
designed time intervals, and then weighed (Wt). Data presented in this experiment were the mean 
values of triplicate measurements. 
The swelling ratio was calculated according to: 
 
swelling ratio (%) = (Wt – W0)/ W0 x 100 
 
where   W0 is the weight of the dried sample. 
Wt  is the weight of the wetted sample after relative soaking period 
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 3.1.2.3  Degradation tests 
To evaluate the sample degradation, the gelatin scaffolds were soaked in 4 ml dH2O, at 37°C. After 
the designated soaking time had elapsed, the scaffolds were freezed and lyophilized due to evaluate 
the real weight after defined degradation time. Data presented in this experiment were the mean 
values of triplicate measurements. 
The degradation was calculated according to: 
 
Weight (%) = 100 - [(W0 – Wf)/ Wf x 100] 
 
where     W0 is the weight of the dried no-depredated sample; 
  Wf is the weight of the dried sample after relative soaking period. 
 
 
 3.1.2.4  Thermal analysis: DSC and TGA 
Thermal gravimetric analysis (TGA) was performed by TA Instrument Q 5000 under nitrogen 
atmosphere and room temperature up to 800 °C, with a heating rate of 5 °C/ min. 
Differential scanning calorimetry  (DSC) was performed by TA Instrument Q 1000 under nitrogen 
atmosphere and setting a temperature stage:  room temperature up to -5°C, and -5°C up to 250 °C, 
with a heating rate of 5 °C min-1. 
 
 
 3.1.2.5  XRD analysis 
X-ray diffraction measurements (XRD) were performed with a Brucker diffractometer (equipped 
with a continuous scan attachment and a proportional counter) with Ni-filtered Cu Kα radiation 
(λ=1.54050 Å). 
 
 
 3.1.2.6  Mechanical test 
The mechanical properties of the scaffolds were evaluated by compression tests. Tests were 
performed using a standard testing machine (Lloyd LR5K instrument, Fareham Hants, U.K.) 
equipped with a 10 N load cell. The gelatin, with and w/o biomineralized coating, cylinders were 
soaked in water until equilibrium swelling, and then tested in an aqueous environment. The 
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deformation range and the speed (mm/min) were calculated respectively as 75% and 10% of 
swelled sample height. 
 
 
 3.1.2.7 Biological test 
 Cell viability 
The human osteoblastic cell strain MG-63 was cultured in α-Modified Eagle’s medium (α -MEM) 
(Bio Wittaker, Belgium) containing 10% (v/v) FBS, 100 U/mL penicillin and 0.1 mg/mL 
streptomycin (HyClone, UK), in a humidified atmosphere at 37 °C and 5% CO2. 
Materials for cell-culture experiments, were prepared to cell seeding by soaking first in 70% ethanol 
(1 h) and then in 1% antibiotic/antimycotic in PBS (2 h), and prewetting in medium (2 h). 7 x 10
4
 
cells, resuspended in 50 ml of medium, were statically seeded onto the scaffold. Following seeding, 
the scaffolds were placed in 24 well culture plates and after the initial 2 h of cell attachment on 
prewetted scaffolds, it was added 1.0 ml of cell-culture medium. The samples were exposed to basal 
medium, comprising α -MEM supplemented with supplemented with 10% Fetal Bovine Serum 
(FBS), antibiotic solution (streptomycin 100 µg/ml and penicillin 100U/ml, Sigma Chem. Co) and 2 
mM  L-glutamine. The scaffolds were maintained in culture for 21 days and the cell-culture 
medium was changed every 2-3 days.  
Cell proliferation was evaluated by using the Alamar Blue assay. This is based on a redox reaction 
that occurs in the mitochondria of the cells; the coloured product is transported out of the cell and 
can be measured spectrophotometrically. The cell–material constructs were removed from the 
culture plates at days 1, 7, 14 and 21, 28 washed with PBS (Sigma–Aldrich, Italy), and placed into 
24 well culture plates. For each construct, 1 ml of DMEM medium without Phenol Red (HyClone, 
UK) containing 10% (v/v) Alamar Blue (AbD Serotec Ltd, Milano, Italy) were added, followed by 
incubation for 4 h at 37 °C and 5% CO2. 200 μl of the solution were subsequently removed from the 
wells, transferred in a 96-well plate and the optical density was immediately measured using a 
spectrophotometer (Sunrise, TECAN, Männedorf, Zurich, Switzerland) at wavelengths of 540 and 
600 nm. The number of viable cells correlates with the magnitude of dye reduction and is expressed 
as percentage of AB reduction [42].  
 
 Alkaline Phosphatase assay 
The alkaline phosphatase activity of the cells onto gelatin materials was determined for 7, 14 and 21 
days of culture. To measure ALP levels, the cells were lysed in cell lysis buffer (BD Pharmingen™) 
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and the ALP activity was measured using the SensoLyteTM pNPP Alkaline Phosphatase Assay kit 
(AnaSpec, DBA, Milano, Italy) according to the manufacturer’s instructions. Briefly, at the end of 
each time point, cultures were washed gently with PBS followed by washing twice with cold 1X 
assay buffer. For extract cell layers the cultures were lysing with 1X lysis buffer with 0.2% of 
Triton X-100. The phosphatase activity was analyzed onto the cell lysates (50μl) by measuring the 
ALP activity when ALP enzyme catalyzes the cleavage of a phosphate group and release p-
nitrophenol from p-nitrophenyl phosphate in alkaline buffer solution after 30 min at 37°C. Sample 
absorbance was measured in a 96-well plate at 405 nm. The ALP activity was calculated from 
standard curve after normalization to the total protein concentration, which was determined using a 
kit Pierce MicroBCA Protein Assay Kit (Thermo Fisher). To correct ALP for the amount of cells 
present in each scaffold, data are presented as nanograms of ALP normalized to the milligrams of 
total protein content (ng ALP)/mg proteins. Each experiment was performed three times in 
triplicate.  
 
 
3.1.2 Results 
 3.1.3.1 Morphological analysis 
Morphological investigations were performed to evaluate four different phenomena:  
1) Internal/external structure of gelatin scaffold realized by liophylization technology; 
2) Structural changes caused by degradation; 
3) Evaluation of different biomimetic treatments successful by EDS analysis: 
 5xSBF1 (4 days) + 5xSBF2 (3 days) 
 CaCl2  (0.1 M for 2 days) + 5xSBF1 (4 days) + 5xSBF2 (3 days) 
 Ca(OH)2 (0.01M for 30 min) + 1.5xSBF1 (4 days) + SBF (3 days) 
4) Mechanical test effect on scaffolds internal and external structure. 
 
 Effect of Lyophilization  
Gelatin scaffolds were realized by lyophilization technology. Lyophilization or freeze drying is a 
process in which water is removed from a product after it is frozen and placed under a vacuum, 
allowing the ice to change directly from solid to vapor without passing through a liquid phase. The 
process consists of three separate, unique, and interdependent processes; freezing, primary drying 
(sublimation), and secondary drying (desorption). In particular the gelatin solutions were freeze at      
 147 
 
-80°C to allow the internal desiderated structure, and then processed for 48 hrs to guarantee 
sublimation and desorption steps.  
 
 
Fig. 1: SEM image: qualitative analysis of pore size. 
 
 
 
 
Fig. 2: SEM images of  A5_1h scaffold (A). Magnification  of internal (B) and external part of  scaffold (C). 
 
 
As shown in the images (figure 2), the internal scaffold has a interconnected porous structure, that 
should improve cells infiltration and growth, moreover for its hydrogel nature allows a nutrient and 
biology fluid transport. 
The external section shows a compact structure may be depending on interaction between gelatin 
charges and mold walls; this effect is independent to mold material, infact the test were performed 
either Teflon or polystyrene (figure 3). 
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     (A)   (B) 
Fig. 3: SEM images of external surface of B10_3h scaffold realized in a Teflon mold (A)                                  
in a polystyrene mold (B). 
 
 
 Effect of Degradation 
The degradation is an hydrolysis process where swelling, porosity and morphological changes are 
critical to its study [27]. Infact, firstly there is a water penetration through pores regions, and 
consequently, occurs the interaction between water solution sites and the hydrophilic groups of the 
hydrogel chains.   
A characteristic morphology of the freeze-dried samples of the water-swollen hydrogel was 
observed. SEM analyses were performed on the samples taken at specific swelling times: 1, 4, 8, 
12, 21, 28 days.     
As shown in the figures 4 and 5, a simultaneously change of both internal and external parts during 
degradation process was observed. In particular the phenomenon is a bulk  erosion and due to the 
particular sample structure, water erosion power consumes faster the internal part than the external 
ones. As consequence of this phenomenon an increasing of surface roughness, and a successive 
pores opening were observed. 
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Fig. 4: SEM images of different gelatin scaffolds surface at different degradation time. 
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Fig. 5: SEM images of different gelatin scaffolds in cross-section at different degradation time. 
 
On the whole, the images show a gradually degradation both the internal and external part of the 
scaffold. The materials preserve the internal structure since 28 days in water solution, to indicate the 
crosslinking effect by EDC. 
 
 Biomimetic treatment  
The first treatment has been investigated is a accelerate Kokubo method, that involves samples 
incubation at 37°C, 4 day in 5xSBF1 and 3 days in 5xSBF2. The EDS (figure 6) analysis of the 
deposited apatite crystals shows the presence of Ca and P peaks typical of hydroxyapatite, 
meanwhile appear others peaks which are characteristic of the presence of impurities such as 
sodium and magnesium, which are common for biomimetic apatite. The Ca/P ratio (1.7), close to 
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the hydroxyapatite one, is the result of a right balance of the Ca/P phases solubility which has been 
assured by the leveling of the pH value down to 6.5 and 6 respectively, during each treatment steps. 
Moreover, it was possible to evaluate a presence of HA deposition on the internal pore walls, 
confirming that the high concentration of SBF solutions induces a fast and uniform deposition of 
hydroxyapatite on the gelatin scaffold.  
 
                              
 
Fig. 6 : SEM/EDS images of gelatin scaffold after accelerate Kokubo treatment. 
 
Furthermore, we performed two different pre-treatments on crosslinked gelatin scaffolds to induce 
higher crystal nucleation of the scaffold surface: 
 CaCl2 solution 0.1M +5xSBF1  + 5xSBF2; 
 Ca(OH)2 solution 0.01M +1.5xSBF1 + SBF. 
 
A preliminary step should catalyzes the apatite nucleation and the homogeneous distribution of 
nuclei on the scaffold surface whereas, a subsequent employment of Mg
2+
 and HCO3
-
 free solution 
(5xSBF2) should promote the growth of apatite crystals (Table 1). In particular, a saline solution 
may promote the Ca
2+
 deposition, in order to accelerate the next step of nucleation.  
As shown in figures 7 and 8, on scaffold surface is evident an encouraging crystal deposition, but 
EDS analysis demonstrated an high presence of impurities, such as different salts common in SBF, 
SBF1 and SBF2 solution used to induce a coating. 
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According to EDS analysis, the accelerated Kokubo treatment shows the best results; infact by this 
method is possible to obtain an hydroxyapatite deposition with a minus amount of impurities. For 
this reason, all the samples were treated by 5xSBF1  for 4 days and 5xSBF2 for 3 days. 
 
 
Fig. 7: SEM and EDS investigations on scaffold after pre-treatment in CaCl2. 
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Fig. 8: SEM and EDS investigations after pre-treatment in Ca(OH)2 solution 0.01M and then soaked in 
1.5xSBF1 and SBF solutions. 
 
 
Fig. 9: Scheme of theoretical behavior (on left) andsperimental behavior (on right) during SBF treatment. 
 
 
 Mechanical test effect 
To evaluate the structural modification of scaffolds after compression test and understood the 
different samples behavior, we propose an image analysis. The SEM images (figure 10) show an 
internal (a) and external (b) surface after mechanical test of B10_6h (a-b left) and                     
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A5_1h (a-b right). It was reported the load direction in order to observe same structural 
modification. In the scaffold realized whit gelatin type A, there is not an internal/external 
orientation after compression; indeed in the other scaffolds, it is possible to observe an orientation 
in load direction. Moreover external surface of B10_6h shows two cricks in perpendicular direction 
to the load one: carry on the test, the external surface. Spite of cricks, the external structure has 
continued to support the applied load avoiding the cricks propagation; the final rupture of the 
sample took place in the direction of loading (figure 10Bleft) 
   
   
   (A)       (B) 
 
Fig.10: SEM images of B10_3h and A5_1h scaffolds after compression test of internal section (A); external 
section (B). 
 
 
 3.1.3.2 Swelling test 
The swelling process could be divided into two stages: first one is represented by the fast swelling 
step occurring before teq, followed by an equilibrium swelling as second step. teq is a time at which  
the swelling became equilibrated and it is important to evaluate the swelling equilibrium.              
To evaluate the gelatin behavior before teq, it was considered a short range time between 1-24 hrs 
and the analysis were done at defined time.  
The swelling equilibrium time for all samples were reported in the table below.  
To study of the gelatin’s swelling behavior for long time (after teq) and to obtain its complete 
screening, it was considered a large time range between 1- 28 days. Independently to crosslinking 
time, A5 and B5 scaffolds show (figure12) a higher water absorption than A10 and B10; this effect 
is correlated to the number of physical and chemical bonds in the structures. 
Comparing the results of both type gelatin scaffolds, crosslinked  and not, is evident their different 
behavior in aqueous environment. Following, it is shown non-crosslinked gelatin diagram. It was 
considerate a testing set, formed by porcine and bovine gelatin at two concentration, 5-10% w/v 
(A5, A10, B5, B10). 
B10_3h A5_3h B10_3h A5_3h 
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Fig. 11: Diagrams concerning the evaluation of swelling equilibrium value for different gelatin crosslinked 
samples at different times. 
  
 
                                               
                                                 
 
Fig. 12: Diagrams concerning the swelling values evaluation of gelatin scaffolds crosslinked by EDC 
(0.7w/w) in the range of 0-28 days. 
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As showed in the diagram 13, it is very difficult separated the two traditional part related to the 
hydrogel swelling behavior: infact, there is not an initial plateau that is an indicator of swelling 
equilibrium value. The curves slope increases up to reach a maximum (higher swelling value), then 
suddenly decrease. 
Moreover non-crosslinked scaffolds show a higher swelling value than crosslinked one, and the 
maximum swelling value was reached faster. 
 
 
 
Fig. 13: Swelling test up to one week on non-crosslinked gelatin A and B (5 and 10wt%). 
 
 
 3.1.3.3   Degradation test 
The lost weight(%) vs time, related to the four different crosslinked gelatin scaffolds is reported 
below.  
The degradation diagram shows that the scaffolds with the lowest gelatin amount (A5 and B5) have 
a slower degradation than the other one (figure 14), probably because their internal structure helped 
the EDC penetration due to minus physical bands; as a consequence there is a magnitude EDC 
effect. Moreover the major degradation rate is registered in the first two weeks, then the degradation 
values reach a plateau zone.  
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Fig. 14: Diagrams of  degradation test and table with %mass loss after 28 days in aqueous environment. 
 
As underline for the swelling behavior, also in this case the result is completely different respect 
non-crosslinked ones.  
Following, it is shown the diagram related to the non-crosslinked gelatin. In this case it was 
considerate a testing set, formed by porcine and bovine gelatin at two concentration, 5-10% w/v.  
As reported in the diagram 15, the gelatin dissolves completely in the first week; even after few 
days the samples show a higher degradation value.  
  
 
Fig. 15: Diagram of non-crosslinked scaffolds degradation behavior. 
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 158 
 
 3.1.3.4  Thermal analysis: DSC and TGA 
To evaluate the crosslinking time effect on gelatin structure is possible to analyze DSC and TGA 
curves. Following are reported thermal analyses on gelatin powder, and one type of gelatin scaffold 
crosslinked at different times (B5_1h, B5_3h, B5_6h).    
        
 
     (A)       (B) 
Fig. 16: DSC analysis: A) gelatin type B scaffold 5%w/v after crosslinked treatment at 1, 3, 6 hrs; B) gelatin 
powder type B. 
 
 
 
 
 
 
 
 
 
Table 2: Initial temperature (Ti), enthalpy (ΔH and ΔHD) and maximum temperature (T and TD) associated to 
gelatin structure degradation (on left), gelatin structure decomposition (on right). 
 
The images (figure 16) show the presence of two important peaks: the first associated to trapped 
water in the structure and gelatin degradation phenomena, and the second to structural 
decomposition. The values of decomposition temperature, T, and decomposition enthalpy, ΔH, 
obtained for gelatin scaffold crosslinked with EDC solutions at different time are reported in Table 
2 (on left). The values of degradation temperature, TD, and degradation enthalpy, ΔHD, obtained for 
gelatin scaffold crosslinked with EDC solutions at different time are reported in Table 2 (on right). 
Ti is the temperature at which start the phenomena. 
 
Ti ΔH T 
Gel 
powder 223,52°C 13     J/g 225,58°C 
 
B5_1h 216,17°C 8,095J/g 222,68°C 
B5_3h 211,07°C 10,23J/g 223,99°C 
B5_6h 211,04°C 9,253J/g 222,81°C 
 Ti ΔHD TD 
Gel 
powder 
 
 
60,32°C 
 
352,6 J/g 
 
112,32°C 
 
B5_1h 42,08°C 539,7J/g 96,52°C 
B5_3h 38,82°C 522,2J/g 91,84°C 
B5_6h 41,01°C 469,9J/g 94,68°C 
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The TGA analysis confirms the presence of two phenomena (figure 17). In particular, the first step 
is related to water evaporation and second to chemical bond C=C breaking. The table 3 shows the 
temperature range and the weight loss associated at themselves, and the residua at 800°C. 
         
             
   (A)       (B)   
            
   (C)       (D) 
Fig. 17: TGA analysis: A) gelatin powder; gelatin B (5% w/v) crosslinked at 1h (B) 3h (C)  and at 6h (D) in 
EDC solution.  
 
 
MATERIAL T range [°C] Weight loss (%) Residual (%) 
Gelatin B 0-200 
200-800 
10,31 
71 
18,69 
B5_1h 0-142 
142-800 
12,25 
70,9 
16,85 
B5_3h 0-137 
137-800 
11,54 
71,21 
17,25 
B5_6h 0-146 
146-800 
11,46 
69,99 
18,55 
 
Table 3: Values related to TGA analysis. 
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 3.1.3.5  XRD analysis 
XRD reflection peaks can be used to monitored gelatin crystallinity before and after crosslinking 
treatment. 
 
 
Fig. 18: XRD pattern of gelatin B powder, gelatin scaffold (B5%) crosslinked by EDC at 1, 3, 6 hrs. 
  
As reported in the diagram, the pure gelatin showed a broad peak at 2θ ≈ 20° that is the 
characteristic peak of gelatin phase. The sharp peak reduction may be related to realization 
processes of gelatin crosslinked scaffold (gelatin dissolved in aqueous environment at 40°C, cooling 
at -80°C, lyophilized and then crosslinked). However, XRD results show a change of crystallinity 
phase of gelatin confirming TGA and DSC analyses. 
 
 
 3.1.3.6  Mechanical test 
Young’s modulus (E) was determined from static, unconfined compression tests carried out at 25°C 
in aqueous media. Higher temperatures were not used because the majority of the gels were not 
adequately stable above 25°C for such test methods. In controlled-deformation mode, samples were 
continuously compressed at a rate of 10% of swelled sample height (mm/min) from an initial pre-
load force (0.01 N), up to 75% of swelled sample height.   
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Preventive mechanical properties were performed in a two different samples sets, in which the last 
part of production protocol is changed. After the crosslinking treatment in EDC solution the 
samples were: 
1)  submitted to second step of freeze-drying; 
2)  dehydrated in ethanol, to induce a de-swelling phenomena. 
 
The results were shown in the following diagrams: 
 
 
Fig. 19: Mechanical test results for samples with a double freeze-drying steps. For all the samples tested it 
was made a crosslinking treatment for 3 h. 
 
 
Fig. 20: Mechanical test results for samples with a one freeze-drying  step. For all the samples tested it was 
made a crosslinking treatment for 3 h. 
 
By this preliminary tests (figures 19 and 20), is evident that double liophylization has a negative 
effect on the gelatin scaffold structure. The table 4 shows an increase of the compression modulus: 
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last column in the table reports this percentage variation. According this results, the mechanical 
characterization is performed on scaffolds with one liophylization treatment. 
 
Material 
Double freeze-drying steps 
E (KPa) ± Std.Dev. 
Single freeze-drying step 
E (KPa) ± Std.Dev.  
E  variation 
(%)  
A5_3h nc  59,6 ± 13,4 77,98 ± 9,6 30,9 % 
B5_3h nc  116,2 ± 25,6 124,7 ± 26,7 7,3 % 
A10_3h nc  123,4 ± 56,1 171,8 ± 21,6 39,1 % 
B10_3h nc  154,7 ± 58,4 512,8 ± 40,9 231,5 % 
 
Table 4:  Evaluation of compression modulus (E) after double and single freeze-drying steps. 
 
We reported a typical curve stress-strain: 
 
 
Fig. 21: Mechanical test performed on gelatin scaffold B5 crosslinked at 1h non biomineralized (B5_1h_NB) 
 
It is possible to separate three different contributes:  
 elastic part (important to determinate the modulus E), it depends on coating-like stiffness; 
 viscous region, associated to internal chains reorganization during compression; 
 last region associated to compact structure, when the porous structure is completely close.   
 
Mechanical properties are important not only to understand the scaffold behavior, but also to obtain 
information on the crosslinking reaction. This information is derived by Young’s modulus values. 
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The data reported in the table 6, represent the mean values (standard error of the mean) of E, 
obtained for gelatin A and B (10% w/v and 5% w/v) crosslinked with EDC at different times (1, 3, 
6 hrs) and the same samples after biomimetic treatment; last column in the table reports the 
percentage variation of compression modulus. 
As confirmed also by Pandit et al.[28] studies (table 5), the modulus E for non crosslinked gelatin is 
same magnitude order lower than crosslinked ones (biomimetic and not). Moreover the tables 6 
show same differences between the samples with and w/o biomimetic treatment. 
  
non crosslinked gelatin  
Sample Modulus (KPa) 
  A_10  0,179 (0,025) 
 
Table 5: Modulus E value obtained in a compression test for gelatin scaffold non crosslinked (type A, 10% 
w/v) [28] 
 
 
Table 6 : Modulus and std. dev. of gelatin A and B (10 and 5 % w/v) crosslinked at 1, 3, 6, hrs (on left), after 
biomimetic treatment (in the middle), and E variation (%). 
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In all tests the samples were equilibrated in deionized water up to equilibrium swelling. Obviously 
teq is different for the gelatin typologies as reported in the swelling tests results (fig. 11). 
 
 
Fig. 22: Histogram of modulus related to all samples, before and after biomimetic treatment. 
 
 
 
Fig.23: Photographs of mechanical test sequence for A5_1h (on left).  Image of broken scaffold B10_6h after 
compression load (on right). 
 
 
 3.1.3.7   Biological test 
To evaluate the influence of material surface on the cellular behavior, it is compared biological 
study on crosslinked gelatin, before and after biomimetic treatment. For this purpose the adhesion, 
proliferation and differentiation studies using pre-osteoblast (MG-63 cell line) were done. A 
biological analysis on crosslinked gelatin scaffolds, before and after SBF incubation, were reported 
in the diagram 24. 
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 (A)                                                                 (B) 
Fig. 24: MG63 cell-line adhesion, proliferation and differentiation of:  (A) gelatin scaffold, ( B) gelatin 
scaffold after biomimetic treatment. 
 
MG-63 cells adhesion results in all samples free treatment were better than the other one. This 
because cells adhesion, after 1 day, strictly depend on the superface material morphology. The 
biomineralized gelatin scaffolds, as reported previously, have undergone a surface modification due 
to incubation for several time in different supersaturated SBF solutions, necessary to obtain 
hydroxyapatite coating. The proliferation and osteogenic differentiation, instead, depend on the 
combination of internal/external scaffold morphology and the presence of active biology signals 
(hydroxyapatite) on the pores surface.  
The proliferation test performed on the both type of scaffolds, at long time 7, 14 and 21 days, shows 
higher values at 7 and 14 days reaching a plateau between 14 and 21 days for scaffold materials 
crosslinked for 3 and 6hrs. Moreover, better  ALP activity results were observed for biomineralized 
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scaffolds confirming that the presence of  solid bioactive signals on surface are important for the 
expression of early marker of osteogenic differentiation as ALP. 
 
 
3.1.4 Discussion 
Tissue engineering has emerged as a promising strategy to repair bone and cartilage defects. Many 
ways for guiding tissue regeneration involve the incorporation of varying degrees of biological 
context into implantable scaffolds to create biomimetic environments. One way to mimic this 
context is to create scaffolds from natural biopolymers such as gelatin, which incorporate many of 
the cues needed by cells (i.e. hydroxyapatite). The understanding of the interaction between bone 
cells and polymer surfaces is of paramount importance in the development of bone/cartilage filler 
biomaterials. 
In this study we evaluated the chemo-physical, mechanical  and biological difference between 
biomimetic and not gelatin-based scaffold.  
Scaffolds were prepared starting to a gelatin solution, realized at Ta and then freezed at -80°C for 
several hours. The water, uniformly distributed into the gel, was sublimated by freeze-drying, to 
produce a three-dimensional structure with interconnected pores, as shown in the SEM image     
(figure  2). The temperature to freeze the samples, was chosen to guarantee porous dimension of      
200 μm (fig. 1). Indeed, freeze-drying technique allows the formation of external coating-like 
compact structure (figure  2) probably derived to contact between mold walls and gelatin solution, 
during freezing; this effect is independent on mold typology (Teflon or polystyrene) (figure 3).  
Gelatin is a natural polymer obtained by collagen denatured; to overcame its fast degradation in 
water environment, it proposes a crosslinking treatments that have the power to stabilized the 
gelatin chain limiting the number of free functional group and consequently the water effects.        
In particular,  EDC solution is used to bond functional groups of amino acids in order to have an 
intramolecular and short-range intermolecular bond (amine bond), with some pendant side branches 
(N-acylurea groups). So crosslinked treatment creates a new stable chemical bonds in the hydrogel 
structure that limiting the internal chains mobility. The concept of chains mobility, for a crosslinked 
and not crosslinked hydrogel, is related to its capability of absorb and hold off water molecules, and 
swollen; it is depend on physical (entanglements) and chemical (hydrogen and/or amine) bonds. 
Obviously, the bonds number strongly depend on gelatin amount: for this reason, in non-crosslinked 
gelatin A and B scaffold realized whit 10%w/v of polymer, the chains have a lower mobility than 
5%w/v ones. In spite of crosslinking treatment takes account of this difference, the samples realized 
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with less gelatin amount have slower degradation and higher swelling values than the other ones.   
In general, the gelatin's hydration mechanism is a capillary phenomenon consisting of water 
molecules penetrating the tiny interstices of triple-helical fibrils in the gelatin matrix, and is one of 
the most important parameter to evaluate hydrogels. In crosslinked structure, this phenomena is 
related also to crosslinking extension. Comparing figures 12 and 13 is evident the crosslinking 
success, and in particular the lower swelling values for B10 and A10, independently to crosslinking 
time.    
The degradation phenomena (hydrolysis) is a bimolecular reaction in which water and the 
functional group possessing the labile bond, are involved [27]. The most important parameter for 
monitoring degradation is molecular weight of both gelatin type. As shown in the diagram 14, 
samples with the lowest gelatin amount (A5 and B5) have a slower degradation than the other ones, 
probably because their internal structure helped the EDC penetration due to minus physical bonds; 
as a consequence there is a magnitude EDC effect. Moreover the major degradation rate is 
registered in the first two weeks, then the degradation values reach a plateau zone. This effect 
should depend on degradation of uncrosslinked gelatin into the scaffold: infact it has been reported 
that after one week in aqueous environment the non-crosslinked gelatin undergoes a completely 
dissolution (fig. 15).   
Besides loss of molecular weight and swelling values, other parameters have been proposed as a 
measure for crosslinking success, like mechanical strength and thermal analyses. In fact, by thermal 
analysis like DSC/TGA is possible to evaluate the thermal stability of gelatin before and after 
crosslinked treatment. For these analyses, raw gelatin powders (as a non-crosslinked sample) and 
gelatin B 5%w/v crosslinked at 1, 3, 6 hrs were considered. 
As confirmed  in literature, the endothermic peak of raw gelatin powder, appeared at 223°C in the 
figure 16, is a chemical decomposition temperature of gelatin [29,30]. This endothermic peak is 
evident also in the gelatin porous scaffold obtained from gel-solution.  
Compared the temperatures related to this phenomena (table 2-left), we observed that gelatin 
powder shows higher T and ΔH respect all crosslinked gelatin scaffolds tested. It may depend on 
the amorphous structure of random coil conformations and lower contents of helical conformations 
in the gelatin crosslinked, meanwhile gelatin powder have a crystallinity structures [30] as 
demonstrated by XRD analysis. Indeed, there is not difference between gelatin scaffolds crosslinked 
at different times because this enthalpy and temperature are associated at phenomena depending to 
the C=C bond on the polymeric chain. B5_1h, B5_3h, B5_6h scaffolds and gelatin powder show 
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also a first large peak (figure 16)  that depends on two different contributes: trapped water in the 
structure, and helix-coil transition of gelatin. 
In general, there are three main types of waters in this structures typology: non-freezable bound 
water, freezable bound water, and free water [31]. A study from Lai et al. [41] demonstrated that 
freezable bound water did not exist in porous gelatin scaffolds, or the amount of this type of water 
was very small. One possible explanation for the water presence, is that the water molecules may be 
interacted with free carboxylic acid and amino groups of gelatin by hydrogen bonding [41]. 
 
 
Fig. 25: Schematic interaction between gelatin structure and non-freezable water molecules by hydrogen 
bonding. 
 
When the two hydrogen atoms of water molecules are firmly fixed to the amino acid residues of 
gelatin, such water is referred to as non-freezable bound water (figure 25); so we could have 
residual water in the structure. Moreover also the humidity could contribute to this phenomena.  
The large peak, indeed, is associated to the helix-coil transition of gelatin. Crosslinking increases 
the thermal stability of gelatin, as shown by the shift of the denaturation temperature to higher 
values. The values of denaturation temperature, TD, and denaturation enthalpy, ΔHD, obtained for 
gelatin scaffold crosslinked with EDC solutions at different time are reported in Table 2 (on right). 
Ti is the temperature at which start the phenomena.   
The TD increasing is in agreement with the simultaneous increase of crosslinking extent. It is 
generally accepted that the endothermic process present in the DSC thermogram of collagenous 
material involves rupture of hydrogen bonds and a rearrangement of the triple helix into a random 
configuration [32-34]. As reported (figure 16), the more stable is B5_1h scaffold, because shows 
the higher denaturation temperature (96.52°C) and enthalpy (539,7J/g); moreover this phenomena 
starts at 42.08°C. For this analysis the influence of external condition, like temperature and 
humidity (e.i. non-freezable bone water derivate by external environment), is equal for all the 
samples. So the contributes that emerge, is only the effect of crosslinking time. 
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To confirm these theories, in the figure 17 it is reported the TGA analysis realized for all samples 
(B5_1h, B5_3h, B5_6h and gelatin powder). The images show the presence of two distinct 
phenomena. The first step has a typical behavior of water loss that confirms the water presence in 
the samples. The second relevant step is associated at thermal degradation of the polymeric chain; 
the heat supplied breaks the carbon-carbon bonds present in the gelatin chain. The relevant   
residual % value, present in all TGA diagrams, is correlated to the carbon residual after pyrolysis. 
In this case the carbon residual remains as ashes because test were made in nitrogen and this 
prevents the formation of CO2 gaseous. 
In order to examine the effect of EDC and of crosslinking time, on crystal structure and crystallinity 
of gelatin scaffolds, XRD pattern are investigated. As show in figure 18, gelatin powder gives a 
typical XRD pattern of gelatin crystalline structure originated from α-helix and triple-helical 
structure. However, the scaffolds prepared from gelatin solution (B 5%w/v) and crosslinked by 
EDC (at 1, 3, 6 hrs) show less developed crystal structure and lower crystallinity. Moreover, 
amorphous structure were observed decreasing crosslinking time and recrystallization of gelatin 
does not occur. 
As said before, also mechanical properties can be used to express the crosslinking effect on the 
structure. The tests were performed in aqueous environment and after swelling equilibration: the teq 
were reported in the figure 13. Our gelatin scaffolds have a particular external surface, that confers 
very relevant mechanical properties at the samples, as suggest comparing with literature results 
[28,43,44]. During the first times of compression test, the load is supported by the external structure 
until its collapse. Then the internal part provides to rearrangement chains and progressively were 
pressed up to fully collapse the structure. The critical point during the test is the external collapse: 
A5 and B5 scaffolds, that present a more soft and swelled structure were intact after the test; usually 
A10 and B10 scaffolds cricked on surface or even broken (figures 10 a-b left, and figures 23-on 
right). Seeing tables 5 and 6, is evident the enormous EDC contribute to improve the gelatin 
mechanical properties. Date in table 6 report Young’s modulus value expressed in KPa; all B10 non 
biomineralized scaffolds have the major E values (581,1 ± 148,0 (KPa), 512,8  ± 41,0 (KPa) and 
539,8  ± 94,4 (KPa) for 1, 3 and 6 hrs of crosslinked, respectively), but the higher E variation (%) 
after biomimetic treatment (224,7 %, 79,5% and 121,6% respectively). The samples that undergo a 
minor variation (%) of  E values are A10_1h, A10_3h and A5_3h (E reduction about 26%, 20% and 
25%) and B5_6h  (E reduction about 12%).  
After compression test, the scaffolds recovery initial shape as presented in the image 23; in the case 
of same B10 and A10 scaffolds, were recorded several broken. 
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Moreover, by mechanical test was demonstrated that double lyophilization weakens the structure 
(figures 19 and 20) and in particular scaffolds realize by single treatment show a modulus’s 
increases of 30,9%, 7,2%, 39,1% and 231,5% (A5_3h, B5_3h, A10_3h and B10_3h) (table 4).  
SEM and EDS analyses were used to evaluate the biomimetic treatment. As illustrated, three 
different approaches were made to obtain hydroxyapatite coating. The accelerated biomimetic 
approach consists of soaking the substrates in simulated body fluids at controlled temperature and 
pH to improve their bioactivity [35,36]. Generally, a thin layer of apatite may be obtained by using 
long immersion times (i.e, 7–14 days) with several refreshment of solution [36,37]. In our case the 
incubation time is 7 days, and EDS (figure 6) confirmed the CaP deposition. 
In this system, the charged density is fixed, that is to say the number of nucleation sites is 
invariable, therefore the size of HA crystalline depended on the rate of crystalline growth: higher 
[Ca
2+
], [PO4
3-
] made them more easy to access the surface of gelatin scaffolds and interactions 
among corresponding groups enhance, which lead to the rate of crystalline growth accelerated [43]. 
Then, we have tried to improve the calcium deposition adding a pre-treatment in CaCl2 0.1M for 2 
days. However, the EDS results show (figure 7) the presence of numerous negative ions (presents in 
supersaturate SBF solution). Explanation should be the acid pH of 5xSBF1 (pH=6.5) and 5xSBF2 
(pH=6). In acid environment (figure 9), infact, gelatin acts as base and takes up H
+
 ions from the 
medium forming -NH3
+
 and  -COOH and proteins become positively charged [38]. So, in this 
condition, all negative charge bond with gelatin, and the CaP deposition became very difficult. 
Indeed, in alkaline medium (figure  9), protein acts as an acid gives H+, forming -COO
-
 and –NH2 
groups and proteins become negatively charged [38]. For this reason we have tried a pre-treatment 
in Ca(OH)2 solution 0.01M (pH = 8-8.5) for several minutes. The reaction to produce Ca(OH)2 is:  
CaCl2 + 2NaOH -> Ca(OH)2 + 2NaCl 
The treatment time was reduced at 30 min because, as demonstrated by Haixia et al. [38], hydrogel 
exhibits extensive swelling in environment with pH>8. Therefore, the osmotic pressure resulting 
from the mobile ion concentration difference between the gel and aqueous phase increased in a salt 
presence and consequently, the swelling ratio increased [39,40]. EDS (figure 8) shows impurities 
presence, and in particular the amount of sodium chloride is very significant.  
In conclusion we are used the accelerated Kokubo method to obtain hydroxyapatite coating. 
However, during this treatment, crosslinked gelatin undergoes a morphological change due to the 
effect of water, temperature, pH and salts presence. The degradation of biomineralized gelatin 
scaffolds justifies lower E compression modulus (table 6) then non biomineralized ones, and also 
the worse MG-63 adhesion response after 1 day (figure  24). Known as, biological response in a 
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short time, strictly depend on the specific material topography, so also the presence of more free 
functional group, such as -COOH,  may contribute to have a better adhesion. In a biomineralized 
scaffold, carboxyl groups are involved in a bond with CaP. 
Proliferation and osteogenic differentiation, instead, depend on the combination of internal/external 
scaffold morphology and the presence of active biology signals (hydroxyapatite) on the pores 
surface. Indeed, biomineralized scaffold shows a better results, in particular in a short times  (7-14 
days). Moreover proliferation and differentiation tests show better results for materials at 5wt% of 
gelatin A; it may depend on the less compact structure. 
  
 
3.1.5 Conclusions 
Biomineralized gelatin scaffold was obtained by a combination of two simple methods as freeze-
drying and biomimetic approach. The contributes of gelatin type/amount (Type A and B at 5 and 10 
% w/v) and crosslinking time (1, 3, and 6 hrs) were evaluated, in order to study crosslinking 
treatment, biomimetic approach and MG-63 cells response.  
This work shows that accelerated Kokubo treatment is able to create an hydroxyapatite coating on 
the surface and into the porous wall; but during this treatment, crosslinked scaffolds undergo a 
morphological change due to the effect of water, temperature, pH and salts presence. For this 
reason, mechanical properties and MG-63 adhesion response, after 1 day, decrease. Indeed, 
proliferation and osteogenic differentiation increase by the presence of active biology signals 
(hydroxyapatite).  
 
Another important result is related to the crosslinking treatment by EDC. We propose three 
different time and analyze the treatment efficiency by physical (swelling and degradation behavior), 
thermal (DSC/TGA) an mechanical tests. Comparing non crosslinked samples and crosslinked one, 
is clear the efficiency of protocol proposed. The analyses confirm that crosslinked treatment by 
EDC at 1h is the best; instead there aren’t relevant difference between 3 and 6 hrs. Its confirm that 
EDC reaction  takes place in a short time.  
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3.2 GELATIN/HYDROXYAPATITE 3D MULTICOMPONENT SYSTEMS 
 
Introduction 
Tissue engineering offers a new promising approach to the creation of biological alternatives for 
bone and cartilage filler implants. Bone tissue is considered as minerals and proteins. The minerals 
are mostly apatites such as hydroxyapatite (HA, Ca10(PO4)6(OH)2), fluorapatite and            
carbonate-apatite [1]. In general, HA is a main component of bone mineral and in some cases 
carbonate-apatite is a main hard tissue component, as in dental enamel [2]. HA is widely accepted 
as a bioactive material for guided regeneration [3]. HA has excellent biocompatibility with hard 
tissues [4,5], and high osteoconductivity and bioactivity despite its low degradation rate, 
mechanical strength and osteoinductive potential [6,7]. Calcified tissue such as long bone and jaw 
bone is considered a biologically and chemically bonded composite between HA and type-I 
collagen [8]. Collagen is biocompatible, biodegradable and osteoinductive, acting as an excellent 
delivery system for bone morphogenetic proteins [9,10]. Gelatins (GEL) are compositionally 
virtually identical to the collagen from which they are derived. They have been shown to be 
biocompatible and resorbable. GEL is readily assimilated by the body [11]. A composite scaffold of 
HA and GEL is therefore expected to show increased osteoconductivity and biodegradation.       
The low mechanical properties exhibited by wet samples, suggesting their use as fillers and not 
replacers defect.  One of the major problems in practice with type-I collagen is its cost and the poor 
definition of commercial sources of this material. Therefore in the present study, collagen type-I 
was replaced by GEL. Traditionally, the HA–polymer composites have been produced by 
dispersing HA powders in the polymer solution. However, the HA powders in this case were not 
dispersed well or were easily agglomerated, and  even settled, which made it difficult to form a 
controlled structure [12,13].  Non-homogeneous distribution of ceramic particles within the 
polymeric matrix induces a dramatically reduction of the bioactive potential of the composite [18]. 
In this context, chemically inspired approaches based on the sol–gel transition and colloidal 
precipitation of calcium phosphates may efficiently improve the particles dispersion by a direct 
control of precipitated grain sizes though the interaction between calcium and phosphate precursors 
under controlled temperature and pH conditions [18,19]. Using this method, the gelatin–HA 
composites have been synthesized to maintain the nanoscale HA precipitates along the gelatin 
structure [14-17]. The major goal in fabricating scaffolds for tissue regeneration is to accurately 
control pore size and porosity. By using Freeze-Drying method, the liquid state structure of 
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composite is locked and the solvent is removed by rapidly cooling under vacuum [20-22].              
1-ethyl-(3-3-dimethylaminopropyl carbodiimide hydrochloride) (EDC) can be used as cross-linking 
agent in the making of GEL-hydroxyapatite composites.  
In this chapter, we propose a gelatin–HA nanocomposites realized by in situ sol–gel transition.      
In this study we want show and compare biological responses and chemo-physical interaction 
between gelatin and hydroxyapatite components.     
 
 
3.2.1 Materials and methods 
 3.2.1.1  Materials  
Gelatin type B (bovine skin, 225 Bloom), and type A (porcine skin, 90-110 Bloom),                       
1-ethyl-(3-3-dimethylaminopropyl carbodiimide hydrochloride) (EDC), calcium nitrate, phosphate 
pentoxide, and all reagents used to prepare SBF solution were purchased from Sigma-Aldrich 
(Milano, Italy). 
 
 
 3.2.1.2  Gelatin-hydroxyapatite: Sol-gel synthesis 
The gelatin–HA nanocomposite scaffolds were fabricated by sol-gel synthesis of HA within a 
gelatin sol and further freeze-drying, as reported in the flow chart (figure 1). Briefly, two types of 
viscous sols, gelatin, type B (pH= 5) and gelatin type A (pH=4.5) solutions were prepared in 
distilled water at 40°C with constant adjustments of the pH (10–10.5). Simultaneously calcium 
nitrate Ca(NO3)2x4H2O  and ammonium hydrogen phosphate (NH2)4H2PO4 solutions were 
dissolved in distilled water and stirred for 2 hrs. The gelatin solutions were mixed progressively 
with calcium and phosphate solution, at constant stirring and at 40°C. Then a pH at alkaline values 
was adjusted to allow the  sol-gel transition, and a stirring for 24hrs was performed to obtain the 
hydroxyapatite aging phenomena. The Ca/P ratio was fixed at 1.67 and the HA contents with 
respect to gelatin-HA were considered at 20 and 30 wt%. The gelatin amount respect the total water 
content is fixed at 10% w/v. After sonication  (3 hrs), the gelatin-HA gel was poured into the Teflon 
moulds (5x10 mm) quenched to -80 °C and freeze-dried for 48 h.     
The dried scaffolds were cross-linked within an acetone–water based solvent (4:1) containing a 
water-soluble 1-ethyl-(3-3-dimethylaminopropyl carbodiimide hydrochloride) (EDC), firstly at 
room temperature for 3h and then  at 4°C for 24 h. The ratio of gelatin scaffold to solvent was fixed 
at 1% (w/v) from preliminary tests to maintain pore structures. The amount of crosslinking agent 
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was 0.7% (w/v) respect volume solution of acetone-water [23]. The samples were fully rinsed with 
distilled water, dehydrated with ethanol (10 minutes at 60:40 and 80:20 ethanol/water, 30 minutes 
100% ethanol) to preserve the internal structure and then left under the hood overnight to allow the 
total solvent evaporation.  
 
 
    (A)      (B) 
Fig. 1: Flow chart of preparation process. (A) preparation of gelatin solution. (B) preparation of GEL/HA 
hybrid material at different concentration. 
 
 
3.2.2 Characterization 
 3.2.2.1  Morphological analysis 
The morphology of composites was characterized by using a scanning electron microscope (SEM) 
and Transmission Electron Microscope (TEM). SEM images were taken by a Quanta FEG200 (FEI, 
the Netherland) Scanning electron microscope. The materials for SEM analysis were prepared by 
deposition of composite scaffold on one side of a double adhesive tape, and then stuck to an 
aluminium stub. The stub was then gold coated in an automatic sputter coater (EMSCOPE SC500, 
20KV) to a thickness of around 30 nm. X-ray energy dispersive spectroscopy (EDAX, Genesis 
2000i) was used for a qualitative estimation of Ca/P ratio on the material. All the samples were, 
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firstly dehydrated using a freeze-dryer, and then broken in section by using a liquid nitrogen in 
order to investigate the cross-section surface. 
The transmission electron microscopy (TEM) images were taken by a Hitachi H-9000NAR model 
instrument operated at an accelerating voltage of 100 kV. Samples for TEM imaging were prepared 
by placing a drop of the aged GELATIN-HA composite suspensions (the suspensions were diluted 
in deionized water and dispersed by ultrasonic waves before use) onto carbon coated copper grids, 
dried in air and loaded into the electron microscope chamber. 
 
 
 3.2.2.2 Thermal gravimetric analyses  
Thermal gravimetric analyses (TGA) were performed by TA Instrument Q 5000 under nitrogen 
atmosphere and room temperature up to 800 °C, with a heating rate of 5 °C/ min. 
 
 
 3.2.2.3 Infrared Spectroscopy FTIR analyses  
Phase analysis was conducted using FTIR spectroscopy was performed on Nicolet Nexus 
spectrophotometer with KBr discs in the 500-4000 cm
-1
 region (4 cm
-1
 resolution, average 64 
scans).  
 
 
 3.2.2.4  Mechanical test 
The mechanical properties of the scaffolds were evaluated by compression tests. The tests were 
performed using a standard testing machine (Lloyd LR5K instrument, Fareham Hants, U.K.) 
equipped with a 10 N load cell. The gelatin, biomineralized and not, cylinders were soaked in water 
until equilibrium swelling, and then tested in an aqueous environment. The deformation range and 
the speed (mm/min) were calculated respectively as 75% and 10% of sample height. 
 
 
 3.2.2.5 Biological test 
 Viability test 
As preliminary biological studies, cell biocompatibility was evaluated by using  MG63 that were 
plated at concentration of 1x10
4
 in triplicate, into a basal medium. All the scaffolds were tested 
(A10_HA20 – A10_HA30 – B10_HA20 – B10_HA30). The medium in cell-load gel materials 
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culture plates were removed after cultured for 1, 3 and 7 and the in vitro cell viability was checked 
by the Alamar blue assay (AbD Serotec, Milano, Italy). This assay quantified the redox indicator 
which changed to a fluorescent product in response to the chemical reduction by mitochondrial 
enzymes such as flavin mononucleotide dehydrogenase, flavin adenine dinucleotide dehydrogenase, 
and nicotinamide adenine dinucleotide dehydrogenase. In addition, a redox phenomenon gave a 
quantitative indication of metabolic activity of live cells. An aliquot of 1mL of Alamar Blue™ 
diluted 1:10 in phenol red-free medium was added to each well and incubated for a further 4 h at 
37°C, 5% CO2. Later, 200µL of this solution was transferred into a 96 well plate for colorimetric 
analysis. Wells without any cells were used to correct any background interference from the redox 
indicator. The optical density was immediately measured with a spectrophotometer (Sunrise, 
TECAN, Männedorf, Zurich, Switzerland) at wavelengths of 540 and 600 nm. The cell viability 
percentage was evaluated in according to the manufacturer’s protocol. The culture medium during 
experimental time was changed every two days.   
 
 
3.2.3 Results 
 3.2.3.1  Morphological analysis 
SEM analysis was used to observe the nanocomposite samples morphology, and the hydroxyapatite 
distribution into the scaffold.  
 
 
Fig. 2: SEM image: longitudinal-section of B10_HA20 scaffold. 
 
As reported in the figure 2,  B10_HA20 longitudinal section have an homogeneous hydroxyapatite 
distribution. Different result was observed for B10_HA30. In fact, figure 3 shows the internal 
longitudinal section of scaffold. It is possible to evaluate a change of morphology due to 
inhomogeneous HA distribution in the polymeric matrix. In particular on a section (shown in 
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figures 3B and D) there is a uniform CaP coating, while on the other one (figures 3C and E) is 
present plate-like crystals, typical HA crystalline morphology. It is possible to explain this 
difference by the presence, into the scaffolds, of HA gradient.   
 
 
Fig. 3 : SEM/EDS analyses of B10_HA30 scaffold. A) morphology change in the scaffold section and HA 
gradient; B) and C) internal section of two scaffold extremities, top and bottom respectively;                       
D) and E) external surface of two scaffold extremities, top and bottom respectively; F) porous magnification. 
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The gradient and the homogeneous distribution of the inorganic component inside the scaffold were 
shown in the figures 3(a) and (b) respectively.  
To evaluate the correlation between nHA crystal shape and HA/GEL ratio, were reported TEM 
images (figure 4): the presence of gelatin in the scaffold reduces the crystallinity on HA 
nanoparticles. 
 
  
Fig . 4: TEM images of HA crystals obtained by sol-gel technique with different gelatin/hydroxyapatite ratio: 
(A) only HA and 70/30 - Gel/HA (B). 
 
 
 3.2.3.2   Thermal gravimetric analyses 
The thermogravimetric plots of the composite scaffolds were used to determine the inorganic phase 
content, which was evaluated from the residual weight of the samples. To perform the analysis, the 
samples were cut in a three part (superior, inferior, central part), that were tested separately, in order 
to evaluate a different hydroxyapatite distribution into the vertical section. The experimental data, 
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reported in tables 1 and 2, were obtained comparing gelatin/hydroxyapatite residual% with gelatin 
scaffolds one. 
In order to evaluate the thermal stability and the phase transformation, TGA of inferior section of 
B10_HA30 scaffold was reported in the figure 6. It was performed a study on different contributes 
to weight loss during analysis.  
 
 
 
Fig. 5: TGA analyses of B10_HA30 up, middle and down part and table with residual value(%). 
 
 
HA gradient 
Sample residual (%) HA residual (%) 
B10_HA30 (up) 39,9 27,9 
B10_HA30 (middle) 29,1 17,2 
B10_HA30 (down) 17,4 5,5 
 
  
B10_3h 14,9  
 
Table 1: residual value (%) of B10_HA30 up, middle and down part, and of gelatin scaffold. 
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Fig. 6: TGA analyses of B10_HA20 up and down part and table with residual value(%). 
 
 
 
 
 
 
 
 
Table 2: Residual value (%) of B10_HA20 up, middle and down part, and of gelatin scaffold. 
 
 
 
 
Fig. 7: B10_HA30 (down) thermogram image and the study of different contributes on the weight loss.  
 
      Uniform HA distribution 
Sample residual (%) HA residual (%) 
B10_HA20 (up) 28,3 16,3 
B10_HA20 (down) 29,2 17,3 
B10_3h 14.9  
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 3.2.3.3  Infrared Spectroscopy FTIR analysis  
The FTIR spectrum of the gelatin /hydroxyapatite scaffold are shown in Figure below. In order to 
obtain information on chemical interaction between organic and inorganic phase, the analyses were 
made on two section of B10_HA30 scaffold: superior (up) and inferior (down) ones. 
As reported in the figure 8, C = O stretching was distributed at 1630-1695 cm
-1
 for the amide I,   N-
H deformation at 1500-1550 cm
-1
 for the amide II [24,25]. The phosphate band is between 900 and 
1200 cm
-1
, and typical peaks of phosphate vibration is at 1019 cm
-1
; peaks for CO3
2-
 vibration mode 
are appeared at the positions of 740, 840, 876 cm
-1
.  
 
 
Fig. 8: FTIR analysis of superior (up) and inferior (down) sections of B10_HA30 scaffold. 
  
 
 3.2.3.4  Mechanical test 
Young’s modulus (E) was determined from static, unconfined compression tests carried out at 25°C 
in aqueous environment. Higher temperatures were not used because the majority of the gels were 
not adequately stable above 25°C for such test methods. In controlled-deformation mode, samples 
were continuously compressed at a rate of 10% of swelled sample height (mm/min) from an initial 
preload force (0.01 N), up to 75% of swelled sample height. 
Mechanical properties are important not only to understand the scaffold behavior, but also to obtain 
information on the crosslinking reaction. This information is derived by Young’s modulus values. 
The data in figure 9 and Table 3 represent the mean values (standard error of the mean) of E, where 
is clear the difference between samples obtained by gelatin type A, and type B; moreover 
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B10_HA20 scaffold compressive modulus (209,183±18.113 KPa) is several magnitude orders 
higher than the other. 
 
 
 
 
 
 
Table 3: Modulus E (KPa) and standard deviation of gelatin/hydroxyapatite scaffold. 
 
 
Fig. 9: Diagram of compression modulus E (KPa) relative to gelatin type A/HA (left)                                  
and gelatin type B/HA (right). 
 
 
 3.2.3.5 Biological test 
Only preliminary biological studies were performed on HAGEL scaffolds. The cell proliferation at 
short time on the different materials (A10_HA20 – A10_HA30 – B10_HA20 – B10_HA30) were 
assessed using Alamar Blue test. Figure 10 shows the effect of the gel materials on the metabolic 
activity of MG63 after 1, 3 and 7 days of culture. According to the data, it can be found that a good 
proliferation was observed for scaffolds at low presence of hydroxyapatite nanoparticles. 
Meanwhile, a reduced proliferation was observed  for materials at HA30%. This behavior was 
explained by a probably increased rate of differentiation of MG63 adhering on the surface of 
scaffold due to more presence of bioactive signals.  
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Sample 
 Modulus 
(KPa) 
Std. Dev. 
A10-HA20 7,0 0,4 
A10-HA30 5,5 0,5 
B10-20 209,2 18,1 
B10-30 19,0 2,9 
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Fig. 10: Alamar Blue asay of all gelatin/hydroxyapatite scaffolds after 7, 14 and 21 days of cell culture. 
 
 
3.2.4 Discussion 
Porous gelatin/hydroxyapatite scaffolds with different gelatin type and inorganic contents, were 
prepared by in situ sol-gel approach and freeze–drying process. As reported in literature [26,27] 
hydroxyapatite should improve the osteogenic differentiation while gelatin should increase the 
chondrocyte proliferation. The aim is create an HA gradient into the scaffold section, in order to 
modulate biological signals. To evaluate homogeneity/ gradient of the inorganic component 
distribution, scaffolds were evaluated by morphological and thermogravimetric analysis.  
SEM images show that inorganic phase into the sample, display a rough surface. Moreover is 
possible to distinguish a completely different morphology on the longitudinal direction: plate-like 
crystals is evident only in the figures 3 C and E. In all images, EDS analyses show that Ca/P ratio is 
very close to hydroxyapatite one (1.67). By sol-gel transition in gelatin solution combined with      
freeze-drying, it possible to obtain a tridimensional gelatin structure completely covered by 
hydroxyapatite crystals. As shown by SEM, and confirmed by TEM, the crystal shape depend on 
HA/GEL ratio. Based on the TEM results, the average of nHA crystalline decrease with gelatin 
presence (as show in figure 4). This may be caused by different intensities of interactions between 
ions; with adding Gel, the abundant supply of COO
-
 coordination sites available for complexation 
with Ca
2+
 ions leads to a very large number of nuclei for the growth of nHA crystalline so that these 
crystalline cannot grow very large [28]. 
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The charged density is fixed in gelatin structure, that is to say the number of nucleation sites is  
uniformly distributed, therefore the size/shape of nHA crystalline depended on the rate of 
crystalline growth, or rather  [Ca
2+
] [PO4
3-
] concentration [29]. Higher [Ca
2+
] and [PO4
3
] lead to the 
rate of crystalline growth accelerated [29].  
In our case, the [Ca
2+
][PO4
3-
] distribution into the solution is inhomogeneous in longitudinal 
direction due to a CaP gradient in the structure: for this reason, in the part where HA presence is 
lower (figures 3B,D), crystals growth slowly and nHA crystalline decrease. Indeed in the part where 
HA presence is higher (figures 3C,D), typical hydroxyapatite plate-like crystals is evident.                 
For this reasons, in the B10_HA20 samples, the higher gelatin (80% w/w) leads the interaction 
between COO
- 
and Ca
2+
 and reduces the crystalline growth. As confirmed by SEM image (figure  2) 
the gelatin structure is completely covered by hydroxyapatite, but the CaP deposition have not the 
plate-like crystal shape (as in the case illustrate in the figure 3B). 
The thermogravimetric plots of the composite scaffolds were used to determine the inorganic phase 
content, which was evaluated from the residual weight of the samples. The experimental data, 
reported in tables 1 and 2, show that in B10_HA20 the inorganic phase content is uniformly 
distributed into the scaffold, and confirm HA gradient in the B10_HA30 sample. HA residual% 
calculate by residual value are very close to the original amounts of calcium phosphate used to 
prepare the scaffolds. Moreover in the B10_HA30 sample the HA gradient is verified by gradually 
HA% reduction ( 27,9 – 17,2 – 5,5%) into the longitudinal section (table 1).  
In order to evaluate the thermal stability and the phase transformation, TGA of inferior section 
B10_HA30 scaffold was reported in the figure 7. The first endothermic region shows (in the deriv. 
weight curve) different peaks, which correspond to three phenomena: the first is the loss of water 
molecules that interacted with free carboxyl acid and amino acid presents in the gelatin, by 
hydrogen bonding (50-162.1°C); the last two, are the loss of dehydration of the precipitating 
complex and the loss of physically adsorbed water molecules of the hydroxyapatite powder (162.1-
255.7°C). These phenomena occur since 300°C, and partially fall in the gelatin degradation range 
(250- 550°C). Moreover, it can be explained by the following reaction:    
Ca10(PO4)6(OH)2 -> Ca10(PO4)6(OH)2-2xOxHx + xH2O  [30, 31] 
The exothermic dissociation of CO3
2– 
is reported [32, 33] to occur at the temperature range between 
500 to 900°C in nitrogen atmosphere.  
The magnification in the diagram 5 (B10_HA30) shows a different behavior in a gelatin 
degradation zone. As reported in literature [34] at this gap, corresponds the degradation of non 
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crosslinked organic phase. So, as will be demonstrate below, it is related with crosslinking 
efficiency. 
The FTIR spectrum of superior (up) and inferior (down) section of gelatin B10%w/v and 30 wt% 
HA composite, are shown in figure 8. The composite spectrum are similar to the spectra of real 
bone [2,35,24]. As reported in literature [22], the band at 1337 cm
-1
 in gelatin B is attributed 
predominantly to the so-called wagging vibration of proline side chains. Therefore, this band does 
not simply represent the carboxyl group, but it is one of a number of bands in the range of         
1400-1260 cm
-1
 which are attributed to the presence of gelatin type-I [24,36]. The peak at        1337 
cm
-1
 band in gelatin shifts at 1400 cm
-1
 in gelatin/hydroxyapatite composite; it has been effectively 
used to confirm the chemical bond formation between carboxyl ions in gelatin and HA phases 
[24,37-38]. During the process of HA-GEL composite, the Ca
2+
 ions will make a covalent bond 
with R-COO
-
 ions of GEL molecules. 
The appearance of an amide I mode indicated that HA-GEL composites adopt a predominantly α-
helical configuration and this is confirmed by the appearance of amide II at ~1540 cm
-1
 [22,38,39]. 
The strong COO
-
 peaks at 1638 cm
-1
 in gelatin move to higher wavenumber at 1651–1655 cm-1 in 
all nH/Gelatin samples due to the Ca
2+
 ions coupled with the COO
-
 through electrostatic interaction 
[40] and the intensity increase with the enhancing of HA content. Infact, peaks at 1422 cm
-1
 in 
B10_HA30 (down) shift to lower wavenumber at 1409 cm
-1
 in B10_HA30 (up); this indicated that 
there are a kind of chemical interactions between the calcium ions and the COO
-
 in gel [28,41,42].  
The intensity of phosphate and CO3
2-
 vibration, suggests the presence of different hydroxyapatite 
amount into the scaffold. In general the process to obtain crystalline hydroxyapatite is more 
complex. It is usually held that the initiation of the mineral crystalline during tissue calcification is 
caused by heterogeneous nucleation [44,45]. The above results demonstrated that the nucleation of 
nHA crystalline on the gelatin surfaces is critically dependent on the charged functions groups that 
existed in the gelatin, e.g. negatively charged COO
-
  and/or C=O groups and positively charged 
amino groups. That is to say the COO
-
, C=O and amino groups offer the nucleation sites for HA 
crystalline through binding or chelating oppositely charged ions, calcium and phosphate [46,47]. 
Therefore, there is a heterogenous nucleation and growth of nHA on the gelatin in-situ. At first, 
calcium ions enrich on the carboxyl groups and amino groups Gel in the solution, and then PO4 
3-
 
enrich on the amino groups of Gel or at the calcium complexes, all these enrichments may be 
attributed to electrostatic interaction or/and polar interaction [28]. In our case are absent typical 
peaks of amino groups and PO4
3-
 interaction, as reported by Yao et al. [28]. Secondly heterogenous 
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nucleation of nHA enrich with Ca
2+
 and PO4 
3-
 at pH 11. Finally nano-crystalline of HA growth, 
stirring at 85 rpm at 40°C for 24 hrs. 
To evaluate mechanical properties and correlation between compression modulus and crosslinking 
efficiency, all the samples were tested in an aqueous environment, after soaking in distilled for 1h. 
As demonstrated  by Goudarzi et al. [22] the compressive modulus of HA-GEL scaffolds should 
increase with HA content. In our case the behavior is inverted (figure 9 and table 3); this could be 
explain by a reduced of crosslinking treatment. Gelatin-hydroxyapatite scaffolds were realized in 
order to promote interaction between COO
-
 of gelatin, and Ca
2+ 
of HA, as previously demonstrated. 
Moreover, crosslinked treatment by EDC, involves COOH of gelatin, and NH2 of carbodiimide. In 
each steps, were taken in consideration gelatin carboxyl groups. SEM/TEM have demonstrated high 
HA presence into the structure. As already explained, the inorganic phase is very relevant in the 
system, so as to create a plate-like crystals, typical of crystalline hydroxyapatite in the zone of 
maximum HA gradient (B10_HA30 samples). Probably, gelatin carboxyl groups were saturated to 
have higher gelatin/hydroxyapatite interaction; so in the following step (crosslinked treatment) there 
were few free COOH groups to permit a good crosslinking. In this perspective, increasing HA 
content, crosslinking efficiency decrease, as also the mechanical properties. Indeed there is a clear 
difference between samples obtained by gelatin type A, and type B; moreover B10_HA20 scaffold 
compressive modulus (209,183±18.113 KPa) is several magnitude orders higher than the other. It 
could be depend on carboxyl group content of different gelatin types; as reported [37,43], gelatin A 
contains 77 COOH per 1000 amino acids while gelatin B contains 118 COOH per 1000 amino 
acids. So probably in the B10_HA20 the total calcium phosphate amount isn’t necessary to saturate 
gelatin carboxyl group, and the crosslinking treatment success. Moreover, gelatin type A has low 
number of carboxyl groups, so as to saturated all of them whit both calcium phosphate 
concentration (20 – 30%). Another date to confirm this theory, is the image of samples after 1h in 
water. 
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Fig. 11: Photo of crosslinked GEL/HA scaffolds dry, and wet (after 1h  in distilled water). 
 
In gelatin/hydroxyapatite scaffold, increasing inorganic phase and decreasing carboxyl group 
(content in polymer typology), success of crosslinking by EDC drastically decreases and 
consequently compression modulus is very low and swelling behavior after 1h (short time)  is very 
relevant. This result is demonstrated also by TGA analysis, and in particular in the magnification 
present in the figure 5. Infact, as said before, the gap corresponds to the non crosslinked organic 
phase, and this is relevant in a scaffold section whit high HA present. 
In accordance with biological preliminary tests, the material are nontoxic, not affecting the cell 
proliferation and shows good biocompatibility. 
 
 
3.2.5 Conclusions 
Porous gelatin/hydroxyapatite scaffolds with different gelatin type (A and B 10%w/v) and inorganic 
contents (20 and 30 %w/w), were prepared by in situ sol-gel approach, and then freeze–drying the 
composites. In our work we have demonstrated that, by an opportune GEL/HA ratio (B10_HA30 
and A10_HA30), is possible to create an HA gradient into the scaffold section, as confirmed by 
morphological (SEM), thermal (TGA) and chemo-physical (FTIR) analyses. Moreover during the 
process, the Ca
2+
 ions will make a covalent bond with R-COO
-
 ions of GEL molecules, determining 
reduced nHA dimension.  Due to the hydroxyapatite gradient, the [Ca
2+
][PO4
3-
] distribution into the 
solution is inhomogeneous in longitudinal direction: for this reason, in the part where HA presence 
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is lower, crystals growth slowly and nHA crystalline decrease. Indeed in the part where HA 
presence is higher, typical hydroxyapatite plate-like crystals is evident.  
Moreover, also the crosslinking treatment by EDC solution, was investigated. Thermal (TGA), an 
mechanical analyses show that in gelatin/hydroxyapatite scaffold, success of crosslinking by EDC 
depend on number of carboxyl group (content in polymer typology) and inorganic phase amount. 
Biological test performed by MG-63, demonstrates nontoxicity and good biocompatibility of the 
materials.  
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Conclusions of chapter 3 
Tissue engineering strategies rely on the use of cells, bioactive factors, and scaffolds or 
combinations thereof. Complex tissues must be engineered with the structural and functional 
characteristics of native tissue in a process that is not only biocompatible but also interactive and 
integrative with neighboring tissues simultaneously. In our case, osteocondral region has a 
distinct tissue (bone and cartilage) with different physic, mechanic, morphology and biology 
characteristics. The extracellular matrix of bone has been described as a composite material 
composed of collagen type I fibrils mineralized with nanocrystals of hydroxyapatite. To mimic 
natural structure, we propose a gelatin (denatured collagen) scaffold biomineralized by nHA. 
The introduction of biological signals (hydroxyapatite) was realized by bulk sol-gel transition 
and surface biomimetic treatment.  
In this chapter, we propose two systems: 
3. Gelatin scaffold crosslinked by EDC solution, and biomineralized by accelerate Kokubo 
treatment; 
4. Gelatin/hydroxyapatite scaffold realized by in situ sol-gel synthesis and crosslinked by 
EDC solution. 
 
In the first structure (1) the matrix is constituted by natural polymer and biological signals (nHA) 
create a coating on the porous surface. In a Kokubo treatment, the HA crystalline depend on 
treatment time: in our systems, after 7 days, there is a sufficient HA crystalline phase to obtain 
an increasing of osteogenic proliferation and differentiation. 
In the other system (2), indeed, the matrix is a combination of gelatin/hydroxyapatite, where the 
biological signals are present into the scaffold as a gradient. The chemical interaction between 
Ca
2+
 and COO
-
 involves a polymeric matrix completely covered by nHA crystalline. In this case 
the crystalline degree is modulated by gelatin/hydroxyapatite ratio (different into the scaffold 
due to the presence of inorganic phase gradient): where [Ca
2+
][PO4
3-
] concentration are higher, 
typical hydroxyapatite plate-like crystals is evident.  
Moreover, our results show the crosslinking treatment (by EDC) successes (1), and its 
dependence on gelatin type and gelatin/hydroxyapatite ratio (2). 
 
In summarize, the two gelatin/hydroxyapatite systems could have a great potential application as 
filler in osteocondral repair and regeneration. 
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Conclusions and future work 
 
n this work  three injectable systems were proposed as  bone-filler (Strontium-substituted 
hydroxyapatite cement, Bioactive hydroxyapatite - graphene oxide, Modified-cellulose 
hydrogels crosslinked by citric acid) and two different   gelatin scaffolds biomineralized by nHA. 
All these systems could have different medical applications, such as: osteoporosis therapy; filler 
for different (in terms of dimension and shape) bone/osteochondral defects caused by tumor 
removal, fractures or congenital defects; carrier to growth factors or pharmacy; detection 
systems; antitumor therapy; or as  multifunctional systems. 
Our research demonstrated that specific nanoscale structure of the injectable material’s surface 
has significant positive effects on osteoblast cell response, including initial cell growth and 
expression of differentiation markers (such as OPN, OCN). Moreover, gel systems support high 
viability of hMSC cells and have a good effect on cell attachment, proliferation and osteoblastic 
differentiation. A promising increase of osteogenic proliferation and differentiation has been 
observed in gelatin scaffold crosslinked by EDC solution and biomineralized by modified 
Kokubo treatment. 
Another important result is the presence of biological signals (HA) gradient into the 
gelatin/hydroxyapatite scaffold realized by in situ sol-gel synthesis. This systems could have a 
great potential application as filler in osteocondral repair and regeneration, allowing a 
simultaneous regeneration of both cartilage and subchondral bone. In that case an osteogenic 
differentiation should increase with the gradient, meanwhile the chondrogenic differentiation 
should decrease inthe same direction. For this aim, as future work we propose a gene 
expression analysis of bone-related markers as osteopontin (OPN) and osteocalcin (OCN) and 
cartilage-related markers as callagen (COL II) aggregan or SOX9. 
 
The distribution and size of the pores, as well as the nano/macro-surface structure, might play 
an important role for osteogenic and chondrogenic differentiation in vitro (as reported in this 
work)  and in vivo. However, future studies will have to identify the relevant parameters of the 
scaffolds and injectable systems to optimize in vivo study. 
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